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Raised intracranial pressure (ICP > 20 mm Hg) occurs in at least thirty
percent of severely head injured patients and is associated with a
significant increase in the number of deaths and severely disabled
survivors. A study of the ICP waveform may yield information of
relevance to the management of raised ICP either as a predictor of raised
ICP or of its underlying cause.
The first section of this thesis describes pilot clinical studies, aimed
at determining the practicality of applying waveform analysis techniques
to the ICP waveform in head injured patients. Following on from the pilot
studies, an observational study in thirty severely head injured patients
was designed and carried out, where fifteen hundred ICP and blood
pressure (BP) waveform samples were collected under microcomputer
control. The waveform samples were analysed through the use of spectral
methods in a systems analysis approach to quantifying pressure
transmission across the cerebrovascular bed. The amplitude transfer
functions, as a measure of cerebrovascular pressure transmission, were
calculated for the first 6 cardiac harmonics from the ICP and BP spectra
and were found to cluster into four classes: those with an overall flat
amplitude transfer function (curve type 1), those with an elevated low
frequency response (curve type 2), those with an elevated high frequency
response (curve type 3) and those exhibiting both an elevated low and an
elevated high frequency response (curve type 4). Curve types 2 and 4
(elevated low frequency, elevated low frequency in combination with
elevated high frequency) were most often associated with raised ICP {ICP
> 20 mm Hg) whereas curve types 1 and 3 (flat, elevated high frequency)
were most often associated with ICP less than 15 mm Hg.
The interpretation of the data from this study was restricted as
concurrent measurements of craniospinal compliance and cerebral blood
flow (CBF), as a measure of cerebrovascular resistance, were not
performed. To aid in the interpretation of these clinically observed forms
of cerebrovascular pressure transmission, an experimental investigation
into the relationship between cerebrovascular resistance, craniospinal
compliance and cerebrovascular pressure transmission was undertaken.
Before such an experimental study could be carried out an improved
method of measuring craniospinal compliance was needed. Existing
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measures of lumped craniospinal compliance such as the volume pressure
response method (VPR) were considered too variable chiefly as a result
of the manual injection method. The VPR technique was modified from a
manual to an automatic injection sequence using an electronic square wave
pressure generator to produce a small (0.05 ml), exact and reproducible
transient volume increase into the CSF space. Compliance was calculated
from the amplitude of the intracranial pressure response to this volume
increment. The ICP response was time-averaged using a biological signal
averager which facilitates separation of the pressure response from
background noise. The new method was validated against the VPR method
in physical and animal models, where it accurately followed compliance
changes and demonstrated significantly less variation between
measurements then the VPR method.
The experimental studies were then performed in animal models of
raised ICP, arterial hypercarbia and arterial hypertension, using the
improved compliance technique. The data obtained from those studies
were an aid to the interpretation of the four forms of cerebrovascular
pressure transmission that were observed in the clinical studies.
A flat amplitude transfer function (curve type 1) indicates equal
transmission of all harmonics of the arterial pressure waveform through
to the CSF space and was found in the experimental studies associated
with ICP less than 15 mm Hg and with normal craniospinal compliance,
normal cerebrovascular resistance and a negative fundamental phase shift.
This form of cerebrovascular pressure transmission may characterize a
functionally normal cerebrovascular bed.
An elevated low frequency pressure transmission (curve type 2) either
solely or in combination with an elevated high frequency pressure
transmission (curve type 4) was associated with raised ICP above 20 mm
Hg. Experimentally, this form of pressure transmission was found whether
ICP increased through intraventricular infusion of fluid or through
inhalation of 5% C02. Associated with these changes, both craniospinal
compliance and cerebrovascular resistance were usually decreased in
conjunction with a more negative fundamental phase shift when compared
to curve type 1. The curve type 2 form of cerebrovascular pressure
transmission seen in patients is indicative of raised ICP, reduced
craniospinal compliance, reduced arteriolar vasomotor tone and increased
vasomotor compliance.
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In the clinical study, the amplitude transfer function curve type 3
(elevated high frequency) was associated with a positive fundamental
phase shift and ICP below 15 mm Hg. From the experimental data a
positive phase was exclusively associated with the post arterial
hypertension stage of the arterial hypertension group of animals where
ICP had decreased to below 10 mm Hg in conjunction with an abnormally
high craniospinal compliance. This combination of factors may indicate a
generalized cerebral vasodilation.
This work should be extended by a further clinical study using on¬
line minute by minute analysis of the ICP and BP waveforms in order to
study cerebrovascular pressure transmission with regard to the
development of raised ICP in head injured patients.
X
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PREFACE
In Britain, severe head injury occurs in 150 per million people per
year, with the majority being under 25 years old. Raised intracranial
pressure (ICP > 20 mm Hg) occurs in at least 30 percent of these patients
and is associated with a significant increase in the number of deaths and
severely disabled survivors. The higher the level of ICP, the greater is
the morbidity and mortality with virtually no survivors when ICP exceeds
50 mmHg. Elevations in ICP can rapidly cause cerebral ischaemia and
irreversible brain damage. The prediction of imminent rises in ICP
coupled with determination of the probable underlying cause is of primary
importance if the rapid matching of appropriate treatment with cause of
raised ICP is to be successful.
A study of the ICP waveform may yield information of relevance to the
management of raised ICP either as a predictor of raised ICP or of its
underlying cause. Towards this end, the first section of this thesis
describes pilot clinical studies, aimed at determining the practicality of
applying waveform analysis techniques to the ICP waveform in head
injured patients and other patients at risk of developing raised ICP. This
section also describes the basic methods and technical development
required to carry out these studies. The results obtained from these
clinical investigations posed questions that required testing in
experimental waveform analysis studies. These were aimed at developing
an improved understanding of the physiological relationship between
cerebrovascular resistance, craniospinal compliance and pressure
transmission across the cerebrovascular bed. The middle section of this
thesis describes the technical development and experimental validation of
an improved method of measuring craniospinal compliance, a development
required by the design of the proposed experimental work. The design
and results of these experimental waveform analysis studies are described




The field of intracranial pressure (ICP) research is a wide ranging
one, and, to date, has been the subject of seven international symposia
embracing such diverse disciplines as neurosurgery, anaesthesia,
radiology, biophysics, electronic and mechanical engineering, mathematics
and computer science. There is an extensive literature on ICP.
Consequently this introductory chapter contains only a limited review of
the historical and current concepts behind analysis of intracranial
pressure and craniospinal compliance that are of direct relevance to this
thesis.
A. Relevant Anatomy of the Craniospinal System
The craniospinal system (Figure 1) comprises brain, spinal cord,
cerebrospinal fluid (CSF), blood and its containing vasculature, and is
enclosed within a rigid skull and vertebral column. Neural tissue
accounts for 70% of the total volume; CSF, blood and extracellular fluid
make up the remaining 30% in approximately equal portions of 10% each.
Under normal conditions, three quarters of the vascular blood volume is
contained within the venous system (1). The CSF is contained within the
ventricles and subarachnoid space.
There are three membranous coverings of the brain and spinal cord:
the dura, arachnoid and pia. The dura is a fibrous tissue containing the
craniospinal constituents and in the cranial vault is immediately adjacent
to the inner table of the skull, whereas in the spinal canal it is separated
from the vertebral column by fatty tissue and a venous vascular plexus.
The arachnoid membrane is an avascular layer of connective tissue
bridging the sulci of the brain and spinal cord, thus forming the major
cisterns, the two largest of which are the cisterna magna and lumbar
cistern. The pia is a thin vascular layer accurately following the contour
of the nervous tissue. The subai^achnoid space is the region contained
between the arachnoid and Pia.
There are four interconnecting ventricles. Two lateral ventricles
within the cerebral hemispheres are linked through the inter-ventricular
foramina of Monro into the single mid-line third ventricle, and the
aqueduct of Sylvius connects the third and fourth ventricles. Entry into
the subarachnoid space is made through three openings within the fourth
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ventricle: a medial foramen of Magendie opening posteriorly into the
cisterna magna and the paired foramina of Luschka opening laterally into
the cerebromedullary cistern. Once outside the ventricular system, the
CSF enters the subarachnoid space, circulates through it and exits into
the superior sagittal sinus through the specialized structures in the sinus
wall, the arachnoid villi.
To superior sagittal sinus
Figure 1: The Craniospinal System, (not drawn to scale) Arrows indicate
the direction of flow of CSF. RLV, right lateral ventricle, LLV, left lateral
ventricle; 3V, third ventricle; IF, interventricular foramina; AS, aqueduct
of Sylvius; 4V, fourth ventricle; FL, foramen of Luschka, FMg, foramen of
Magendie, CC, central canal.
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B. Literature Review of Intracranial Pressure and Craniospinal Compliance
1. History
The history of this subject (2,3,4) starts from the doctrine named after
Monro (5) and Kellie (6), which proposed that the brain and its contained
blood were incompressible, enclosed in a rigid and inextensible skull, of
which the total volume remained constant. In its original form the Monro-
Kellie doctrine did not take into account the CSF as a component of the
cranial compartment. The concept of reciprocal volume changes between
blood and CSF was introduced in 1846 by Burrows (7) and later extended
in the early twentieth century by Weed et al (8,9) to allow for reciprocal
changes in all the craniospinal constituents.
Kocher (10) in 1901 translated into clinical terms the four stages of
cerebral compression proposed almost 25 years earlier by the experimental
studies of Duret (11). Kocher described four stages of cerebral
compression related to the expansion of intracranial brain tumours. In
stage 1, the initial increase in tumour volume is compensated by a
reduction in volume of the other intracranial components, chiefly CSF and
venous blood. This spatial compensation results in no net increase in
intracranial volume or pressure and hence no clinical symptoms. In stage
2 the compensatory mechanisms are exhausted, ICP increases and the
patient becomes drowsy with headache. Stage 3 is characterized by a
considerable increase in ICP, an associated deterioration in conscious
level with intermittent elevations of blood pressure (BP) accompanied by
bradycardia. In the fourth and final stage, the patient is unconscious,
with bilateral fixed dilated pupils and falling BP usually leading to death.
Cushing (12,13,14), then a research worker for Kocher, described in
both experimental and clinical studies the close relationship between
increases in ICP and BP and proposed that the BP rose in order to
maintain adequate blood supply to the hind brain, the stimulus to this
vasopressor response believed to be medullary ischaemia (15,16).
At about this time a false confidence developed in the lumbar CSF
pressure technique (lumbar puncture) which caused Cushing's findings
to be challenged. Reports emerged (17,18,19) that some patients showing
clinical signs of brain compression had normal lumbar CSF pressures and
that in other patients elevations in BP were found at times when ICP was
well below the level of BP.
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Partly because of this apparent dissociation between ICP and clinical
symptoms, emphasis switched away from ICP measurement towards the
relationship between craniospinal volume and pressure, particularly the
importance of the elastic properties of the craniospinal system. Ayala
(20,21) studied the fall in lumbar pressure which occurred when CSF was
removed from patients, describing the degree of decline in terms of the
volume of CSF removed and the "elasticity" of the meninges. "Ayala's
index" developed from this work and is defined as the fall in pressure
divided by the volume of fluid removed. This index was found to be low
in patients diagnosed with benign intracranial hypertension and high in
patients with cerebral tumours.
Weed, Flexner and Clark (22,23,24,25) systematically studied the effect
of hydrostatic columns on the elastic properties of the craniospinal system
by observing the pressure and volume changes during up/down head
tilting experiments in animals. They defined a coefficient of elasticity
based on Hook's law (Eo = stress/strain) which failed to show any change
under a variety of experimental conditions. Their work was critically
reviewed by Massermann who carried out similar studies in patients
(26,27). Ryder (28) was the first to characterize the craniospinal volume-
pressure relationship as a non-linear quantity describing it as a
hyperbolic function which implies an increase in elastance as pressure
increases. This was in conflict with the work by Weed and co-workers
although the latter group only studied the elastic properties over a
limited physiological pressure range. Furthermore, it was also partly the
work of Ryder (29) which restored confidence in intracranial pressure
measurement by demonstrating a differential pressure between
intraventricular and lumbar CSF pressure recording. This phenomenon
was reported as early as 1895 by Bayliss (30) who noted it was impossible
to obtain valid ICP measurements below the tentorium during later stages
of progressive supratentorial brain compression.
It was not until the 1960's when Lundberg (31) published his now
classic monograph that interest in clinical ICP measurement was rekindled.
Using ventricular fluid pressure recording in brain tumour patients,
Lundberg was the first to delineate the frequency with which raised ICP
occurs clinically, at times reaching pressures as high as 100 mm Hg.
Lundberg also described three types of spontaneous pressure wave
fluctuations: "A" waves or plateau waves of large amplitude (50 - 100 mm
6
Hg) with a variable duration (5 - 20 min.), "B" waves which are smaller
(up to 50 mm Hg), sharper waves with a dominant frequency of 0.5 - 2 per
minute, and finally "C" waves which are small (up to 20 mm Hg) rhythmic
oscillations with a frequency of 4 - 8 per minute.
This work was then extended to include head injuries (32,33),
intracranial haemorrhage (34), post-hypoxic brain damage (35) and benign
intracranial hypertension (36). ICP can therefore increase under an
assortment of experimental and clinical circumstances, the frequency often
being underestimated by the lumbar pressure recording technique. This
phenomenon of pressure underestimation was fully defined by Langfitt
and co-workers (37,38) in experimental studies of extradural brain
compression where progressive loss of transmission of ICP across the
tentorial hiatus occurred, with the pressure in the posterior fossa and
lumbar subarachnoid space progressively under-reading the ventricular
pressure and eventually returning to normal pressure.
Some of the most important work at this time was also carried out by
Langfitt's group (39) who redefined Kocher's four stages of cerebral
compression under controlled experimental conditions in Rhesus monkeys
with simultaneous measurement of arterial and intracranial pressure,
jugular or sagittal sinus pressure, cerebral blood flow (CBF) and
measures of brain metabolism. They defined stage 1 as the period of
spatial compensation, with very little increase in ICP despite slow inflation
of an extradural balloon. Electroencephalogram (EEG), CBF and brain
oxygenation were normal and stable at this time. Stage 2 occurred at the
end of spatial compensation and was characterized by an exponential
increase in ICP with a steady extradural balloon inflation rate. Towards
the end of this stage, ICP increased by more than 15 mm Hg with 0.1ml
injections into the extradural balloon, and spontaneous increases in BP
occurred which initiated further increases in ICP. Further waves of
increased ICP could be triggered at this time by hypercapnia and
hypoxia. In stage 3, ICP was approaching the level of BP with the
vasomotor reflexes becoming less effective in driving BP up above the
ICP. EEG slowed and became flat as ICP reached the level of BP. At this
stage, altering the arterial concentration of carbon dioxide (PaC02) had
no response, an effect which Langfitt termed vasomotor paralysis. Also
at this stage induced changes in BP produced almost identical changes in
ICP. Deflation of the balloon at this stage could cause a return of ICP to
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normal levels, with a partial return of EEG. If balloon inflation continued,
stage 4 was entered where decompensation was irreversible, BP dropped
and death followed. Deflation of the balloon at this time resulted in only
a temporary fall in ICP.
2. Current Concepts
Following on from this earlier work, the research carried out in the
1970's and early 80's provides much of the basis for our current concepts
of intracranial pressure and craniospinal compliance.
Marmarou, interested in CSF dynamics in relation to the pathological
state of hydrocephalus, was the first to provide a full mathematical
description of the craniospinal volume-pressure relationship. Marmarou
(40) developed a mathematical model of the CSF system which produced a
general solution for the CSF pressure. The model parameters were
subsequently verified experimentally in an animal model of hydrocephalus.
As a corollary from this study, Marmarou demonstrated that the non-linear
craniospinal volume-pressure relationship could be described as a
straight line segment relating the logarithm of pressure to volume, which
implies a monoexponential relationship between volume and pressure
(Figure 2). The slope of this relationship Marmarou termed the pressure-
volume index (PVI) which is the notional volume required to raise ICP
tenfold. Unlike elastance (change in pressure per unit change in volume
dP/dV), or its inverse, compliance (change in volume per unit change in
pressure dV/dP), the PVI characterizes the craniospinal volume-pressure
relationship over the whole physiological range of ICP.
The PVI is calculated from the pressure change resulting from a rapid
injection or withdrawal of fluid from the CSF space (Figure 3), and has
found widespread use both clinically and experimentally as a measure of
lumped craniospinal compliance (41,42,43,44,45,46). Any factor increasing
in volume within the craniospinal axis will deplete available compensatory
exchange space (decompensation), reduce compliance and eventually lead
to increased intracranial pressure. Shapiro (47) has found that a PVI
reduced by 80% of control values to be predictive of raised ICP in
paediatric head injury. Tans and Poortvliet (48), also using the PVI in
patients, state that the values of 10 and 13 ml to be key values, with





PVI = notional volume required to raise ICP tenfold.















PVI = notional volume required to raise ICP tenfold.
VPR = elastance (dP/dV) normalized to a 1 ml injection volume.
Po = initial pressure Pp = peak pressure dV = volume injected
Figure 3: PVI and VPR Techniques.
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At about the same time that Marmarou introduced the PVI technique,
Miller and co-workers (49,50) defined a further measure of the
craniospinal volume-pressure relationship, the volume pressure response
(VPR). The VPR, calculated from the intracranial pressure response
resulting from a rapid bolus injection of saline into the CSF space, was
a direct measure not of compliance but of its inverse: elastance. The VPR
technique was in several ways preferable to the PVI technique in that it
was a simpler measure of craniospinal volume depletion, involving none of
the assumptions about the monoexponential nature of the pressure versus
volume relationship inherent in Marmarou's technique. Furthermore, the
VPR increases in value as the patient's condition worsens, which makes
it easier to understand clinically.
Miller pointed out that if there were only a single volume-pressure
curve then no new information would be gained by measuring compliance
or elastance, and a knowledge of absolute ICP alone would suffice in
determining the state of a patient's craniospinal volume decompensation.
However, Miller and co-workers (51,52,53) have shown that the shape of
the volume-pressure relationship changes under a variety of conditions
between patients and within patients at different times and under
different circumstances. In head injured patients, the VPR correlated
better to the degree of brain mid-line shift, as imaged on C-T scan, than
it did to absolute ICP alone. The VPR served as an indicator for surgical
decompression, critical levels being between 3-5 mm Hg/ml (50,54).
Lofgren (55,56,57,58) extended the ICP range over which the volume-
pressure relationship was studied, including a negative pressure range
(relative to atmospheric pressure). In experimental studies in dogs using
spinal block techniques, he showed the volume-pressure curve to be the
sum of two separate curves representing high compliance related to the
spinal portion of the dural sac and a low compliance curve, at elevated
ICP, related mostly to the cranial portion (Figure 4). At the most elevated
ICP, there was a sudden decrease in elastance as ICP approached diastolic
pressure, possibly due to shifting of blood from the vascular bed when
CBF ceased (56).
The importance of vascular factors as a determinant of lumped
craniospinal compliance was shown clearly by the work of Gray and
Rosner (59,60) who showed that, when CBF autoregulation was intact with
cerebral perfusion pressure (CPP) levels greater than 50 mm Hg, there
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Figure 4: Extended Volume-Pressure Relationship (Adapted from Lofgren,
reference 55).
was a linear increase in PVI with increasing CPP. However, with CPP's
below the autoregulatory range, CBF fell progressively followed this time
by increases in the PVI again. This work demonstrates that the PVI is a
complex function of CPP, the direction of the CPP-PVI relationship
dependent on whether CPP is above or below the autoregulatory range for
CBF. Similarly the role of vascular factors in the pathogenesis of raised
ICP was demonstrated by Marmarou (61) who studied the relative
contributions of CSF and vascular factors to raised ICP in head injured
patients, concluding that CSF parameters accounted for only one-third
of the ICP rise after severe head injury, and that vascular mechanisms
may be the predominant factor in elevation of ICP.
Anile and co-workers (62) have demonstrated that compliance is time
dependent showing that the VPR calculated from slow, medium and rapid
bolus injections yields different values. They conclude that lumped
craniospinal compliance can be divided into two components based on the
rate of injection of the volume bolus: physical compliance and
physiological compliance. Physical compliance is a measure of such factors
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as expansion of spinal dura matter and of any minute amount of brain
compression and skull expansion that may occur (63). Physiological
compliance of the intracranial system is related to cerebrovascular
alterations, particularly venous outflow resistance (64).
This data shows that to understand craniospinal pressure-volume
relationships, the dynamic and the viscoelastic properties of CSF, nervous
tissue and vascular factors must be considered. Zee and Shapiro (65),
using a gas bearing electrodynamometer and a linear variable
displacement transducer, measured the relationship between brain
compression force and displacement to study the viscoelastic properties
of the brain. They demonstrated that dogs, made hydrocephalic with
intracisternal injection of kaolin, developed brains which became less stiff
(more compliant) and more viscous than normal brain. They propose that
this weakening of brain tissue may account for the increase in brain
compliance associated with hydrocephalus, although the time course of
these changes is still unknown.
Walsh and Schettini (66) have shown that brain tissue elasticity bears
no relation to lumped craniospinal elastance as measured by the VPR. The
brain elastic response was measured extradurally with a coplanar
transducer recording the brain displacement simultaneous to the pressure
required to cause that brain displacement. The resulting pressure versus
brain displacement relationship is similar to the pressure versus injection
volume relationship previously described. The tangent of this brain
elastic response curve is a parameter GQ which is a measure of brain
tissue elasticity. They have shown in ten dogs in an extradural balloon
inflation model of raised ICP, that the VPR increases with increasing ICP
but Gfl remains unchanged. Upon cardiac arrest, however, the VPR
decreases and G0 increases. They propose that G0 increases due to an ion
shift from the extracellular to the intracellular compartment, leading to
increased intracellular water and hence increased cellular tension (67).
From this work it is clear that a knowledge of a patient's craniospinal
volume-pressure relationship is an adjunct to ICP measurement for
predicting states of raised ICP. However, the use of the PVI or VPR
methods is not without disadvantages. With these techniques there is an
increased risk of infection, usually due to staphylococcus epidermis, with
reported infection rates ranging from 0.5% up to 9% (31,68,69). Other
disadvantages include a risk of provoking secondary pressure rises with
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rapid volume injection through activation of secondary vasodilation
(70,71). Furthermore, variability between measurements is high as it is
difficult to manually inject consistent volumes of fluid rapidly at a
constant rate of injection. As a result an average of repeated measures
is usually required.
As a consequence of these limitations the PVI or VPR tests are not
routinely used in neurosurgical practice. In an effort to find a less
invasive means to obtain this data Avezaat and Van Eijndhoven (70,73)
systematically studied the ICP waveform pulse amplitude (ICPpjs^ as a
measure of craniospinal elastance. The rationale behind this concept is
that with each heartbeat there is a pulsatile increase in cerebral blood
volume, the equivalent of a small intracranial volume injection, and the
ICPplse *s intracranial pressure response to that volume increment and
should therefore be directly related to the craniospinal elastance (dP/dV).
That is, as craniospinal elastance increases (compliance decreases) the
ICPpjse should increase. The observation that as ICP increases so does the
amplitude of the intracranial pressure pulsations is not a new one, having
been first described in 1866 by Leyden (72).
Avezaat and Van Eijndhoven first extended the mathematical
description of the exponential craniospinal volume-pressure relationship
by introducing a constant term Po into the pressure-volume equation
(Figure 5). Primarily for mathematical convenience this term shifts the
volume-pressure curve as a whole up or down its axis which allows
correction for pressure transducer reference position and postural
changes. Mathematically, Po is the pressure at zero elastance (see eqtn.
1 in Figure 5) and must therefore have physiological significance as a
determinant of the normal intracranial equilibrium pressure (Peq).
Lofgren (56) showed that alterations in CVP can shift the pressure-volume
curve up or down its axis which would suggest CVP may be a factor
determining Po.
Avezaat and Van Eijndhoven described the mathematical relationship
between ICPpjse and ICP by substituting the ICP pjse for the elastance
(dP/dV) and pulsatile blood volume for the volume injection (Appendix A).
This relationship was verified in both clinical and experimental studies.
where: p = icp Ve = elastic volume
Peq = equilibrium ICP (addition to total volume)
E1 = Elastic coefficient Po = constant term
V/pQ dVe dVeH
Ve —>
The exponential volume-pressure relationship is described mathematically:
E1 dVe
equation 1) P = Peq e -T Po
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Figure 5: Exponential Volume-Pressure Relationship (Adapted from Avezaat
and Van Eijndhoven, reference 70).
They found the ICPpjse increased linearly with ICP up until a pressure of
60 mm Hg whereupon a breakpoint occurred (Figure 6). Above 60 mm Hg
the ICPpjse increased more rapidly with increasing ICP. They argue that
the breakpoint is a marker for loss of CBF autoregulation, postulating
that onset of vasomotor paralysis causes a decreased arteriolar inflow
resistance which results in an increased phase shift between the inflow
and outflow pulsatile blood volume. This translates to an overall
increased intracranial pulsatile blood volume and will tend to increase the
slope of the ICPpjse versus ICP relationship.
It is assumed the pulsatile blood volume (dV), the input function to the
elastance calculation (dP/dV), is unchanging. This is a tenuous
assumption in severely injured patients some of whom may have
compromised or fluctuating cardiovascular function. As a consequence of
the dependence of the ICPpjse versus ICP relationship on the pulsatile
blood volume, the clinical utility of this technique as a measure of lumped
craniospinal elastance is limited unless a measure of the pulsatile blood
volume can be monitored simultaneously and controlled for in patients.




Figure 6: ICPp]se vs ICP Relationship (Adapted from Avezaat and Van
Eijndhoven, reference 70).
Portnoy and Chopp recognized the importance of measurement of the
input function in an analysis of the ICPpjse and were the first to apply a
systems analysis approach to the ICP waveform (78). Systems analysis is
a technique whereby an attempt is made to define the physical
characteristics of a system using only the system input and output
signals (79). Portnoy's and Chopp's method assumes the BP waveform is
the chief input signal to the cerebrovascular system and the ICP
waveform is the output response to that stimulus. Both BP and ICP
waveforms are converted into the frequency domain by Fourier analysis,
and the resulting frequency spectra are used in the calculation of the
system transfer function. The system transfer function consists of
amplitude and phase components. The amplitude transfer function is a
measure of how much pressure is transmitted through the cerebrovascular
bed at a given frequency. The phase transfer function is a measure of
how much a pressure signal is phase shifted as it is transmitted through
the cerebrovascular bed at a given frequency.
Using these methods, Portnoy and Chopp (81) found, in an experimental
model of raised ICP in cats, that arterial hypercarbia and hypoxia
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produced an increase in ICPpjg? and an increase mainly in the fundamental
of the amplitude transfer function. The changes induced were greater
than those caused by intraventricular infusion of saline to the same ICP
level. The VPR was less during hypercapnia than during intraventricular
infusion at the same ICP level, which suggests that the increase in ICPpjse
is related to arteriolar vasodilation and not to steepening of the
craniospinal volume-pressure relationship.
Extending their model by including analysis of the sagittal sinus
pressure (SSP) waveform in dogs (82), Portnoy et al found that the ICP
waveform and SSP waveform were almost identical, indicating that the
ICPpjse is derived from the cerebral venous bed. With the animals
breathing pure oxygen it was observed that an attenuation of the
amplitude transfer function fundamental occurred in the transmission of
the arterial pulse through to the CSF space under conditions of low ICP
(ICP < 7 mm Hg). They attributed this attenuation to functional
autoregulatory tone of the precapillary cerebral resistance vessels, and
further demonstrated that a flat amplitude transfer function (equal
transmission of all harmonics) can be experimentally induced by
intraventricular infusion of mock CSF or arterial hypercarbia. They
propose that the conversion from an attenuated low frequency
transmission to a flat amplitude transfer function is evidence for reduced
arteriolar vasomotor tone.
Applying these techniques to hydrocephalic dogs, Portnoy et al (83)
found that when ICP was less than 9 mm Hg, there was an attenuated low
frequency transmission from BP to ICP; however, when ICP was greater
than 12 mm Hg a flat amplitude transfer function was present. These
findings in hydrocephalic dogs were identical to non-hydrocephalic
controls, and they concluded that pressure transmission from BP to ICP
in hydrocephalic dogs was determined by the cerebrovascular bed and not
the hydrocephalic process.
Branch (84), also from Portnoy's group, recording the pressure
waveform from a small cortical vein, provided further evidence that the
ICP waveform was derived from the cerebral venous bed by demonstrating
that the ICP and cortical venous amplitude spectra were identical across
a variety of experimental conditions.
Using similar techniques to Portnoy and Chopp, Takizawa et al (85)
have shown that the first four harmonics of the ICP waveform and the
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amplitude transfer function all show a positive correlation to raised ICP
and an inverse correlation to CPP. A distortion factor "k" was used to
show that as ICP increased towards 50 mm Hg the ICP waveform became
more like a sine wave, changing less as ICP continued to increase.
Takizawa (86) also found that cerebrovascular pressure transmission
increased to saline infusion and arterial hypercarbia equally when ICP
was recorded either in the lateral ventricle or in the cisterna magna, but
transmission was attenuated to the lumbar space. This attenuation to the
lumbar space was decreased by saline loading the craniospinal axis. They
propose that the spinal sac functions as a low pass filter to the
conduction of the ICPpjg?
Also using a systems analysis approach to studying cerebrovascular
pressure transmission, but using different methods, Kasuga et al (87)
have demonstrated resonance within the intracranial cavity in dogs. They
randomized pressure pulse transmission into the cranial cavity through
the control of an implanted cardiac pacemaker. Using the carotid pulse
waveform as an input function and the extradural pressure waveform as
the output function, they calculated the transfer function from the
autocorrelation of the input function and the cross correlation of the
input and output functions by means of a least squares method. They
showed that the amplitude transfer function decreased between the
frequencies of 1 and 7 Hz, then suddenly increased to form a marked peak
at about 10 - 15 Hz, whereupon the phase transfer function also changed
from positive to negative. This showed that the lower frequencies of the
pulse wave were suppressed during transmission through the intracranial
cavity and that resonance was present under normal intracranial
conditions. Kasuga et al (88) subsequently showed that with both
extradural balloon inflation and intraventricular infusion models of raised
ICP in dogs, the resonant frequency increased above the control value.
Associated with this increase in resonant frequency, there was an
increased transfer of the low frequency components. However, with
arterial -hypercarbia, ICP increased but with no significant change in the
resonant frequency, although low frequency pressure transmission
increased in a similar fashion to both groups.
Finally, Bray and Robertson (89) using Fourier analysis of the ICP
waveform in patients, identified two main frequency bands in the ICP
waveform power spectrum. The centroid (power weighted average
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frequency) of the low frequency band (0,2 - 2.6 Hz) they correlated to
cerebral blood flow using the nitrous oxide method, while the high
frequency band centroid (4 - 15 Hz) they found inversely correlated to
the PVI as a measure of craniospinal compliance. Further clinical
experience (90) with the high frequency centroid showed that the
percentage of time spent with a high frequency centroid greater than 9
Hz bore no relation to ICP but that the centroid frequency correlated
exponentially to increased mortality. Case reports showed that the high
frequency centroid was a better measure of the clinical state of the
patient than was the absolute ICP alone.
C. Aims
It would appear from this review of the literature that the systems
analysis approach to studying cerebrovascular pressure transmission may
prove to be a powerful aid to the investigation of the pathophysiology
and, of more immediate clinical importance, the prediction of raised ICP.
To date, these reported studies have been performed in experimental
models of raised ICP, but this approach has yet to be applied to patients
in a systematic fashion.
Of the two systems analysis methods reported, the method used by
Kasuga et al (87) is clinically impractical, while the method of Portnoy and
Chopp (78) is unproven in a clinical setting. The primary purpose of the
work described in this thesis is to determine the feasibility of applying
this approach to patients, and in doing so to define the inherent
variability of the pressure transmission characteristics of the
cerebrovascular bed in patients at risk of raised ICP. A secondary aim
of this work, not yet addressed in the current experimental literature, is
to define better the relationship between cerebrovascular pressure
transmission, cerebrovascular resistance and craniospinal compliance, a
knowledge of which may prove of value in the interpretation of the
clinical data.
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CHAPTER II. CLINICAL STUDIES
The aim of this work was to make a series of analytical measurements
of intracranial pressure in head injured patients applying the principles
of systems analysis. To do this required a number of methodological
studies which are also described in this section.
A. General Methods
1. Systems Analysis
Systems analysis is a technique whereby an attempt is made to define
the physical characteristics of a system using only the system input and
output signals (79) (Figure 7). In the present studies, the assumption is
made with this analysis that the cardiac based pulsations of the BP
waveform are the chief input signal ( f(t) ) to the cerebrovascular system
and, similarly, the same pulsations in the ICP waveform are the output
response ( g(t) ) to that stimulus. Both BP and ICP waveforms are
transformed from the time domain into the frequency domain by Fourier
analysis (80) which permits any complex waveform to be described as a
series of simpler component harmonics, consisting of a fundamental or
first harmonic (related to the heart rate frequency) and a series of
higher harmonics at multiples of the fundamental frequency. The Fourier
analysis technique, as applied to systems analysis of cerebrovascular
pressure transmission, will be only summarized in this section. A fuller
description of the analytical method is given in Appendix B. The system
transfer function ( H(w) ) is defined as the relationship that describes
how the stimulus signals are transformed by the system into response
signals. The transfer function consists of amplitude and phase
components. As an example (Figure 7), the first component of the
amplitude transfer function is calculated as the ratio of the first cardiac
component harmonic in the ICP spectrum ( G(w) ) to the amplitude of the
first cardiac component harmonic in the BP spectrum ( F(w) ). This
process is repeated for each of the significant ICP and BP cardiac
component harmonics present in the ICP and BP amplitude spectra. By
similar means, the difference between the ICP and BP phase values (phase
shift) for each of the measured cardiac component harmonics yields the
phase transfer function. The amplitude transfer function is a measure of
how much pressure is transmitted through the cerebrovascular bed at a
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given frequency. The phase transfer function is a measure of how much
a sinusoidal pressure signal is shifted in phase as it is transmitted
through the cerebrovascular bed at a given frequency.
Figure 7: Systems Analysis.
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2. Pressure Measurement
The general criteria of pressure recording accuracy have been well
reviewed by Fry (91), Geddes (92) and Gabe (93). The weakest link in the
pressure recording system is often the catheter-transducer system used
for monitoring pressure. The catheter-transducer system consists of a
pressure transducer and any fluid-filled linkages (needles, tubing, 3-way
taps) that may separate the pressure source from the pressure sensor.
A catheter-transducer system can be described as a second order
mechanical system consisting of a mass of fluid which acts against the
viscous (damping) and elastic properties of the walls of both the catheter
and the pressure transducer dome (94,95).
Hanson and Warburg (95) demonstrated that a fluid-filled catheter-
transducer system, if underdamped, will oscillate at its own natural
frequency and can produce significant pressure waveform amplitude and
phase distortion. The degree of distortion will depend on the damping
factor (13) of the system. The natural frequency and damping properties
of a system can be tested by applying a step or transient pressure to the
input of the system and recording the output pressure response
(Appendix C). This transient response or "pop" test technique can show
that for most purposes a damping factor of 0.64 (optimal damping) is
desirable as the amplitude error will be less than 2% for up to two-thirds
of the natural frequency of the system and the phase lag will be
approximately linear over this range.
Transient response analysis of the fluid-filled catheter-transducer
system used in these studies has shown, from a series of 10 sequential
pop tests', that it is underdamped (13 = 0.310 +- 0.021^) with a resonant
frequency of 21 Hz. Figure 8 shows the configuration of the catheter-
transducer system used for pressure measurement throughout these
studies which consisted of a Medex'' Novatrans strain gauge transducer,
a 30 cm connecting line, two 3-way taps, an acudynamic^ adjustable
'For each of the 10 sequential pop tests a new Medex transducer dome,
Cordis catheter, 3-way tap and Acudynamic adjustable damping device was fitted
to the test apparatus.
'mean +- SD
"Medex Inc., Ohio, USA
^Abbott Critical Care Systems, Chicago, USA
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damping device, and for ICP measurement a Cordis" subdural catheter or,
for BP measurement, typically an 18 gauge 2.25 inch needle. The
acudynamic adjustable damping unit is a device which, when placed in
series with the catheter-transducer system tubing, can be adjusted to
provide an optimally damped (13 = 0.622 +- 0.04") flat frequency response
with minimal amplitude distortion up to 14 Hz (96) (Appendix C). Bench
testing determined the optimal setting of the acudynamic adjustable
damping device for standard lengths and diameters of catheters and
needles used for pressure monitoring throughout this study (Table 1).










Vygon 18g 19.5 Hz 0.298 2 1/4 0.6OO
Vygon 20g 19.4 Hz 0.362 1 3/4 0.667
Cathlon 18g 19.5 Hz 0.286 2 1/2 0.608
Cathlon 20g 19.8 Hz 0.240 2 0.617
Cordis Sub
Dural
21 Hz 0.310 2 1/2 0.622
Test Conditions: — Medex Novatrans transducer
— 30 cm extension tufcnng
— Acudynamic adjustable darrping device
— 2 X 3—way taps




Pressure was also monitored in these studies by Camino' catheter-tip
transducer systems (Figure 9). These fibre-optic devices have at the tip
a semi-rigid membrane with a mirrored surface. This membrane deflects
as pressure is applied to it. A source at the other end of the fibre sends
light towards the tip, which is reflected back towards photosensitive cells,
and the amount of light reflected is proportional to the deflection of the
membrane tip and hence the applied pressure. Camino catheter-tip
pressure transducers have a natural resonant frequency well outside our
analysis frequency band and, when used with the appropriate high
frequency research monitors (420 XP), have a flat amplitude frequency
response up to 70 Hz. Table 2 summarizes the static and dynamic
characteristics of the transducer systems used throughout this study.
Table 2: Static and Dynamic Characteristics of Pressure Transducer
Systems. *
Characteristic Medex Novatrans Camino Bentiey Trantec
Pressure Range —50—>400 mmHg —10->250 mmHg -100->300 mmHg
Linearity
l Hysteresis





O3 mmHg/ 0.2 mmHg/ 0.2 mmHg/
Degree C Degree C Degree C
Frequency
Response
DC—>14 Hz DC—>70 Hz DC—>25 Hz
1'Camino Laboratories, San Diego, USA
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Figure 8: Clinical Catheter-Transducer System. A, Medex Novatrans
transducer; B, Acudynamic adjustable damping device; C, 2 X 3 way taps;
D, 30 cm low compliance extension tubing; E, Cordis subdural catheter.
Figure 9: Camino Catheter-Tip Transducer System. A, Camino 420XP high
frequency research monitor; B, Camino catheter-tip ICP transducer.
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3. Data Collection
ICP was monitored subdurally by Camino catheter-tip transducers
using the Camino 420 XP research monitors. Over 80% of ICP recordings
were obtained using the Camino system, whilst the remaining ICP
recordings were obtained using optimally damped Medex fluid-filled
systems connected to Kontron^ Supermon patient monitors. BP was
monitored through radial artery cannulation by optimally damped Medex
fluid-filled catheter-transducer systems connected to Kontron Supermon
patient monitors.
Samples of ICP and BP waveform data were stored to a magnetic tape
by a TEAC^ MR-10 FM cassette analogue data recorder. Data collection was
under automatic microcomputer control using an IBM-XT^1 microcomputer
configured with a general purpose interface bus adapter controlling the
TEAC data recorder. Automatic and manual starting and stopping of the
waveform data collection could be carried out at any time. With each
waveform segment stored to tape, a computer file was created storing the
starting tape count and the time and date of sample collection. Comments
could be entered and stored to the current active computer file at any
time, thus allowing precise annotation of significant events. A flow chart
summarizing the data collection program is contained in Appendix D.
A two channel variable gain amplifier, incorporating a 5th order low
pass filter with a corner frequency of 70 Hz, was designed and built to
allow conditioning of the analogue waveform data prior to digitizing. The
fast roll off filter characteristic (30 db per octave) of this amplifier
limited frequencies higher than 70 Hz from aliasing with the sampling
frequency. A schematic diagram for the amplifier design is contained in
Appendix E. The entire waveform recording system, including pressure
transducers, patient monitors, FM tape recorder and pre-aliasing low-
pass filter, had a flat amplitude frequency response from DC to 70 Hz +-
1 db (DC to 14 Hz +- 1 db with the optimally damped fluid-filled catheter-
transducer system) and a linear phase shift of 0.096 radians/Hz.
Corrections were carried out in software for the linear phase shifts
^Kontron Ltd., Watford, U.K.
"Teac Corp., Tokyo, Japan
10IBM UK LTD., Portsmouth, U.K.
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inherent in the waveform recording system. The frequency analysis of
the waveform recording system is contained in Appendix F.
4. Data Analysis
Waveform data stored to tape was analysed off-line by a microcomputer
based waveform analysis system developed for this project. An Apricot"
XEN-i microcomputer running the 32-Bit 80386 microprocessor at 16 MHz
forms the basis of the system. An enhanced graphics adapter displays
740 X 348 pixel graphics for display of raw and transformed waveform
data. Twenty seconds of concurrent ICP and BP waveform data (8192
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points) is digitized at a sampling rate of 400 Hz using a Data Translation
DT2818 analogue to digital converter (A/D). The DT2818 uses a 12-bit
simultaneous sample and hold A/D converter, which allows 4 channels of
analogue data to be sampled within 5 nanoseconds at a resolution of
1/4096 of the full scale pressure range. Aliasing artifacts are avoided by
restricting the bandwidth of the waveform data using pre-alias filtering
in combination with the technique of four times over sampling (97,100).
Once digitized, the sampled ICP and BP waveforms are displayed
graphically so as to allow a waveform segment free of mechanical and
other non-physiological artifacts to be selected for analysis. A graphics
cursor permits measurement of ICP and BP waveform event amplitudes and
periods prior to spectral analysis. The sampled ICP and BP waveform
segments consist of three main terms: a slow sinusoidal term (0.2 - 0.3 Hz)
linked to respiration rate, a higher frequency term (1 - 3 Hz) linked to
heart rate, and a DC or static pressure term (Figure 10). The DC term,
if not removed prior to spectral analysis, will cause a very large side lobe
in the spectrum to obscure the lower frequency components (80). To
prevent this, the arithmetic mean term of each waveform segment is
calculated and subtracted from each waveform data point value. This
mean rejection algorithm removes the DC term present in the ICP and BP
waveforms while leaving the respiratory component and cardiac component
frequencies unaffected.
"Apricot Computers Ltd., Birmingham, U.K.
"Data Translation Ltd., Marlboro, USA.
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Figure 10: Sampled BP and ICP Waveform Segments. T1 = period of heart
rate, T2 = period of respiration, DC term = static pressure.
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The BP waveform cardiac component systolic peak nearest the apex of
respiration is taken as the starting point for analysis, and the following
4096 points of both ICP and BP waveforms are then selected for spectral
analysis. To improve the accuracy of the spectrum, prior to spectral
analysis, the initial and final 10% of the waveform segment is multiplied
by a Hanning window function (97) which helps to prevent "end effects"
(80) from causing the appearance of large side lobes around peaks in the
spectra.
The standard Fast Fourier Transformation (FFT) algorithm published
by Cooley and Tukey (98) is used for calculation of the discrete Fourier
transform. A 4096 point FFT is calculated on each ICP and BP waveform
segment. The ICP and BP amplitude spectra, calculated from the Fourier
transform (Appendix B), are displayed and a graphics cursor allows
measurement and recording of the amplitude, frequency and phase of the
spectral peaks at each measurable harmonic component in the amplitude
spectrum for both the ICP and BP waveforms. The frequency resolution
of the amplitude spectrum, calculated as the quotient of the sampling rate
and sample number, is 0.098 Hz. Figure 11 shows the amplitude spectrum
of the ICP waveform (including raw waveforms) from a patient with normal
ICP compared with that of a patient exhibiting raised ICP. There is a
large harmonic at the respiratory frequency (0.2 Hz = 12 breaths/minute),
while the largest harmonic is seen at 1.4 Hz (84 beats/minute) which is the
cardiac component fundamental. The higher harmonics are all multiples
of the cardiac component fundamental.
The amplitude and phase transfer functions are then calculated from
the ICP and BP amplitude spectra and raw Fourier transformed data by
standard methods (79) (Appendix B). Only the cardiac component
harmonics in the amplitude spectra are used in the calculation of the
amplitude and phase transfer functions. Figure 12 shows the amplitude
and phase transfer functions from a patient with normal ICP compared
with that of a patient with raised ICP. All software is written in the C
programming language. A flow chart summarizing the data analysis
program is contained in Appendix G.
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A measure often used in describing the amount of variation in a
population is the coefficient of variation (CV) (99):
CV = (sample standard deviation/sample mean) x 100
To assess the variance of the method in the study population, thirty
sequential samples of ICP and BP waveforms were collected from a stable
normotensive, normovolemic head injured patient with normal ICP (ICP <
15 mm Hg). The mean and standard deviation for each of the first 8
cardiac component harmonics were calculated and expressed as the
coefficient of variation. Figure 13 is a plot of the coefficient of variation
for each of the first 8 cardiac component harmonics from the amplitude
and phase transfer functions. For the amplitude transfer function data,
the first 5 harmonics have a coefficient of variation of less than 10%, the
6th and 7th show a variation of between 20% and 30% and the 8th
harmonic shows a variation of greater than 45%. With the phase transfer
function data, only the fundamental phase shows a variation of less than
20%, harmonics higher than the 4th showing very large variation between
repeated measurements. Abrupt changes in phase between the 4th and
6th harmonics, often from a positive to a negative phase (phase cross¬
over), were frequently noted in the patient data and may be the source
of the large variation above the 4th harmonic in the phase transfer
function.
2. Effect of Blood Pressure Measurement Site
Use of the radial artery waveform as a measure of the input signal to
the cerebrovascular bed is not ideal. The abdominal, iliac, carotid,
subclavian and thoracic pressure waveforms have each been used by
previous workers in this field, in experimental studies, as the input signal
to the cerebrovascular bed (78,81,82,101). Both clinical and experimental
studies were performed to determine the effect of different arterial
pressure measurement sites on the amplitude and phase transfer
functions.
a. Experimental Study
In an experimental study in cats, the intraventricular ICP waveform
was recorded through an optimally damped fluid-filled catheter-
transducer system. A Camino catheter-tip pressure transducer was
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placed in the thoracic segment of the descending aorta, through a femoral
cannulation, for measurement of the arterial blood pressure waveform.
Sequential measurements of the amplitude and phase transfer functions
between the BP and ICP measurement sites were obtained during
withdrawal in ten 1.5 cm steps of the arterial catheter towards the
periphery. As a measure of the effect of catheter withdrawal on the
amplitude and phase transfer function harmonics, the mean and standard
deviation between samples collected over the entire withdrawal procedure,
was calculated for each harmonic and expressed as the coefficient of
variation. Figure 14 is a plot of the coefficient of variation expressed as
a function of harmonic number.
With the amplitude transfer function data, the fundamental showed the
least variation (16%), while all higher harmonics showed equal variance
(28% - 33%) to catheter withdrawal. With the phase transfer function
data, only the fundamental phase showed a variation of less than 20%,
while the higher harmonics showed very large variation which increased
progressively with catheter withdrawal.
This data indicates that catheter position does affect the amplitude
transfer function, but independently of frequency; that is, the harmonics
higher than the fundamental are equally affected by catheter position,
with no frequency dependent effects being demonstrated. The
fundamental was affected less than higher harmonics indicating that the
amplitude transfer function calculated using a peripheral BP measurement
site may be biased in favour of the fundamental but by no more than the
inherent variability from repeated measurements from the study
population. In contrast to this, the phase shift is greatly affected in a
frequency dependent manner by catheter position. The phase transfer
function calculated from a peripheral BP measurement site will be



































Figure 13: Coefficient of Variation of the Amplitude and Phase Transfer
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Figure 14: Coefficient of Variation of the Amplitude and Phase Transfer
Functions, from BP Catheter Withdrawal.
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b. Clinical Studies
In one stable normovolemic patient, for a short period during changing
of BP monitoring from the radial to femoral sites, simultaneous radial
pressure waveform and the lower abdominal aorta pressure waveform
(through optimally damped radial and femoral artery cannulae) were
recorded. The amplitude and phase transfer functions (Figure 15)
calculated from both BP measurement sites to ICP (ICP/Aorta, ICP/Radial)
showed very similar configuration, with the ICP/Radial amplitude transfer
function showing overall a marginally greater transfer function at all
frequencies. The phase transfer functions, however, were markedly
different above the fundamental phase, the ICP/Radial phase transfer
function showing a more positive phase than the ICP/Aortic phase
transfer function.
In another patient, after accidental cannulation of the carotid artery
during insertion of a jugular catheter, the carotid and radial pressure
waveforms were simultaneously recorded for a brief period and the
transfer functions from both BP sites and the ICP waveform were
compared (Figure 16). The carotid and radial to ICP amplitude transfer
functions showed similar configuration up until the 5th harmonic where
the carotid/ICP transfer function demonstrated a moderately greater
transfer (< 30%). Similar to the previous patient, however, the two phase
transfer functions were markedly different above the fundamental phase,
the ICP/Radial phase transfer function showing a more positive phase
which increased progressively with frequency, the ICP/Carotid phase
transfer function showing less frequency dependence.
This clinical data indicates there is no marked effect of peripheral BP
measurement site on the first 6 cardiac component harmonics of the
amplitude transfer function. In contrast to this the phase transfer
function above the fundamental phase is greatly affected by BP
measurement site.
With a variation between repeated measurements of greater than 20
percent it may be difficult to define significant changes in the amplitude
transfer function harmonics greater than the 6th and phase transfer
function greater than the fundamental phase. Based on this data the
waveform analysis in this thesis is limited to the amplitude transfer
function up to the 6th harmonic of the cardiac frequency, and the phase
shift of the fundamental alone.
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Figure 15: Amplitude and Phase Transfer Functions Calculated from





















Figure 16: Amplitude and Phase Transfer Functions Calculated from
Simultaneous Carotid and Radial Artery BP Sites.
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3. Effect of Positive Pressure Ventilation
Positive pressure ventilation parameters can affect mean ICP (102,103).
Its effects on the cerebrovascular amplitude transfer function and
fundamental phase shift are unknown. Waveform data from a
normotensive, normovolemic head injured patient with normal ICP (ICP <
15 mm Hg) has been obtained, showing the effects of two ventilation
parameters: inspired to expired ventilation time (I/E ratio) and positive
end expiratory pressure (PEEP).
Figure 17 shows the effects of three levels of I/E ratio (25%, 33% and
50%) and three levels of PEEP (+5, +10, +15 cm H20) on the amplitude
transfer function and fundamental phase shift. It can be seen that both
I/E ratio and PEEP affect predominantly the fundamental in the amplitude
transfer function, where increasing values of I/E ratio and PEEP lead to
increasing transfer of this frequency. Increasing I/E ratio was associated
with a small increase in the fundamental phase shift in a negative
direction. PEEP shows no consistent effect on the fundamental phase
shift. ICP increased from 12 to 14 mm Hg with no change in BP when I/E
ratio was increased. ICP increased from 13 to 14 mm Hg while BP dropped
from 93 to 82 mm Hg when PEEP increased. End tidal C02 (ETC02)
remained constant at 4.1 kPa.
These data demonstrate that I/E ratio and PEEP can affect the
fundamental of the amplitude transfer function and the fundamental phase
shift.
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Figure 17: The Effects of I/E Ratio and PEEP on the Amplitude Transfer
Function and Fundamental Phase Shift.
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4. Effect of Hypocapnia
Experimental data from the work of Portnoy et al (81) and Takizawa et
al (86) indicate that PAC02 affects chiefly the fundamental of the
amplitude transfer function. The effect of PAC02 on the amplitude
transfer function and the fundamental phase shift in head injured
patients is unknown.
Samples of ICP and BP waveforms were recorded from a normotensive
head injured patient with normal ICP (ICP < 15 mm Hg) during
progressive hypocapnia (ETC02 4.1 decreasing to 3.02 kPa) induced by
removal of excess ventilatory dead space.
Figure 18 shows the effect of progressive hypocapnia on the first 6
harmonics of the amplitude transfer function and the fundamental phase
shift. It can be seen that it is predominantly the fundamental and second
harmonics of the amplitude transfer function which are affected by PAC02,
higher harmonics showing little or no response to progressive hypocapnia.
The fundamental phase shift shows no significant response to progressive
hypocapnia. ICP decreases from 13 mm Hg to 11 mm Hg and BP from 92 to
88 mm Hg in response to progressive hypocapnia.
These data demonstrate that ETC02 can affect the low frequency
components of the amplitude transfer function.
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Figure 18: The Effects of Hypocapnia on the Amplitude Transfer Function
and Fundamental Phase Shift.
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5. Effect of Jugular Compression
Obstruction of intracranial venous outflow caused by turning of the
head can increase mean ICP (104,105). The effects of obstruction of
intracranial venous outflow on the amplitude transfer function and
fundamental phase shift in head injured patients is unknown.
Samples of ICP and BP waveform data were recorded from a
normotensive, normovolemic head injured patient with normal ICP (ICP <
15 mm Hg). Four sequential twenty second waveform samples were
recorded both before and during compression of the right jugular vein.
Figure 19 shows the effect of compression of the right jugular vein on
the first 6 harmonics of the amplitude transfer function and on the
fundamental phase shift. Values for each harmonic are expressed as mean
+- standard deviation for the four sequential samples. It can be seen
that it is predominantly the higher harmonics (4th, 5th and 6th) in the
amplitude transfer function which are affected by jugular vein
compression. The fundamental phase shift became more negative with
jugular vein compression. In association with jugular compression, ICP
increased significantly from 17 to 29 mm Hg (P < 0.01)^ and BP increased
from 87 to 90 mm Hg while ETC02 remained unchanged at 4.0 kPa.
These data demonstrate that obstruction to intracranial venous outflow
can affect the higher harmonics of the amplitude transfer function.
^Paired Student's t-test.
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The Effect of Jugular Compression on
The Amplitude Transfer Function
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* P < 0lO1
Figure 19: The Effects of Jugular Compression on the Amplitude Transfer
Function and Fundamental Phase Shift.
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C. An Observational Study in Head Injured Patients
The purpose of this study was to determine whether the systems
analysis method could detect, in head injured patients, any pressure
transmission characteristics of the cerebrovascular bed associated with
raised ICP. In doing so, the inherent variability of cerebrovascular
pressure transmission in the head injured population could also be
defined.
1. Methods
Five minute samples of ICP and BP waveform data from 30 head injured
patients, timed to coincide with clinical recordings by the nursing staff,
were collected to tape, as previously described (page 18). This data was
recorded once every half hour during the monitoring period which ranged
from 2 to 14 days in the head injury intensive care unit.
All patients being ICP monitored had sustained a major head injury
and were sedated (Phenoperidine: 2-4 mg/hour), paralysed
(Pancuronium: 4 mg/hour) and mechanically ventilated with intermittent
positive pressure ventilation. Ventilator and respiratory parameters were
recorded, and were maintained constant during each segment of ICP
recording (ventilation rate = 12 breaths/minute, percentage inspired time
= 25%, percentage expired time = 65% with a 10% pause, peak inflation
pressure = 15 to 20 cm H20, percentage arterial oxygen saturation (Sa02)
> 95%, ETC02 = 3 to 4 kPa). Patients were positioned supine with 10
degrees of head up tilt. Head position was standardized and excessive
flexion or rotation of the neck corrected.
With each waveform analysis the following physiological data were
recorded: ICP, BP, CVP, heart rate (HRT) and core body temperature (Tc).
In addition to each ICP and BP waveform collected, the most recently
sampled arterial blood gas values (PaC02, Pa02, pH) were recorded.
Waveform samples were excluded from the analysis under the following
circumstances:
a) blocked, overdamped or faulty pressure monitoring equipment
(including: catheters, transducers and fluid-filled connecting tubing);
b) samples from patients with major chest trauma;
c) samples within 30 minutes of physiotherapy;
d) samples within 120 minutes of therapy for raised ICP;
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e) samples from patients with a clinical history of peripheral vascular
disease;
f) samples from patients whose age was greater than 69 years.
2. Results
a. Patient Population
The study population consisted of 30 head injured patients (20 males,
10 females) with ages ranging from 6 to 62 years old (median age 23
years). On admission, 27 patients scored 8 or less on the Glasgow Coma
Scale (GCS), 2 patients were GCS 9-12 and 1 patient was GCS 13-15.
Computerized Tomographic (CT) scans showed that twenty patients
exhibited focal brain lesions (8 acute subdural haematoma, 5 chronic
subdural haematoma, 7 intracerebral haematoma) and ten patients
presented with diffuse brain injury.
b. Transfer Function Data
The waveform database comprised 1500 ICP and BP waveform samples
(50 per patient). Pilot samples (n = 100) from the waveform database
underwent spectral analysis. The amplitude transfer function for the
first 6 cardiac component harmonics were calculated and found to cluster
into four classes (Figure 20): those with an overall flat amplitude transfer
function (curve type 1), those with an elevated low frequency response
(curve type 2), those with an elevated high frequency response (curve
type 3) and those exhibiting both an elevated low and high frequency
response (curve type 4). The remaining 1400 samples then underwent
spectral analysis and were prospectively coded into the four curve types
based on the following criteria:
Curve type 1: All harmonics were within 100% of the amplitude of the 3rd
harmonic.
Curve type 2: The 1st harmonic was at least twice the amplitude of the
3rd harmonic, and all harmonics higher than the 1st had
amplitudes within 100% of the 3rd harmonic.
Curve type 3: One or more harmonics above the 3rd harmonic were at
least twice the amplitude of the 3rd harmonic, while the
first and second harmonics were within 100% of the
amplitude of the 3rd harmonic.
Curve type 4: Any amplitude transfer function not meeting the criteria
of curve types 1, 2 and 3.
Figure 20: Observational Study Pilot Amplitude Transfer Function Data. A)
Flat; B) Elevated Low Frequency; C) Elevated High Frequency; D) Elevated
Low and High Frequency Cerebrovascular Pressure Transmission.
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Twenty-eight amplitude transfer functions were excluded because one or
more of the higher harmonics were immeasurably small.
The distribution of the amplitude transfer function harmonic samples
was found to be log-normal. A log transformation of the data produced
an approximately normal distribution (see Appendix H) with a Kolmogorov-
Smirnov (Lilliefors modification) goodness of fit test^ approaching
acceptance of the null hypothesis, that is, not significantly different from
a normal distribution (KS statistic < 0.15 with greater than 200 degrees
of freedom). Table 3 lists the Kolmogorov-Smirnov goodness of fit
statistic for each harmonic broken down by amplitude transfer function
curve type. The 95% confidence limits were calculated from the
transformed data for each of the 6 harmonics classed by amplitude
transfer function curve type. Figures 21 and 22 show the plots for the
averaged amplitude and fundamental phase shift data respectively, classed
by curve type, together with the 95% confidence limits for each harmonic.
With the fundamental phase shift data, also grouped by amplitude
transfer function curve type (Figure 22), the phase shift for curve type
2 and 4 are both more negative compared to curve type 1. Furthermore,
the fundamental phase shift for curve type 3 shows a positive phase shift
compared with the other curve types.
c. Physiological Data
Table 4 is a breakdown of the physiological data by amplitude transfer
function curve type. BP was not significantly different between groups;
however, curve types 2 and 4 (elevated low frequency, elevated low
frequency in combination with elevated high frequency) were most often
associated with raised ICP (ICP > 20 mm Hg) whereas curve types 1 and
3 (flat, elevated high frequency) were most often associated with ICP less
than 15 mm Hg. Despite a strong association between ICP and amplitude
transfer function curve type this effect failed to reach statistical
significance (P = 0.352) tested by a "within patients design" multiple
analysis of variance (MANOVA) comparison, with HRT, BP, CVP, Tc, PaC02,
Pa02 and pH acting as co-variates in the analysis. The small patient
numbers per group may be relevant to this result. There was no
significant difference in any of the co-variates (HRT, BP, CVP, Tc, PaC02,
Pa02 and pH) between amplitude transfer function curve types.
^SPSS Inc., Chicago, Illinois
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Table 3: Breakdown of Kolmogorov-Smirnov Goodness of Fit Tests by
Curve Type and Harmonic for the Transformed (Natural Log) Amplitude
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Figure 21: Observational Study Amplitude Transfer Function Data with 95%
Confidence Limits for each Harmonic. A) Flat; B) Elevated Low Frequency;


























































































































































































Table 5 is a breakdown of principal pathology (diffuse/focal) by
amplitude transfer function curve type. It is interesting to note that in
the diffuse pathology group, there is a majority of amplitude transfer
function curves type 3 (55%) compared with curve type 1 (12%), curve
type 2 (2%) and curve type 4 (31%). Samples from patients with focal
injuries show very few amplitude transfer function curves type 4 (7%)
compared with a more even distribution (35%, 25%, 33%) amongst the other
curve types.
Table 5: Breakdown of Principal Pathology (Diffuse/Focal) by Amplitude
Transfer Function Curve Type.
Curve Type Diffuse Focal Total
1 52 (12%) 330 (35%) 382
2 10 (2%) 233 (25%) 243
3 239 (55%) 306 (33%) 545
4 134 (31%) 68 (7%) 202
Total 435 937 1372
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D. Discussion of Results
This is the first study to demonstrate, through the use of a systems
analysis approach, definable patterns of pressure transmission across the
cerebrovascular bed in a head injured population.
A consideration of the observed data, based on amplitude transfer
function curve type, in relation to previous work by other investigators,
may prove useful as an aid to interpreting these results.
a. Curve Type 1 (Flat)
A flat amplitude transfer function was associated mostly with ICP below
20 mm Hg (mean ICP = 15 mm Hg). A flat amplitude transfer function
indicates equal transmission of all the arterial pressure waveform
harmonics through to the CSF space. Kasuga et al (88) have noted a
decreased pressure transmission in the low frequency range of 1 to 7 Hz
in their control group of dogs with normal ICP (ICP < 10 mm Hg) which
tended to increase with ICP at or near 15 mm Hg. Similarly, Portnoy et
al (82,86) observed attenuation of the amplitude transfer function
fundamental in the transmission of the arterial pulse through to the CSF
space under conditions of low ICP (ICP < 7 mm Hg). Furthermore, Portnoy
et al (83) found, in hydrocephalic dogs, attenuated low frequency
transmission when ICP was below 9 mm Hg and a flat amplitude transfer
function when ICP was greater than 12 mm Hg. They attributed this
attenuation to functional autoregulatory tone of the precapillary cerebral
resistance vessels, and further demonstrated that a flat amplitude
transfer function (equal transmission of all harmonics) can be
experimentally induced by intraventricular infusion of mock CSF or
arterial hypercarbia. Portnoy et al propose that the conversion from an
attenuated low frequency transmission to a flat amplitude transfer
function is evidence for reduced arteriolar vasomotor tone.
The mean ICP in this curve type 1 group (15 mm Hg) is within the ICP
range associated with a flat amplitude transfer function as reported by
Portnoy and the increased low frequency pressure transmission as
reported by Kasuga. This observed form of pressure transmission cannot
be attributed to arterial hypercarbia as all patients were maintained
normocarbic (Table 4). Table 6 is a breakdown of amplitude transfer
function curve type by patient distribution. Within the 30 patients
monitored, 18 patients exhibited, at some point, amplitude transfer
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functions of curve type 1, and of those 18 patients, only 3 did not go on
to demonstrate other forms of amplitude transfer function curve type. Of
these 15 patients that did go on to show other curve types, only 3
patients exclusively demonstrated curve types 1 and curve types 3, both
associated with lower ICP (ICP < 15 mm Hg). Of the remainder, 12 out of
18 patients (67%) also demonstrated either curve types 2 or 4, both
associated with raised ICP (ICP > 20 mm Hg).
These data support the view that the amplitude transfer function
curve type 1, despite its association with lower ICP, may indicate reduced
cerebrovascular tone and be predictive of raised ICP. However, in the
absence of transfer function data from a control group of patients (normal
subjects with ICP monitoring), with which to compare, or independent
evidence of the functional state of the cerebrovascular autoregulatory
mechanisms, this statement is speculative.




Curve Type at Any Time
tt Patients Exhibiting
Curve Type Exclusively
1 18 3 (16%)
2 1 1 2 (18%)
3 16 8 (50%)
4 10 2 (20%)
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b. Curve Type 2 (Elevated Low Frequency)
This amplitude transfer function curve type was characterized by an
elevated low frequency pressure transmission which was most often
associated with ICP above 20 mm Hg. It was chiefly the fundamental that
was elevated. Portnoy et al (81) and Takizawa (86) have both
demonstrated the dependence of the fundamental in the amplitude transfer
function on C02 induced alterations in cerebrovascular resistance. This
effect of C02 on the fundamental was supported by the pilot data
reported in this thesis (page 37) on the effects of hypocarbia on the
amplitude transfer function. It is well established that increased C02
tension in arterial blood increases CBF (107) by decreasing
cerebrovascular resistance predominantly through dilation of the major
resistance vessels; the small bore arteries and arterioles (169). Following
on from this it seems likely, that the greatly increased low frequency
pressure transmission seen with this curve type 2 amplitude transfer
function is as a result of marked dilation of the small bore arteries and
arterioles.
Portnoy et al (82) suggest that a greatly increased transfer of the
fundamental may be a marker for impairment of the autoregulatory
function of these resistance vessels. However, an increased fundamental
transmission could be due either to loss of autoregulatory tone or
paradoxically to intact autoregulation compensating for reduced cerebral
perfusion pressure through active vasodilation. Some measurement of
local CBF or flow/metabolism coupling such as the AJD02 (arterial to
jugular bulb oxygen difference) would be required to distinguish these
conflicting mechanisms. Interestingly, Portnoy recently reports (108) an
account of the amplitude transfer function taken from a patient in the
neurosurgical intensive care unit after evacuation of an acute epidural
haematoma. This patient demonstrated a marked increase in the
fundamental relative to the other harmonics, very similar to the amplitude
transfer function curve type 2. Concomitant measurement of AJD0<> was
8.7 ml 02 % which suggests the presence of ischaemia. Portnoy further
states that postoperatively, this form of amplitude transfer function is
common and often associated with patients who can easily develop a rapid
rise in ICP.
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c. Curve Type 3 (Elevated High Frequency)
In this study a high proportion of amplitude transfer functions (40%)
demonstrated elevated high frequency harmonics without an associated
increased fundamental. This was mostly associated with an ICP below 20
mm Hg.
Within the 30 patients monitored, 16 patients exhibited, at some point,
amplitude transfer functions of curve type 3, and of those 16 patients, 8
(50%) did not go on to demonstrate other forms of amplitude transfer
function curve type. This distribution of waveform data supports the
view that the amplitude transfer function curve type 3 may be more
representative of normal cerebrovascular tone. This is supported by a
report from Portnoy (108) on an amplitude transfer function identical to
a curve type 3 transfer function recorded from a patient following
removal of an epidural haematoma. AJDOj at this time was 6 ml 02 %
suggesting ischaemia was not present. Portnoy states that the presence
of this pattern of amplitude transfer function, even in the presence of
elevated ICP, is usually a good prognostic sign for improved outcome.
Kasuga et al (87), applying pressure pulse waves into the CVB,
demonstrated a resonance in the intracranial compartment in dogs. This
resonant peak occurred under control conditions in the higher frequency
range from 10 to 15 Hz, a frequency which is nearly within range of the
5th and 6th harmonics of the amplitude transfer function found in
patients1^. They demonstrated that the resonant frequency increased
when ICP was experimentally increased by intraventricular infusion of
mock CSF or through inflation of an extradural balloon (88).
Bray and Robertson (89,90) in a clinical study of the power density
spectrum of the ICP waveform, showed two predominant frequency bands;
the higher band (4 - 15 Hz) they associated with the ringing or resonant
properties of the intracranial compartment and they demonstrated a
strong inverse correlation between the frequency at which the resonant
peak of the high frequency band occurred and intracranial compliance as
measured by the PVI. That is, as intracranial compliance decreased the
resonant frequency increased. They further demonstrated that an
^This is assuming the higher heart rate of the dog, approximately 2-3 Hz,
is considered in the calculation.
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increase in the frequency of the resonance above 9.0 Hz was predictive
of poor outcome in patients.
The results from the pilot study (page 39) on the effects of jugular
compression on cerebrovascular pressure transmission, would confirm the
association of altered compliance with high frequency pressure
transmission. Although compliance was not measured in that study, ICP
increased with jugular compression and it is conceivable that the ICP
change was a result of intracranial vascular engorgement secondary to
the distal obstruction in venous outflow (109). Associated with jugular
compression in that study, the fundamental phase became more negative,
which is consistent in electrical terms with increased system capacitance,
or its equivalent in mechanical terms: compliance.
These reports would support the hypothesis that an elevated high
frequency pressure transmission, as seen with the amplitude transfer
function curve type 3, is an indication of the start of a resonant peak in
the transfer function, and its detection is indicative of high intracranial
compliance and a favourable prognosis for ICP. A state of reduced
compliance, either with or without raised ICP, will tend to increase the
resonant frequency beyond that of the frequency of the 6th harmonic and
hence the level of detection by this method. This would result in the
transformation from a curve type 3 amplitude transfer function to another
form (curve types 1,2 or 4) which may be predictive of, or associated
with, raised ICP.
d. Curve Type 4 (Elevated Lowt and High Frequency)
This group was the smallest in number and most often associated with
ICP raised above 20 mm Hg. Following on from the previous discussion,
one could speculate that the elevated fundamental with this form of
pressure transmission would indicate reduced arteriolar tone but, in
association with an elevated high frequency pressure transmission, is
indicative of high intracranial compliance.
The distribution of amplitude transfer function curve types between
patients (Table 6) demonstrates that most patients exhibited at least two
forms of transfer function, one of which was associated with raised ICP
(curve types 2 and 4). It is unclear whether this amplitude transfer
function curve type 4 represents a distinct form of cerebrovascular
pressure transmission or a transition period from one form to another.
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E. Discussion of Methods
Several assumptions are made with the systems analysis approach
which should be considered as sources of error. The chief assumptions
are:
1) the cerebrovascular bed can be described as a linear system;
2) the BP and ICP waveforms are periodic signals;
3) the BP waveform at the radial artery is a measure of the input signal
to the cerebrovascular bed;
4) the ICP waveform within the subdural space is a measure of the output
signal from the cerebrovascular bed.
Furthermore, not related to systems analysis but a potential source of
error:
5) the waveform sample selection process was unbiased and
representative for any given patient.
1. Linear Model of the Cerebrovascular Bed
A linear model is often assumed for reasons of mathematical
convenience (appendix B, page 194). Most physiological systems contain
non-linear elements. The craniospinal system, of which the
cerebrovascular system is an element, is described by a non-linear
volume-pressure relationship (28,110,111,112). The validity of the
assumption of a linear model is especially important when comparing
frequencies present in an output waveform with those of an input
waveform. Major non-linearities in a system can generate sum and
difference frequencies (and their multiples) between interacting input
signals (97). In a non-linear system, an output signal component
frequency may not be related to the same component frequency of the
input signal.
Evidence of the validity of the assumption of a linear model for the
cerebrovascular bed is based on the observation that the cerebrovascular
system output frequency spectrum (ICP waveform) does not contain any
frequency elements which are not also present in the cerebrovascular
system input (BP waveform) and, if present, are of sufficiently small
amplitude to be considered insignificant. Furthermore, it can be assumed
that provided only small perturbations in intracranial volume are
considered, then the resulting intracranial response can be approximated
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as a linear segment on an otherwise non-linear input-output relationship
(70). Chopp and Portnoy (78) have reported a high coherence value
between the BP pulse and the ICP pulse waveforms as measured by the
coherence function (79), which signifies linear transmission.
2. ICP and BP Waveforms as Periodic Signals
A periodic signal is one that repeats itself exactly after a fixed length
of time. The Fourier analysis method assumes extension by periodicity;
that is, a waveform sampled at time (t) is identical to another one sampled
one full period (T) later: f(t + T) = f(t) (Appendix B, page 193).
Giddens and Kitney (113) have shown that heart rate in healthy adults
is not constant but continuously variable with a low frequency heart rate
variability (HRV) component around 0.05 Hz due to thermoregulatory
mechanisms, a component around 0.1 Hz arising from baroreceptor activity
and a component at the respiratory frequency (> 0.2 Hz). They also
demonstrated in neonates that heart rate correlated strongly with breath
amplitude, leading to what they term a breath amplitude sinus arrhythmia.
Branch et al have also shown increased variability in the ICP spectrum
induced with the slow respiratory wave component (114). Lowensohn et
al (115) demonstrated HRV was present in head injured patients and
reported a correlation between raised ICP and decreases in HRV although
this was not reproduced in a later study (116). It is still not clear if HRV
is modified in severely head injured patients.
These reports indicate that beat to beat variability of the BP and ICP
waveforms can occur. To overcome this, in this study, 20 seconds of ICP
and BP waveform data was collected and 10 seconds was analysed. This
analysis window allowed at least one full period of the respiratory
component to be collected. The period of respiration was constant in this
study as the patients were all mechanically ventilated by a standard
protocol. Therefore, any beat to beat variability induced due to the
respiratory fluctuation would tend to be averaged over the entire analysis
window. However, an increased variation of the BP harmonic frequencies
could occur equivalent to that of the beat to beat variation due to heart
rate variability (+- 0.2 Hz) that is not of respiratory origin. In this
analysis, any variation in harmonic frequencies seen in the BP spectrum
was always matched by an equal variance in the corresponding harmonics
of the ICP spectrum. Although this a potential source of error, the
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graphics display software allowed manual measurement (+- 0.098 Hz) of the
same harmonic frequency of the ICP waveform as was chosen for the
equivalent BP harmonic frequency, thus ensuring this source of variation
did not affect the calculation of the transfer function.
O'Rourke and Taylor (117) studying the impedance of the femoral bed
using Fourier analysis of pressure and flow waveforms, found that despite
marked sinus arrythmia, the impedance values derived from the first
harmonic of a rapid beat corresponded with values derived from the third
harmonic of a slow beat. They proposed that this apparent linear
response, under conditions thought to be non-linear, might be accounted
for by the large damping of the femoral artery causing each wave,
although transient, to be regarded as part of a steady state oscillation.
The same relationship may be true for the cerebrovascular bed; when
transfer functions are calculated from waveform samples with different
base heart rates and normalized with respect to the fundamental, there
is good agreement in the frequency at which events such as a resonant
peak in the transfer function occur.
3. Radial BP as an Input Signal
The question of whether the BP waveform at the radial artery is a
measure of the input signal to the cerebrovascular bed can be approached
by first considering what is the origin of the BP pulse.
The origin of the BP pulse can be derived from a study of the
component frequencies. There are three main terms: a DC or static
pressure term, a slow sinusoidal term (0.2 - 0.3 Hz) linked to respiration
rate and a higher frequency term (1-3 Hz) linked to heart rate (Figure
10). All three component frequencies must originate from within the
"chest", the site for the cardiovascular and respiratory systems. As a
first approximation, a reasonable site for measurement of the "origin" of
the BP pulse would be a cannula or transducer situated within a large
vessel in the thoracic cavity, such as in the aortic arch, which would be
under the influence of both cardiovascular and respiratory systems.
However, if a transfer function analysis of cerebrovascular pressure
transmission is shown to provide information of clinical importance to the
management of head injured patients, then its methods must be clinically
practical. In an intensive care unit, there are practical and ethical
limitations to the use of more central sites for routine pressure
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monitoring. The errors caused by use of the radial artery as a measure
of the input to the cerebrovascular bed have been quantified as
discussed in the general methods section of this chapter. The results
indicate that under controlled conditions, and within a select population
of patients (predominantly young, otherwise healthy men with no previous
history of peripheral vascular disease), the errors of peripheral BP
measurement are no greater than the inherent variability of the method
upon repeated measurement (20 - 30 percent error for the amplitude
transfer function). This degree of error would be a limiting factor if
subtle changes in the transfer function were believed to be important.
However, the classification of cerebrovascular pressure transmissions into
categories of amplitude transfer function curve types 1 to 4, which
demonstrate amplitude differences of more than 100% between certain
harmonics, is readily distinguishable.
4. Subdural ICP as an Output Signal
Measurement of the ICP pulse from the subdural space is not ideal, but
placement of an intraventricular catheter, particularly in patients with
collapsed ventricles or mid-line shift, is often not possible. Takizawa (86)
has shown that simultaneous ICP waveform recording in the lateral
ventricle and cisterna magna yields identical spectra, but found
attenuation of the higher harmonics from the recording in the lumbar
space. Provided there is CSF communication between the intracranial
compartments, Takizawa's findings of identical waveform recording from
the lateral ventricle and cisterna magna might be extended to the
intracranial compartment as a whole. This view is supported by the
recent report by Crutchfield et al (195) who used the Camino catheter-
tip pressure monitoring system in dogs and showed identical ICP
waveform and pressure recording during simultaneous monitoring of
intraventricular, intraparenchymal and subdural pressure.
Furthermore, Yano et al (130) who studied patients with various
pathological processes affecting both right and left hemispheres, could
show no difference between concurrent left and right subdural pressure
recordings. They concluded that the supratentorial space could generally
be considered as one compartment regardless of the differences in types
of intracranial lesions. Similar to Yano's findings in patients, Crutchfield
et al (195) demonstrated in an experimental study in dogs, that there was
no difference between concurrent left and right subdural pressure
recordings during unilateral epidural balloon inflation. In contrast to
this, Broaddus et al (131) have shown pressure differentials within the
subdural space in patients, ipsilateral to major pathology as seen on CT.
However, they used subdural bolt pressure sensors for ICP measurement,
a method prone to erroneous measurement, particularly with elevated ICP
(132).
Based on these reports, ICP waveform recording in the subdural space
is probably representative of the waveform throughout all the intracranial
compartments. This may not be the case, however, for absolute ICP as
there must be some pressure differential from the ventricles to the
subarachnoid space, otherwise there would be no impetus to CSF flow in
this direction (133,134). Furthermore, it is recognized that in head
injured patients the CSF compartments are often compressed. In which
case, in order to minimize measurement error, it is particularly important
to monitor the subdural ICP waveform with a catheter-tip transducer
which is less likely to be affected by compression of the CSF compartment
than a fluid filled catheter-transducer system (137).
The use of the ICP waveform as a measure of the output of the
cerebrovascular bed assumes that the site of transmission of the
cerebrovascular pulse into the CSF space occurs at the terminal portions
of the cerebral venous system. There has been much published in
support of arterial (118,119,120,121,122,123), venous (124,125,126) or both
arterial and venous (127,128,129) sites of transmission of the
cerebrovascular pressure pulse into the CSF space.
The most convincing evidence comes from Portnoy's group (84,125,126).
This group showed that when the transverse sinuses in dogs were
obstructed and the venous flow redirected through a cannula to a flask
before being returned to the animal via the femoral vein, the sagittal
sinus pressure pulse was still present. This indicates that, under normal
conditions, the CSF pulse is not a retrograde phenomenon from the right
side of the heart but an antegrade pulse of arterial origin which is at
some point transmitted into the CSF space. Branch et al (84)
demonstrated that the amplitude spectra from pressure waveforms
simultaneously recorded from the CSF space and a cortical vein were
identical. This indicates that the CSF pulse is transmitted from the vein
to the CSF or vice-versa. Thin walled veins are more likely to pulse than
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thick walled arteries and arterioles (82). This would facilitate
transmission from the veins into the CSF. This argues in favour of
transmission of the pulse from the veins to the CSF rather than from the
arteries to the CSF and then to the veins.
This evidence would support the concept that the cardiac pressure
pulse enters the cerebrovascular bed, passes through the arteries,
arterioles and small diameter venules and veins of the cerebrovascular
bed in an antegrade direction before being transmitted into the CSF space
from the large calibre thin walled veins.
5. Sample Selection
Thirty severely head injured patients were monitored in the intensive
care unit over periods ranging from 2 to 14 days. Five minute waveform
samples were collected to tape every 30 minutes timed to coincide with
clinical recordings from the nursing staff. To be consistent amongst
patients, samples from the same period of patient management were chosen
for analysis. For the following reasons the early period of management,
usually the first 2 to 3 days, produced the most controlled data:
i) patients were most intensively monitored by medical and nursing staff
during this period;
ii) comments were entered more frequently and accurately to the data
collection computer system by nursing and medical staff, thus allowing
more precise annotation of significant events;
iii) monitoring equipment (transducers, fluid-filled tubing, acudynamic
adjustable damping devices, patient monitors) were new and more
frequently calibrated;
iv) after stabilization of physiological parameters patients were observed
for the first 2 to 3 days under controlled sedation, being paralysed
and mechanically ventilated to a standard protocol (page 41). However,
after this period, provided ICP was normal for 24 hours, sedation and
paralysis were reduced, in preparation for the patient to be clinically
assessed. During this latter period, the patient's level of sedation was
unpredictable, with occasional patient movement and respiratory effort
being made against the ventilator.
Ideally, 48 hours of data collection would yield 96 waveform samples
for analysis. In fact, considerably fewer valid samples were available as
certain forms of nursing care, physiotherapy, routine x-rays, CT scan
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investigation, and regular blood gas sampling would interrupt or interfere
with one or both of the ICP and BP waveform recordings. Chiefly for
these reasons, 50 waveform samples were selected per patient. The choice
of samples was determined from the ICU nursing charts and selected to
provide a representative sample over the range of intracranial pressures
exhibited by the patient over the initial 2 to 3 day period of monitoring.
Waveform samples were excluded from analysis as described previously
(page 41). The exclusion criterion d) "samples within 120 minutes of
therapy for raised ICP" was set at 120 minutes based on the work of
Dearden and Miller (138) in a paired comparison of hypnotic and osmotic
therapy on ICP reduction after severe head injury. They showed that in
a group of 17 head injured patients, hypnotic therapy (thiopentone: 5
mg/kg given over 5 minutes or gamma hydroxybutyrate: 60 mg/kg iv
given over 10 minutes) had a time to maximum reduction of ICP of 18
minutes (range 5 to 26 minutes) and a total duration of ICP reduction of
32 minutes (range 1 - 104 minutes), whereas osmotic therapy (mannitol: 0.5
g/kg iv given over 5 minutes) had a time to maximum reduction of ICP of
24 minutes (range 1-55 minutes) and a total duration of ICP reduction
of 59 minutes (range 14 - 116 minutes). Although this criterion should
avoid waveform sampling during the maximum effect of hypnotic and
osmotic therapy, some longer term effects on the cerebrovascular bed
cannot be eliminated, particularly as mannitol's effect on blood viscosity
in man lasts at least two hours (139).
Every effort was made to ensure that a representative sample was
taken from the waveform database for a given patient. However, the
unpredictable nature of "artifacts" not annotated in the ICU charts or on
the computer print-out were not noticed until the waveform was displayed
graphically, which meant that the first choice for a given sample
occasionally was discarded. Therefore, some unconscious sampling bias
may be present. However, the frequency with which it was necessary to
discard the first choice of a waveform sample was small (< 5%) and
consequently is not likely to have a significant effect.
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F. Conclusions
In conclusion, these studies have demonstrated definable patterns of
cerebrovascular pressure transmission in head injured patients. Certain
forms of cerebrovascular pressure transmission may be predictive of
raised ICP, or of its underlying cause. The interpretation of the data
from this study can only be speculative as concurrent measurements of
craniospinal compliance and CBF (as a measure of cerebrovascular
resistance) were not performed.
What is required, to aid in the interpretation of these clinically
observed forms of cerebrovascular pressure transmission, is an
investigation into the relationship between cerebrovascular resistance,
craniospinal compliance and cerebrovascular pressure transmission.
This data might best be obtained experimentally, under more controlled
conditions, in an animal model of raised ICP.
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CHAPTER III. AN IMPROVED METHOD OF COMPLIANCE MEASUREMENT
It has been proposed that changes in lumped craniospinal compliance
may, at least in part, be responsible for specific patterns of amplitude
transfer function in head injured patients. The most commonly used
methods of measuring craniospinal compliance depend upon the rapid
injection of known volumes of fluid into the CSF space with immediate
measurement of the resultant increase in CSF pressure. This is expressed
as mm Hg per ml of added CSF volume in the volume-pressure response
(VPR) or as in the pressure volume index (PVI), this being the notional
volume that when added to the CSF space would produce a tenfold rise in
ICP.
It is difficult to inject equal volumes of fluid manually at a constant
and rapid rate of injection. As a result, the measurement of lumped
craniospinal compliance using the VPR and PVI volume-pressure tests is
not routinely carried out in neurosurgical practice largely because of the
high variability of measurements. For example, Borgenson and
Christensen (140) in a lumbar-ventricular perfusion study in patients
failed to show a relationship between PVI and ICP due to the large
variation in PVI measurements. Similarly, an attempt to correlate the
amplitude of high frequency harmonics, in the amplitude transfer function
from BP to ICP, to craniospinal compliance, as measured by the VPR, failed
for identical reasons (141).
Before an experimental study of the relationship between
cerebrovascular pressure transmission and craniospinal compliance can be
performed, an improved method of measuring craniospinal compliance is
needed.
Modification of the VPR technique from a manual to an automatic
injection sequence would be the first step in improving the
reproducibility of measurements. This chapter describes the development
of an automatic method for measuring craniospinal compliance and its
subsequent validation in feline models, of raised ICP and arterial
hypertension, hypotension and hypercarbia.
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A. Theory
The volume-pressure response method consists of manual injection of
fluid into the CSF space through a cannula or needle inserted into either
the lumbar cistern, the cisterna magna or the lateral ventricle. Typically
the injection tubing is also connected through a 3-way tap to a strain
gauge transducer for measurement of the pressure response resulting
from the volume injection. The VPR (dP/dV) is then calculated from the
mean ICP response (dP) after rapid injection of 0.5, 1, 1.5 and 2 ml of
saline (dV). The sequence of events is as follows: the 3-way tap is
positioned to allow injection of the volume bolus into the CSF space, the
volume injection is then given over 1 second, and immediately after
injection the 3-way tap is closed off to the syringe and opened on to the
pressure transducer to allow recording of the pressure response. Closing
the 3 way tap to the syringe produces an infinite outflow resistance
(ignoring leaks in the injection and pressure measurement system) to the
now volume loaded CSF space. This volume load is gradually dissipated
by the craniospinal system through the normal CSF outflow resistance
channels.
This process can be described in electrical terms (Figure 23) where
resistance R1 is the injection tubing resistance, capacitor CI is the
lumped craniospinal compliance (compliance and capacitance are equivalent
terms'^) and resistance R2 is the CSF outflow resistance. The volume
injection flows through the injection tubing resistance (Rl) and charges
up the "craniospinal capacitance" (CI) which is discharged (once the 3-
way tap is closed) through the CSF outflow resistance (R2).
Two modifications to the existing method have been carried out (Figure
1 C
24). A pressure generator , originally used for testing the frequency
response of catheter-transducer systems, has been modified to allow the
triggered production of rectangular wave pressure pulses of 150 mm Hg
amplitude and 100 mSec duration. When these pressure pulses are applied
to the end of the injection tubing resistance (Rl) a small volume injection
results (approx. 0.05 ml) into the CSF space. The second modification to
'^Compliance in mechanical terms is analogous to capacitance in electrical
terms. Compliance can be defined as the volume (V) difference resulting from
a pressure (P) difference (dV/dP). Capacitance can be defined as the charge
(q) difference resulting from a potential (v) difference (dq/dv).
^Biotek Inc., Vermont, USA.
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the method involves reduction of the injection tubing resistance (Rl) so
that it is considerably (at least ten times) less than the CSF outflow
resistance (R2). Provided the injection tubing resistance (Rl) is
considerably less than the outflow resistance (R2) and the injection
resistance (Rl) is left open to atmospheric pressure after volume
injection, than the injected volume bolus will leave the system
through Rl rather than through the much higher resistance R2.











T1 - 100 msec
For R1 « R2 T 2 = 1 sec
|
P1 = 150 mm Hg
Figure 24: Electrical Model of Modified VPR Method.
It can be shown through the application of Thevenin's theorem'® (142)
that R2 is in parallel with R1 (Figure 25) and if R2 is very much greater
than Rl, R2 can effectively be ignored. This simplifies the first
approximation model to a series RC circuit (Figure 25), where Rl is the
injection tubing resistance and Cl is the lumped craniospinal compliance.
It can be further shown (Appendix I) that the value of the
"craniospinal capacitance" or compliance can be easily calculated from the
standard capacitance charge equation (equation 1) provided the following
are known: injection tubing resistance (Rl), peak input pulse pressure
(Vp), input pulse dui-ation (Ti), and the intracranial pressure (Vc) after
Ti seconds.
'®Thevenin's theorem states that any circuit can be analysed as a series
voltage source (V^) and resistance (R^. V ^is calculated as the open circuit
voltage. R^ is calculated as the equivalent resistance when all sources are
reduced to zero potential. In this case, the pressure generator source is short




C1 = L-(,«-«,) J
R1
Equation 1: SPR Method Equation.
This method has two advantages over the existing VPR technique:
1) it can be easily automated;
2) it is less invasive in that:
i) the volume injection can be smaller and of shorter duration,
particularly if averaging techniques are used to separate the ICP
response (Vp) from background noise;
ii) the injected volume leaves the system after compliance testing
through the injection tubing resistance.
Physical model tests were carried out on the method to determine the
optimal parameters (injection tubing resistance, input pulse amplitude and
duration), the accuracy compared with an independent measure of
compliance, and the sources of error.
For convenience, the new method under test will be referred to in all
following text as the "Short Pulse Response" (SPR) method.
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Figure 25: First Approximation Electrical Model of Craniospinal System.
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B. Physical Model Testing
1. General Methods
Figure 26 is a block diagram of the SPR measurement system. A two
channel biological signal averager^ produces, during averaging mode, 5
volt trigger pulses of 0.1 mSec duration. These pulses are modified by
a "pressure signal and timing conditioning unit" to produce variable
voltage (0 - 2.0 volts) and duration (20 - 1000 msec) rectangular wave
pulses. A schematic diagram of the "pressure signal and timing
conditioning unit" is given in Appendix J. These variable voltage and
duration pulses trigger the pressure generator to produce pressure
pulses of equal duration and pressure amplitude with a conversion of 100
mm Hg/volt, and a rise time of 2 msec. The pressure pulses are then
applied to the system under test through optimally damped fluid-filled
?0low compliance tubing . A Camino catheter-tip pressure transducer is
placed within the dome of the pressure generator to measure the input
pressure pulse and similarly a pressure sensor is placed within the
system under test to record the pressure response to the input stimulus.
Both recorded input and output pressure signals are then conditioned by
the "pressure signal and timing conditioning unit" prior to input to the
biological signal averager. After removal of the DC component the signals
are filtered through low pass filters with a cutoff frequency of 100 Hz.
The conditioned signals are then averaged with a stimulus presentation
rate of 1 Hz and a sweep time (averager maximum) of 1 second. All
physical model test responses are the average of 10 stimulus
presentations. The input pressure pulse is averaged on the first channel
and the system pressure response on the second channel of the averager.
Amplitude and latency cursors on the averager allow measurement of the
peak input pressure (Vp), the duration of the input pulse (Ti) and the
peak system pressure resulting from the pressure stimulus (Vc). Once
the injection tubing resistance (Rl) is known, the system compliance can
be calculated according to equation 1 (page 67).
^Medelec MS92a. Medelec Ltd., Surrey, UK.
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2. A Physical Model of the Craniospinal System
A simple physical model of the craniospinal system was built to allow
testing of the SPR method. Figure 27 is a block diagram of the physical
model. It consists of a 20 ml syringe (mock cranium) filled with 10 ml of
saline (mock CSF). A fluid coupling system was inserted into the 10 ml
"CSF" space of the syringe and consisted of a 19 Gauge 5 cm metal needle,
a 30 cm length of low compliance tubing, two 3-way taps and an
Acudynamic adjustable damping device. Also placed within the syringe
was a second identical fluid coupling system connected to a strain gauge
21transducer system'1 for measuring the pressure within the syringe. Table
2 (page 22) summarizes the static and dynamic characteristics of this
catheter-transducer system. Transient response analysis of the catheter-
transducer system determined that 2.25 turns on the Acudynamic tap were
required to produce optimal damping. Quantities of air could be added or
removed from the syringe to alter the compliance of the model.
3. Injection Tubing Resistance
Figure 28a illustrates the method used for measurement of the injection
tubing resistance. A bucket of saline was seated on a drip stand so that
it could be adjusted to different heights above the injection tubing. The
resulting pressure head of saline was connected to the injection tubing
by a 2 metre length of large bore (2 cm) hose pipe. The saline was
allowed to flow and the volume of fluid collected over one minute from a
range of bucket heights. The resistance of the injection tubing was
calculated from the average slope from a sequence of five pressure
versus flow experiments (Figure 28b). There was no evidence of
turbulent flow over the pressure range tested, as all the pressure versus
flow curves were linear. The resistance of the injection tubing used
throughout these experiments was 3.5 +- 0.17 mm Hg/ml/min^. A
prerequisite of the SPR method is that the injection tubing resistance R1
is considerably (at least ten times) less than the CSF outflow resistance
(R2) (page 65). This condition was met, as the normal CSF outflow
21
"Bentley Trantec physiological pressure transducer. Bentley Trantec Inc.,
Irvine, USA.
^value is mean +- standard deviation.
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resistance in the cat was 105 mm Hg/ml/min^, which is over 30 times
greater than the 3.5 mm Hg/ml/min resistance of the injection tubing (Rl).
Figure 27: Block Diagram of the Physical Model Apparatus (not drawn to
scale).
^This value of CSF outflow resistance is the average of three investigators'
published normal values. References (41,42,143).
Figure 28a: Block Diagram of the Injection Tubing Resistance Measurement
Apparatus.
Calculation of Injection Tubing
Resistance from Pressure—Flow Slope
Run --A-- Run — Run •••+--• Run —*— Run
1 2 3 4 5
Pressure (mm Hg)
Figure 28b: Calculation of the Injection Tubing Resistance.
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4. Effect of In jection Tubing on the Pressure Pulse
The injection tubing distorted the pressure pulse before it reached the
system under test. Figure 29 illustrates the effect of different amounts
of damping, through adjustment of an Acudynamic adjustable damping
device placed in series with the injection tubing (Figure 27), on
correcting the distortion. It was found that 1.75 turns of the Acudynamic
tap produced optimal conditions.
Figure 29: Effect of Damping on the Injection Tubing Pressure Pulse.
Arrows indicate onset of stimulus.
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5. Input Pulse Amplitude Series
The effect of different pressure pulse amplitudes on the measured
compliance was determined. Figure 30a illustrates a typical input
pressure pulse and output pressure response measured from the physical
model. The physical model was set up with 1 ml of injected air in the
syringe. Sequences of compliance measurements were performed at input
pressure pulse amplitudes of 100, 125, 150, 175 and 200 mm Hg. Figure
30b shows the average of 5 measurements of compliance at each input
pressure amplitude. There was a difference of less than 5% between the
compliance calculated at 100 mm Hg and that calculated at 200 mm Hg.
The larger the input pulse amplitude, the larger the system response,
so that less averaging is required to separate a response from
background noise. This will be particularly relevant in the animal model
tests where the pressure response will require separation from the
background ICP waveform. The maximum pressure pulse amplitude that
the pressure generator can produce is 200 mm Hg. To prevent reduction
of the lifespan of the pressure generator through overuse at the limit of
its operating range, 150 mm Hg was selected as the optimal pressure pulse
amplitude.
6. Input Pulse Duration Series
The effect of different input pressure pulse durations on the measured
compliance was determined. The physical model was set up with 1 ml of
injected air in the syringe. Sequences of compliance measurements were
performed at input pressure pulse durations of 50, 100, 150, 200 and 250
msec. Figure 31b shows the average of 5 measurements of compliance at
each input pressure duration. There was a difference of 27% between the
compliance calculated at 50 msec and that calculated at 250 msec. The
reason for this large difference can be seen in the input pulse shape from
the 250 msec duration run (Figure 31a). The pressure generator is failing
to maintain a constant pressure as can be seen by a distinct sag and
overshoot during and at the completion of the pressure pulse period.
This phenomenon is better understood in relation to the mechanism of the
pressure generator.
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Pulse Input & Output Functions
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Figure 30b: Effect of Increasing Pulse Amplitude on SPR Compliance.
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Figure 31a: Effect of Pulse Duration on Input Pulse Distortion.
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Figure 31b: Effect of Increasing Pulse Duration on SPR Compliance.
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This pressure generator (Figure 32) is based on a moving coil piston
attached to a metal diaphragm which is actuated by a constant force
generated by the moving coil current. The pressure change within the
dome results from the interaction of force and area (pressure =
force/area). However, the force acts against the compliant properties of
both the generator diaphragm and the system under test. The sag and
overshoot demonstrated with the 250 msec pulse duration can be
accounted for by the stiffness of the generator diaphragm absorbing part
of the pressure output (hence the sag) and also, upon removal of the
pulse, results in the diaphragm sucking extra fluid back from the test
system (hence the overshoot).
This pulse duration study demonstrates that, with long pulse durations
at least, the compliance of the pressure generator diaphragm should be
considered in the calculation of system compliance.
Fluid Filled Dome
N = Number of Turns of Wire
I = Moving Coil Current
Figure 32: Diagrammatical Representation of Pressure Generator
Mechanism.
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As shown in Appendix K, however, provided the pulse duration is
considerably less than the total RC time constant of the system under
test, then the generator diaphragm compliance can be effectively ignored.
In practice this is the case, as can be seen, for example, by analysing the
condition where the craniospinal compliance of the cat decreases from the
normal value^ of 0.025 ml/mm Hg by 200 percent to 0.0063 ml/mm Hg. The
RC time constant for the system is then calculated as the resistance (R)
210 mm Hg/ml/sec^ multiplied by the compliance (C) 0.0063 ml/mm Hg
which equals an RC time constant of 1.32 seconds which is still over 13
times the input pulse duration of 100 msec.
The pulse duration of 100 msec was selected on the basis that it was
the minimum duration which was still significantly greater than the 2 msec
rise time of the pressure generator.
7. An Independent Measure of Compliance
The SPR method required validation against an independent measure
of compliance. The simplest measure of compliance within a linear model
is to infuse fluid slowly within a closed system and record continuously
the linear increase in pressure within the system. The slope of the
resultant volume-pressure relationship is the compliance of the system.
Figure 33a is a block diagram summarizing this method which for
convenience is referred to in all following text as the "Infusion Method".
The physical model was set up with 1 ml of injected air in the syringe.
The infusion method consists of a Harvard servo-controlled synchronous
motor infusion pump^, which infuses fluid into the system at a constant
rate of 0.0393 ml/min. for a duration of four minutes. Pressure is
measured within the syringe by an optimally damped fluid-filled catheter-
transducer system which is sampled at 1 Hz for 4 minutes (240 seconds)
24 This value is the average of 4 investigators' published compliance values
at normal ICP from experimental studies in cats. References (41,42,46,73).
9 r
"The injection tubing resistance is 3.5 mm Hg/ml/min. To convert this to
units expressed as mm Hg/ml/sec the value is multiplied by 60, giving 210 mm
Hg/ml/sec.
2fi
Harvard synchronous motor infusion pump model 940. Harvard Apparatus
Ltd., Kent, UK.
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under microcomputer control by a 12 bit A/D converter.^ The resolution
of pressure measurement is 0.0610 mm Hg . For each pressure value
sampled, the volume increment is calculated as the infusion rate of 0.0393
ml/min divided by 60 seconds which equals 0.000655 ml. The sampled
pressure and volume data is stored to a data file. The 240 volume
increments are then plotted against the corresponding 240 pressure
increments and the compliance calculated from the slope of this volume
versus pressure relationship. Appendix L is a flow diagram of the
infusion method data collection program. Figure 33b contains an example
plot of an infusion method volume-pressure run.
8. Comparison of SPR and Infusion Methods
The SPR method was compared with the infusion method in the physical
model over a range of compliances produced by the introduction of
increasing quantities of air into the physical model. The physical model
was set up initially with 1 ml of injected air in the syringe. Through the
positioning of a 3-way tap, compliance was measured alternately, over a
range of compliances (1 - 5 ml air), by the infusion method followed by
the SPR method. This entire sequence was carried out five times, with
the average and standard deviation between runs calculated at each level
of compliance for both methods. Figure 34 shows sample input and output
pressure responses from the SPR method for the 1 and 5 ml injected air
runs. The infusion method volume-pressure curves are also shown for
the 1 and 5 ml injected air runs.
Figure 35 is a plot comparing the measured compliances^ for both the
SPR and infusion methods. The maximum difference was 7% between the
two methods. The degree of difference was independent of compliance.
?7
Tecmar Lab Master. Tecmar Inc., Cleveland, USA.
Pressure resolution was calculated as the calibrated transducer pressure
range (250 mm Hg) divided by the 12 bit A/D resolution (2^ = 4096 discrete
levels) yielding 0.0610 mir Hg (250/4096).
oqValues are means +- standard deviations.
Servo—Controlled
Figure 33a: Block Diagram of Infusion Compliance Method Apparatus.
Infusion Compliance Method
volume (n = 240)
Pressure (mm Hg)
























































































































































































































































































































































































9. Sources of Error
a. Camino Transducer Error
Pilot experiments in the physical model using the Camino system for
measurement of pressure within the syringe demonstrated large errors
when the SPR method was compared with the infusion method. Figure 36
is a plot of the two methods compared over 3 levels of compliance
produced by addition of 1, 2 and 3 ml of air into the physical model. The
SPR method overestimated compliance compared to the infusion method,
the difference between the two methods becoming greater with increasing
compliance. This difference disappeared when the Camino system was
replaced by an analogue strain-gauge transducer system (Figure 35).
The Camino catheter-tip transducer system is a digital system with 8-
bit resolution over the 260 mm Hg pressure ranged This yields a
pressure resolution of 1 mm Hg . If a measurement error of 1 mm Hg
were made with the Camino system this could cause large errors in the
measured compliance. This can be best seen with a sample calculation.
With a normal cat compliance of 0.025 ml/mm Hg and an SPR method volume
injection of approximately 0.05 ml, the pressure response would be 2 mm
Hg". If the pressure response measured by the Camino system were
underestimated or overestimated by 1 mm Hg, giving measured pressure
responses of 1 or 3 mm Hg, this would yield calculated compliances of 0.05
and 0.0167 ml/mm Hg respectively. This represents a difference of 100%
and 50% respectively from the actual compliance of 0.025 ml/mm Hg. As a
result of this large source of error, the Bentley Trantec analogue strain
gauge transducer system was used for pressure measurement within the
physical model. The static and dynamic characteristics of this catheter-
transducer system have been previously described (page 71). A similar
calculation can be performed to determine that the pressure resolution
required to keep the measurement error less than 10 percent is 0.1 mm
9 A
"Camino transducers cover the pressure range from -10 mm Hg to 250 mm
Hg.
^An 8-Bit system can resolve 256 (2^) discrete levels. The pressure
resolution is then the pressure range covered (260 mm Hg) divided by the
digital resolution (256 discrete levels) which yields 260/256 = 1.015 mm Hg or
approximately 1 mm Hg.
9 0
Compliance (C) is change in Volume (dV) divided by change in pressure
(dP). C = dV/dP. Knowing dV and C then dP can be solved: dP = dV/C.
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T33Hg0'1. An analogue transducer calibrated over a pressure range from 0 to
200 mm Hg when sampled by the 12 bit (4096 points of resolution) A/D
converter of the SPR method signal averager yields a pressure resolution
of 0.048 mm Hg (200/4096).
COMPLIANCE (ml/mmHg)
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Figure 36: Comparison of SPR and Infusion Method using the Camino
Transducer System.
A compliance (C) change of 0.002 from the normal cat compliance of 0.025
is an 8% change. The pressure increment (P) resulting from this compliance
change, assuming a constant volume (V) injection of 0.025 mis (worst case), is
P = V/C. This yields a change from 1 to approximately 1.1 mm Hg. A pressure
resolution of 0.1 mm Hg is required to detect this change.
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b. Effect of Air Bubbles
To ascertain the error in compliance measurement caused by air
bubbles in the measurement tubing, increasing quantities of air (0.1, 0.3,
0.5 and 0.7 ml) were injected into the injection tubing resistance (Rl)
during measurement of a fixed compliance within the physical model. The
entire sequence of volume injections was carried out five times. The total
injection tubing volume was 1.4 ml. With the largest volume injected (0.7
ml) half of the injection tubing resistance contained air. Figure 37 is a
^4
plot of air bubble volume versus measured compliance . Compliance was
overestimated when there was air contaminating the injection tubing
resistance. There was an average of 5% overestimation in compliance for
each 0.1 ml of added air.^
The Effect of Air Bubbles in the
Injection Tubing on SPR Compliance
AIR VOLUME (ml)
Figure 37: The Effect of Air Bubbles in the Injection Tubing on SPR
Compliance.
11
Values are means +- standard deviations.
^See page 111 of the discussion section for consideration of the
measurement error due to invisible trapped air in the injection fluid.
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c. Measurement Error
Compliance is calculated using equation 1 (page 67). The calculation
will be affected by measurement error from two sources: the measurement
of the injection tubing resistance (Rl), and the measurement of input
pulse duration (Ti), input pulse amplitude (Vp) and output pulse amplitude
(Vc). The latter group of measurements is all obtained from the signal
averager.
Five sequential measurements of the resistance of the injection tubing
(Rl) produced a mean resistance of 3.5 +- 0.17 mm Hg/ml/min. Taking two
standard deviations away from the mean produces a range of resistance
values of 3.16 to 3.84 mm Hg/ml/min. The error caused in the calculation
of compliance using these two limiting values of injection tubing
resistance was 10 percent.
The measurement accuracy of the pressui'e pulse duration (Ti) is
governed by the 4 msec averager time base resolution, which would cause
a maximum error of 4% in the measurement of the 100 mSec pulse duration.
Similarly, the measurement accuracy of the input (Vp) and output
pressure (Vc) amplitudes is governed by the 2 mV resolution of the
display gain amplifier, which would cause a maximum error of 10% in the
measurement of Vp and Vc.
Having determined the major sources of error in the SPR method and
compared the accuracy of the method with the infusion method of
compliance measurement, the SPR method was next compared with the VPR
method in animal models.
C. Animal Model Testing
1. Methods
Twelve cats of both sexes, each weighing between 2.5 and 5.5 Kg, were
split into three groups: an ICP group (n = 4), a BP group (n = 4) and a
C02 group (n = 4). All animals were induced with ketamine
hydrochloride^ (30 mg/kg I.M.) and atropine sulphate^ (0.05 mg/kg I.M.),
^This calculation assumes a worst case Vc amplitude of 20 mV.
^Ketalar. Parke-Davis, Eastleigh, UK.
00
"Antigen Ltd., Roscrea, Ireland.
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followed by alpha-chloralose03 anaesthesia given as a 1% solution (75
mg/kg I.V.). Figure 38 is a diagram summarizing the animal preparation.
Both femoral veins wrere cannulated with polyethylene tubing^" (internal
diameter 0.86 mm) for infusion of fluids and drugs. Both femoral arteries
were cannulated for arterial blood gas sampling^ and to allow monitoring
of arterial pressure through placement of a Camino catheter-tip pressure
transducer into the descending thoracic aorta. The animals were given
a tracheostomy, intubated and then were ventilated with intermittent
positive pressure ventilation at a stroke rate of 25 breaths/min and a
i 9
tidal volume of 30 ml . Ventilatory volume was adjusted as required to
keep the animals normocarbic (PaC02 35 - 40 mm Hg). The animals were
ventilated during surgical preparation with a gas mixture of 60% oxygen/
40% nitrous oxide and were maintained post surgery on oxygen alone.
Muscle paralysis was induced with pancuronium bromide^ (0.7 mg I.V.)
repeated hourly. Each animal's body temperature was maintained constant
at 38 degrees Celsius with a homeothermic blanket system^. The auditory
canals were infiltrated with 1% lignocaine gel^ after which the animal was
placed in a stereotactic frame in the sphinx position, the scalp and
temporal muscles were reflected and bilateral burr holes were drilled in
the skull 7 mm posterior and 4 mm lateral to bregma for cannulation of the
lateral ventricles with 2 inch 19 gauge needles^ (78). The continuous
4 7infusion method1 was used for location of ventricles. In addition, a
midline incision was made in the posterior fossa, and a 19 gauge 2 inch
^Sigma Ltd., Poole, UK.
^Portex Ltd., Hythe, UK.
^Blood gas analyser IL system 1302. Instrument Laboratories, Milan, Italy.
4 9''Harvard ventilator model 665A. Harvard Apparatus Ltd., Edenbridge, UK.
^Pavulon. Organon Teknika Ltd., Cambridge, UK.
^Harvard homeothermic blanket system. Harvard Apparatus Ltd.,
Edenbridge, UK.
^Astra Pharmaceuticals Ltd., Kings Langley, UK.
4 fi"Needles were modified spinal needles cut to a 2 inch length with the sharp
bevels filed smooth.
^Reference 70 page 105.
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metal needle was placed into the cisterna magna through the foramen
magnum. The needle insertion holes were sealed by cyanoacrylate
adhesive^ to prevent CSF leaks. ICP was monitored through the left
ventricular cannula using an optimally damped fluid-filled catheter
transducer system as previously described (page 71). The right
ventricular cannula was used for infusion of saline or Hartman's solution
into the CSF space for altering the baseline ICP. The cisterna magna
cannula was connected to the SPR method pressure pulse generator for
applying input pressure pulses to the CSF system for measurement of
craniospinal compliance, the method having been previously described
(page 69). Through the positioning of a 3-way tap, the cisterna magna
cannula could be redirected to the VPR method test apparatus which
consisted of a 30 cm low compliance tube, a 3 way tap and a 1 ml syringe,
the VPR method also having been previously described (page 64). The
ICP response to the SPR and VPR pressure and volume pulses were
recorded through the left lateral ventricular cannula. All pressure
transducers were calibrated against a water column and zeroed with
reference to the plane of the stereotactic frame ear bars.
4 P
RS components Ltd., Corby, UK.
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2. Statistical Analysis
All comparisons between two groups of data were tested statistically
with a students paired t-test. Curve fits were performed on some data
to characterize the trend of the data. A power function was found to be
the approximating function that best fit the shape or general trend of the
data. The curve fits were performed using a least squares regression
according to the power formula^: y = ao xal
3. Comparison of SPR and VPR Methods wTith Raised ICP
a. Protocol
The ICP of four animals was raised in five stages from 10 to 100 mm Hg
by infusion of saline (3 - 60 ml/hour) into the right lateral ventricle.
Placement of a cannula into the cisterna magna caused a variable loss of
CSF. So that all animals could start from the same ICP baseline, ICP was
raised, by slow intraventricular infusion (3 ml/hour) of saline, to a
starting baseline level of between 10 and 15 mm Hg.
At each level of ICP, four sequential measurements of craniospinal
compliance were performed by both the SPR and VPR methods with five
minutes separating each measurement. With two of the animals the SPR
preceded the VPR method, while with the remaining two animals the VPR
preceded the SPR method. For the SPR method, the compliance for a
given level of ICP was the average of the four sequential compliance
measurements, w?here each measurement was the signal average of 50
stimulus presentations. For the VPR method, the compliance for a given
level of ICP was calculated from the mean pressure response after rapid
injection of 0.5, 1, 1.5 and 2 ml of saline^1. In addition to compliance, the
following physiological data was recorded: ICP, BP, Tc, PaC02, Pa02 and
pH.
b. Results
Figure 39 shows sample output pressure pulses recorded from an
animal at normal ICP (13 mm Hg) and at elevated ICP (90 mm Hg)
^Power function converted to a linear equation ie:
y = ao xal => lny = al In x + In ao
5&VPR (dP/dV) is the inverse of compliance dV/dP. The VPR was calculated
and this value was then inverted to yield the compliance.
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demonstrating that even at elevated ICP the signal average of 50 stimulus
presentations is sufficient to remove the background ICP pulse waveform.
Figure 39: Sample SPR Output Pressure Responses at Low and High ICP
in the Animal Model.
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Figures 40a and 40b are plots of the calculated compliance versus ICP
as measured by both the SPR and VPR methods. Data points^ from all
four animals are pooled. Both methods show a decrease in compliance with
increasing ICP. The VPR method overestimates compliance compared to the
SPR method and also demonstrates greater variability between
measurements. All VPR compliance values from all four animals were
greater than the corresponding SPR compliance values, indicating that the
overestimation is independent of whether compliance was first measured
by the SPR or VPR method. The amount of overestimation ranged from
20% to 162% with a mean of 77%. The coefficient of variation (CV) as
previously described (page 30) was used as a measure of the
reproducibility between the four sequential measurements of compliance
of both methods. The CV for the SPR method ranged from 0.6% to 9.3%
with a mean variation between measurements of 2.6%. The VPR method
showed a CV ranging from 5.6% to 48% with a mean variation between
measurements of 17%. Table 7 is a breakdown of the physiological data
averaged across all four animals and grouped by ICP level^.
^Values are means +- standard errors.
C 0
Values are means +- standard deviations.
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Figure 40a: SPR Compliance vs Increasing ICP in the Animal Model.
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Figure 40b: VPR Compliance vs Increasing ICP in the Animal Model.
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4. Comparison of SPR and VPR Methods with Arterial Hypertension and
Hypotension
a. Protocol
The BP of four animals was first lowered and then raised in stages.
Pooling the data from all animals gave a range of BP from 20 mm Hg to 220
mm Hg. BP was lowered with intravenous infusion (10 - 40 ml/hour) of
trimetaphan camsylate^ (2.5 mg/ml). BP was raised with intravenous
infusion (6 - 40 ml/hour) of Angiotensin 11^ (100 ug/ml) and supplemented
as required with adrenalin^ (0.2 mg/ml at 10 - 40 ml/hour). ICP was
raised, by slow intraventricular infusion (3 ml/hour) of saline, to a
baseline level of between 10 and 15 mm Hg.
At each level of BP, four sequential measurements of craniospinal
compliance were performed by both the SPR and VPR methods with five
minutes separating each measurement. In addition to compliance, the
following physiological data was recorded: ICP, BP, Tc, PaC02, Pa02 and
PH.
b. Results
Figures 41a and 41b are plots of the calculated compliance versus BP
as measured by both the SPR and VPR methods. Data points^ from all
four animals are pooled. Both methods show a decrease in compliance with
increasing BP. Similar to the results with raised ICP the VPR method
overestimates compliance compared to the SPR method and also
demonstrates greater variability between measurements. The amount of
overestimation ranged from 28% to 214% with a mean of 89%. The
coefficient of variation (CV) between the four sequential measurements at
each level of BP for the SPR method ranged from 0.4% to 4.6% with a mean
variation between measurements of 2.56%. The VPR method showed a CV
ranging from 3.8% to 49.3% with a mean variation between measurements
of 16%. Table 8 is a breakdown of the pooled physiological data.
^Arfonad (Trimetaphan camsylate). Roche Products Ltd., Welwyn Garden
City, UK.
54Sigma Ltd., Poole, UK.
^Antigen Ltd., Roscrea, Ireland.
cp
Values are means +- standard errors.
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Figure 41a: SPR Compliance vs BP in the Animal Model.
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Figure 41b: VPR Compliance vs BP in the Animal Model.
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5. Comparison of SPR and VPR Methods with Arterial Hypercarbia
a. Protocol
The arterial C02 tension of four animals was raised in two stages by
the administration of 5% and 10% C02 in the inspired gas mixture. ICP
was raised, by slow intraventricular infusion (3 ml/hour) of saline, to a
baseline level of between 10 and 15 mm Hg.
At each level of C02, four sequential measurements of craniospinal
compliance were performed by both the SPR and VPR methods with five
minutes separating each measurement. In addition to compliance, the




Figure 42 is a barchart graph of the grouped compliance data as
measured by both the SPR and VPR methods at normocarbia and at two
levels of hypercarbia. Table 9 is a breakdown of the physiological data
averaged across all four animals and grouped by the inspired C02 level.
With 5% inspired C02 the PaC02 increased from a baseline of 37.6 mm Hg
to 59.8 mm Hg (P < 0.01) increasing further still with 10% C02 to 117 mm
Hg (P < 0.01). ICP also increased significantly rising from a baseline
value of 13 mm Hg to 25 mm Hg (P < 0.01) and increasing to 34 mm Hg (P
< 0.01) with 10% C02. Associated with these changes, both methods
showed a decrease in compliance with 5% C02 although only the SPR
method showed a statistically significant decrease (P < 0.01). With 10%
inspired C02, compliance increased towards control levels, although this
change did not reach statistical significance. There was a large variation
in compliance across animals. However, within one individual animal,
similar to the ICP and BP groups, the SPR method showed less variation
(CV = 1.8% to 10.9% with a mean of 4.9%) compared with the VPR method
(CV = 3.4% to 41% with a mean of 14.2%). The amount of overestimation of
the VPR method compared with the SPR method ranged from 21% to 171%
with a mean of 52%.
r n
3 Compliance was averaged across all four animals; values are means +-
standard errors.
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6. SPR Method and Blood Brain Barrier Damage
Two animal experiments were carried out to determine whether the
repeated application of pressure pulses into the CSF space induced by
the SPR method produced damage to the blood brain barrier or to the
neuronal parenchyma.
a. Protocol
Both animals were prepared as previously described (page 87) with the
exception that intraventricular cannulae were not placed and cranial
surgery, other than exposure of the foramen magnum, was not performed.
This was to eliminate surgery and ICP monitoring as a source of trauma
to the brain. Pressure pulses were applied through the cisterna magna
cannula as normal. A sequence of fifty pressure pulses was applied, once
every 15 minutes for 8 hours. In one animal, forty minutes before the
end of the protocol, 8 ml (2 ml/Kg body weight) of a 2% Evans Blue Dye^
was given intravenously to assess major blood brain barrier disruption
(144). In the second animal, at the end of the protocol, trans-cardiac
perfusion-fixation using a formaldehyde, acetate, methanol buffer mixture
(40:1:1) was performed as described by the method of Brierly and Brown
(145). After the brain was perfusion fixed, it was removed, sectioned and
stained with Haematoxylin, Eosin and Luxul Fast blue stains. Sections of
both brains were examined by a neuropathologist for evidence of blood
brain barrier breakdown or focal tissue damage.
b. Results
Figure 43 is a photograph of coronal slices taken from the brain of the
animal injected with Evans Blue Dye. Nine slices are shown extending in
5 mm steps from the forebrain to the cerebellum. The brain slices show
normal brain parenchyma, no evidence of brain shift and no focal or
hemispheric swelling. There is also no evidence of intraparenchymal
staining with Evans Blue Dye. Although some very patchy and light
superficial subarachnoid staining is evident. The histological examination
of perfusion-fixed brain showed no evidence of cortical, deep nuclear or
white matter damage. There was, however, a patchy polymorphic
infiltration of the Virchow-Robin spaces.
^Sigma Ltd., Poole, UK.
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Figure 43: Photograph of Coronal Slices of a Cat Brain injected with Evans
Blue Dye after Repetitive SPR Compliance Measurement.
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D. Discussion of Results and Methods
The idea of short pulse analysis of craniospinal compliance is not new.
Marmarou (40) in his thesis^ considered that the theoretical pressure
fiO
response resulting from an impulse volume function was a rapid increase
in pressure followed by an exponential return to resting level. The peak
pressure recorded was a function of the injected volume, the initial
pressure and the system compliance, while the exponential decay was a
function of the compliance and outflow resistance. The SPR method
described in this chapter has transformed this theory into a practical
method where the forcing function is not an idealized impulse volume but
a practical short duration pressure pulse. The peak pressure recorded
is a function of the input pressure, the injection resistance and the
system compliance and the decay is a function of compliance and the
outflow resistance, although with the SPR method the outflow resistance
is the injection tubing resistance and not the CSF outflow resistance.
The physical model for testing of the SPR method was kept simple, as
the intention was not to model the craniospinal system, but only to
provide a means of optimizing the methodological parameters (tubing
resistance, input pulse amplitude and duration) and determining the
sources of error. The compliance range over which the SPR method was
tested in the physical model extended from 0.001 to 0.006 ml/mm Hg. This
range is approximately five times less compliant than would be found
physiologically, larger compliances being found too difficult to reproduce
in a physical model. Nonetheless, it is more important to perform physical
model testing at reduced compliances where the accuracy and
reproducibility of compliance measurement is more critical.
Further evidence towards the validity of the assumption that the CSF
outflow resistance (R2) is considerably greater than the injection tubing
resistance (Rl) was derived from pilot animal work. The CSF outflow
resistance was determined by two independent methods both at normal ICP
(8 mm Hg) and at elevated ICP (90 mm Hg). Appendix M describes the two
methods used for calculation of CSF outflow resistance at both normal and
^Marmarou's thesis (40) Fig 28, page 60.
fin
An impulse function is a theoretical function approximated by a pulse of
infinite amplitude and infinitely small duration.
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elevated ICP. The CSF outflow resistance at normal ICP was the lowest
with both methods, giving values of 55 and 78 mm Hg/ml/min respectively,
the average of the two methods yielding 66 mm Hg/ml/min which is
approximately 20 times greater than the injection tubing resistance (Rl)
of 3.5 mm Hg/ml/min. At elevated ICP the outflow resistance increased to
157 and 104 mm Hg/ml/ min respectively with a mean between methods of
130 mm Hg/ml/min which is approximately 40 times greater than the
injection tubing resistance Rl.
A further source of error of the SPR method is the assumption that the
generator diaphragm compliance does not affect the measured craniospinal
system compliance. The condition under which this was shown to be valid
was that the total RC time constant of the system was considerably
greater than the input pulse duration time (Ti). However, with ICP's
greater than 60 mm Hg, the system compliance may become sufficiently
small as to negate these conditions. In this case, the generator
diaphragm compliance (C2) will need to be considered in the calculation
of the system compliance (CI). The animal experiments have shown that
even at high ICP the SPR method measures compliance with the same
relationship to ICP as the VPR method. Figure 44 is a superimposed plot
of the SPR method and VPR method compliance measurements^ versus ICP.
C 1
Values are the average compliance (+- standard error) across all four
animals at each stage of ICP.
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Figure 44: Superimposed Plot of SPR and VPR Methods vs Increasing ICP.
106
It can be seen that the two methods follow a parallel course with
increasing ICP. If, with reduced system compliance, the generator
compliance were increasingly affecting the SPR compliance measurement,
then one would expect to see a divergence of the two methods as ICP
increases. A possible reason why this is not observed may be that as the
system compliance (CI) and generator diaphragm compliance (C2) are
effectively in series , both are subject to the effects of raised ICP. It is
likely that both compliances are reduced to the same degree with raised
ICP, which causes the relative pressure drop across the two series
capacitors to be unchanged^. Future modifications of this method should
attempt to reduce the generator compliance as a source of error.
The SPR method shows less variability between measurements than the
VPR method. In all three experimental groups, the SPR method
demonstrated a coefficient of variation between measurements at least five
times smaller than that of the VPR method. The SPR method appears to
be less invasive than the VPR method. This is seen from Figure 45a which
shows that after a set of 5 sequential SPR method compliance runs, ICP
returned to baseline. This was not the case, however, with the VPR
method where occasionally, particularly with the larger 2 ml volume
injection, secondary ICP rises occurred immediately following the VPR
injection, in some cases taking 30 minutes or longer to return to baseline
ICP levels (Figure 45b). This phenomenon has been reported by other
investigators (70,148) under both experimental and clinical conditions.
e 0
"'This can be shown by using Thievenon's theorem, see footnote 4.
Taking C2 into account the series capacitance is now
(C1*C2)/(C1+C2). If C2 >> CI then the effective capacitance is CI. If both CI














Figure 45a: The Effect of the SPR Compliance Method on ICP.
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Figure 45b: The Effect of the VPR Compliance Method on ICP.
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Although 150 mm Hg pressure pulses are generated by the SPR
measurement method, the pressure that develops within the CSF space is
dependent on the system compliance. The animal experimental work has
shown that the maximum pressure that develops as a result of the SPR
method is 40 mm Hg which occurs when the animal's compliance is most
compromised (ICP > 100 mm Hg). Under more compliant circumstances, a
smaller pressure response will develop. It can be seen from Table 10
that, although repeated pressure pulses are applied by this method
directly over the brain stem, there is no significant effect on heart rate,
systolic or diastolic blood pressure.
The brain pathology results showed that there was no effect of the
SPR method on either blood brain barrier permeability or focal grey and
white matter tissue. In particular, the hippocampus, cerebellar purkinje
cells and lamina III of the cortical laminae appeared normal. The presence
of the patchy subarachnoid polymorphic infiltration may be an
epiphenomenon of the invasive experimental method as this type of
subarachnoid infiltration has also been reported by another investigator
(146) using a similar cat protocol, but not using the SPR method. The
polymorphic infiltration may also explain the slight extravasation of Evans
Blue Dye into the subarachnoid space. Further experimental work is
needed to study the longer term effects of this pulse technique on the
brain.
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Table 10: The effect of the SPR method on Heart Rate and BP. Individual
and averaged data from a set of 5 sequential SPR method compliance runs.
The compliance from each run is calculated from the average of 50 150 mm
Hg pressure pulses applied at a repetition rate of 1 Hz. There is no
statistically significant effect of the SPR compliance method (paired t-
test) on either BP or Heart rate.



























With the SPR method, similar to other investigators (147,149), the
craniospinal system is modelled as a simple first order system, where a
CI
lumped compliance is the only reactive component . Other investigators
have modelled the craniospinal and cerebrovascular systems more fully as
second or higher order systems containing a series of distributed
compliances (150,151,152,153). The inertial properties^ of the craniospinal
system have also been considered (62,87,88). If there is inertance present
in the craniospinal system, there was no evidence of it exerting an effect
during compliance measurement with the SPR method. This can be seen
from Figure 39 which shows the pressure response plots at both normal
and elevated ICP. There is no oscillation seen on the decay portion of
either response, although oscillation would be expected if significant
inertance was present (79). There may be inertance to the craniospinal
system, but its effects may be insignificant when such a small and rapid
volume perturbation to the system (approx. 0.05 ml over 100 msec) is
involved.
In the physical model tests, it was found there was an average of 5%
overestimation in compliance for each 0.1 ml of added air to the injection
tubing. This degree of error is with reference to air added to the
injection tubing and does not consider the effects of tubing compliance
and leaky connectors on the absolute system compliance. Furthermore,
the high compressibility of air makes it impossible to remove all trapped
air unless boiled distilled water and tedious filling techniques are applied
(93). In order to make the SPR method practical, particularly if future
development of the method is aimed towards producing a system that can
be used clinically, all tests were carried out with room temperature normal
saline as the injection fluid. The VPR compliance method in both
experimental and clinical studies use room temperature normal saline as
A reactive component is one that responds or reacts to change. The
current that charges a capacitor is dependent on the rate of change in voltage
(dV/dt). Similarly, inductors are also reactive elements. The voltage developed
across an inductor is dependent on the rate of change of current (dl/dt).
c r
In electrical terms the inertance is equivalent to inductance. An inductor
(L) will inhibit changes in current (I) by developing a potential difference
opposite in polarity, and thus opposing the source causing the change in
current. The amplitude of the induced potential difference (VL) is dependent
on the rate of change of the current (dl) produced by the source. VL = L x
dl/dt.
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the injection fluid. As a consequence, the error in measuring compliance
caused by using normal saline as the injection fluid will not affect the
comparison of the SPR with the VPR technique.
The large overestimation of compliance by the VPR method compared to
the SPR method should be considered. Some of the overestimation may be
because the VPR method is more susceptible to contamination with air,
which would tend to increase the measurement of compliance. It is more
likely, however, that the difference between the two techniques is a
result of the dynamic properties of the two methods. The VPR method
involves injection of much larger volumes than the SPR method which
would cause a greater perturbation to the system, and furthermore the
volume injection is given over the much longer time interval of 1 second,
ten times longer than the SPR method. Anile et al (62) have reported that
compliance measurement is time dependent. They have shown that if the
VPR injection volume of 0.3 ml is given slowly over one second (similar to
these studies where 0.05 - 0.2 ml was given over one second) then the
measured compliance is dependent on whether the CSF system was open
or closed to atmospheric pressure. If the CSF system is closed, the
measured compliance is similar to that of a rapid injection sequence (0.05
ml injected as quickly as possible). If, however, the CSF system is open
to atmosphere, the slow VPR injection causes fluid to be displaced more
readily from the craniospinal compartment resulting in gross
overestimates of compliance compared to the rapid injection sequence.
The level of overestimation was dependent on ICP but ranged from 20% to
several hundred percent with the higher levels of ICP. The explanation
proposed for this phenomenon is based on Anile's division of compliance
into physical and physiological compliance. Physical compliance they
define as being the true compliance of the system related to the expansion
of the spinal dura matter and any small compression of the brain or
expansion of the skull that may occur. It is recognized that blood can be
ejected from the cerebrovascular bed as fluid is injected into the CSF
space (40,41,126). Physiological compliance, therefore, is probably
dependent on cerebrovascular properties, in particular venous outflow
resistance. With a large volume injection given over a longer period,
there is time for the inertance of the cerebral blood volume to be
overcome. As a result some blood is ejected from the craniospinal
compartment so that the total intracranial blood volume is reduced and
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compliance is therefore greater. Rapid injection would tend to inhibit
fluid flow because of the inertance of the fluid. The faster the rate of
injection, the greater the inhibition of fluid flow. Based on the preceding
discussion, it is feasible that the SPR method is measuring principally the
"physical compliance" of the craniospinal system, which would be expected
to be less than the lumped physical and physiological compliance as
measured by the VPR method.
E. Conclusions
The aim of the work described in this chapter was to improve the
reproducibility of compliance measurement in order to facilitate an
experimental study in animals of the relationship between craniospinal
compliance, cerebrovascular pressure transmission and cerebrovascular
resistance. The SPR method appears to be a more accurate, less variable
and less invasive method of measuring craniospinal compliance compared
to the VPR method. The major sources of compliance measurement error
with the SPR method have been quantified and are not negligible.
Nonetheless, the errors are likely to be small compared to the overall
biological variation that will be inherent to the proposed experimental
studies.
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CHAPTER IV. EXPERIMENTAL STUDIES
After showing that waveform analysis of human cerebrovascular
pressure transmission is feasible and following the development of an
improved method for measuring lumped craniospinal compliance, the
purpose of this experimental study was to measure both parameters under
conditions expected to change either or both craniospinal compliance and
cerebrovascular pressure transmission. Raised ICP will reduce
craniospinal compliance. An increase in arterial PC02 can cause cerebral
vasodilation and thereby alter cerebrovascular pressure transmission. An
increase in arterial pressure can produce changes in both compliance and
pressure transmission dependent on the state of cerebral autoregulation
and whether or not ICP is elevated.
The SPR method of measuring lumped craniospinal compliance with its
improved reproducibility between measurements, was applied to an
investigation of the relationship between cerebrovascular pressure
transmission, craniospinal compliance and cerebrovascular resistance in
experimental models of raised ICP, arterial hypercarbia and arterial
hypertension. The results from the three arms of this study are
presented first, each with a short commentary, followed by a final
discussion.
A. General Methods
Twelve cats of both sexes, each weighing between 2.0 and 5.2 kg, were
split into three groups: an ICP group (n = 4), a C02 group (n = 4) and a
BP group (n = 4). Animals were prepared surgically as previously
described (page 87). In addition to the measurement of craniospinal
compliance as described in the last chapter (page 69), cerebrovascular
pressure ti-ansmission between BP and ICP was measured (page 18) using
a catheter-tip pressure transducer placed in the descending segment of
the thoracic aorta for recording of the BP waveform while the ICP
waveform was recorded through placement of an optimally damped fluid-
filled catheter-transducer system placed in the left lateral ventricle
through a 19 gauge 2 inch needle catheter. Cerebrovascular resistance
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was calculated^ as the quotient of cerebral perfusion pressure to cerebral
blood flow (CBF) where CBF was the average from four measurement sites.
1. CBF Measurement
CBF was determined through the use of the hydrogen clearance
technique (155,156,157). Appendix N describes the hydrogen clearance
method for measurement of CBF, the H2 electrode design and electrode
etching process. Cranial burr holes were drilled while being irrigated
en
continuously with cool saline. Four platinum electrodes01 were placed in
two pairs straddling the sagittal suture, 20 mm posterior to Bregma and
5 mm lateral to the midline. Electrodes were positioned with the aid of an
operating microscope, and inserted, using a microdrive, directly through
unopened dura to a depth of 1.5 mm into the cerebral cortex, and were
sealed in place with cold curing dental acrylic^. Electrodes were
CQ
polarized to +400 mV relative to a Ag/AgCl reference electrode which was
wrapped in a saline soaked gauze and placed in a subcutaneous pouch.
Electrodes were allowed to stabilize for 30 minutes post insertion. The
first blood flow measurement from each experimental animal was discarded.
During a blood flow measurement, hydrogen gas was administered in a 10%
concentration through one of two parallel inspired gas circuits proximal
to the ventilator input. Hydrogen was given for 10 minutes after which
the animals inspired gases were switched to the parallel circuit not
containing hydrogen. The hydrogen electrode current during the
desaturation phase was sampled online at 1 Hz for the entire desaturation
^From Ohm's law, resistance (R) is the quotient of potential difference (V)
and current (I). R = V/I. In equivalent terms, cerebrovascular resistance (CVR)
is equal to the quotient of the pressure drop across the cerebral vascular bed,
that is, cerebral perfusion pressure (CPP) (CPP = BP - ICP) divided by cerebral
flood flow (CBF). CVR = CPP/CBF. This assumes that ICP is an accurate measure
of cerebral venous pressure due to the vascular waterfall effect (159,160).
^Platinum wire (0.2 mm diameter) Engelhard Sales Ltd., Chessington, UK.
The platinum wire is electrolytically etched to a tip diameter between 10 - 20
microns which tapers back over 1.5 mm to a base diameter of 100 microns. Total
exposed length of platinum is 1.5 mm, the remaining wire is sealed with an
epoxy-resin cement.
^Simplex Rapid (pink). Nobel Pharma Ltd., Harrow, UK.
CQ
Clark Electromedical Instruments, Pangbourne, UK.
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period by a microcomputer based blood flow measurement system (158).
After the re-establishment of a stable baseline, approximately 15
minutes after hydrogen gas inhalation had ceased, a baseline correction
algorithm was used to correct for any drift in the hydrogen electrode
70
during desaturation when compared to the pre-hydrogen baseline . The
natural log plot (Ln) was then calculated from the logarithm of the
difference between each sampled point and its corresponding baseline
value. The first 20 seconds of desaturation was discarded as potentially
contaminated with arterial recirculation artefact (157). The initial slope
index of CBF (ISI) was then calculated from the slope of the subsequent
one minute period (155). Clearance curves in these studies were
predominantly biexponential. The ISI values reported are the average of
the ISI flows from the four hydrogen electrodes. Appendix 0 is a flow
chart describing the H2 clearance analysis program.
2. Statistical Analysis
All comparisons between two groups of data were tested with a
students paired t-test. All averaged data is expressed as means +- SEM.
B. Induced Intracranial Hypertension
This set of experiments was designed chiefly to determine whether ICP,
raised through intraventricular infusion of mock CSF, as a model of a
diffuse intracranial hypertension, would affect predominantly low or high
frequency pressure transmission across the cerebrovascular bed. In
addition, the relationship and time course between the changes in
pressure transmission, craniospinal compliance and cerebrovascular
resistance would be observed.
1. Protocol
The ICP of four animals was raised in four stages from 10 to 70 mm Hg
by infusion of saline or Hartman's solution (3 - 60 ml/hour) into the right
lateral ventricle. ICP was raised through slow intraventricular infusion
of saline to a starting baseline level of between 10 and 15 mm Hg.
70
Baseline drift is assumed to be linear. A sloping baseline is forced from
the pre-hydrogen baseline to the final minute of the sampled desaturation curve
using a linear regression algoi'ithm.
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At each level of ICP, four sequential 20 second samples of ICP and BP
waveform data were stored to FM magnetic tape for subsequent offline
calculation of cerebrovascular pressure transmission. This was
immediately followed by four sequential measurements of craniospinal
compliance using the SPR method. Compliance for a given level of ICP was
the average of the four sequential measurements, where each measurement
was the signal average of 50 stimulus presentations. Five minutes after
compliance measurement, CBF was determined using the hydrogen
clearance technique, with 10 minutes of hydrogen saturation. Just prior
to desaturation, arterial blood gas samples were taken. During the initial
slope phase of desaturation, BP and ICP were recorded for calculation of
the CPP.
2. Results
Figure 46 is a combined plot of cerebrovascular pressure transmission
(amplitude transfer function and fundamental phase shift), craniospinal
compliance and cerebrovascular resistance versus increasing ICP. Table
11 contains physiological data (ICP, BP, CPP, Tc, PaC02, Pa02, pH)
recorded at each stage in the protocol. To prevent obscuring the
relationship between amplitude transfer function curves, the associated
standard error bars were not plotted. Table 12 contains the amplitude
transfer function data with standard errors for each harmonic, broken
down by ICP level.
ICP increased from 10 to 65 mm Hg (P < 0.001) which was associated
with a fall in CPP from 139 to 88 mm Hg. These changes were followed by
and exponential decrease in craniospinal compliance from 0.0097 to 0.0024
ml/mm Hg (P < 0.01). The amplitude transfer function increased at all
frequencies with increasing ICP. The first harmonic was used as a
measure of low frequency pressure transmission and the 4th harmonic as
a measure of high frequency pressure transmission. Both low and high
frequencies increased significantly compared to baseline (P < 0.05) with
increasing ICP. There was no significant change in the fundamental
phase shift with increasing ICP. Cerebrovascular resistance did not
change significantly with increasing ICP as seen by the decrease in the
initial slope flow from 35.2 to 21 ml/lOOg/min, which was followed by a





































































































































































































These results demonstrate that an increase in both low and high
frequency pressure transmissions across the cerebrovascular bed occurs
with diffusely raised ICP. This increase in pressure transmission is
associated in a stepwise fashion with reduced craniospinal compliance, and
occurs in the absence of any detected change in lumped cerebrovascular
resistance. Over the range of CPP tested in this group of non-
autoregulating animals (88 - 140 mm Hg), cerebrovascular pressure
transmission is dependent only on mechanisms governing craniospinal
compliance.
C. Induced Arterial Hypercarbia
Since the previous group of animals demonstrated no change in
cerebrovascular resistance to raised ICP, none of the observed changes
in cerebrovascular pressure transmission could be attributed to
cerebrovascular resistance. To investigate this further, the following set
of experiments was designed to force alterations in cerebrovascular
resistance and craniospinal compliance independently. Cerebrovascular
resistance was altered through the administration of C02 in the inspired
gases and craniospinal compliance was altered through the application of
abdominal compression.
1. Protocol
The arterial C02 tension of four animals was raised in two stages with
administration of 5% and 10% C02 in the inspired gas mixture. At each
level of C02, four sequential 30 second samples of ICP and BP waveform
data were stored to FM magnetic tape for subsequent offline calculation
of cerebrovascular pressure transmission, which was immediately followed
by four sequential measurements of craniospinal compliance using the SPR
method. During the normocapnic stage of the protocol, five minutes after
the last SPR measurement, a fixed weight was placed upon the animal's
back, which compressed the abdomen against a rigid spherical object,
approximately the size of a closed fist, which had been inserted between
the animal's abdomen and the base of the stereotactic frame. While
abdominal compression was applied, a further set of four sequential
waveform and compliance measurements was obtained. Abdominal
compression was then stopped, five minutes after which a set of waveform
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and compliance measurements was obtained. As before, compliance for a
given stage of the protocol was the average of the four sequential
measurements, where each measurement was the signal average of 50
stimulus presentations. Five minutes after the post abdominal
compression waveform and compliance measurements were obtained, CBF
was determined through the use of the hydrogen clearance technique,
with 10 minutes of hydrogen saturation. Just prior to desaturation,
arterial blood gas samples were taken. During the initial slope phase of
desaturation, BP and ICP were recorded for calculation of the CPP.
2. Results
Cerebrovascular pressure transmission and CBF changes with altered
C02 were sufficiently different between animals to cause grouped analysis
to obscure the relationship between the two variables. As a result, the
relationship between cerebrovascular pressure transmission, craniospinal
compliance and cerebrovascular resistance will be reported individually
for the four animals.
Table 13 contains the physiological data (ICP, BP, CPP, Tc, PaC02,
Pa02, pH) recorded at each stage in the protocol averaged across all
animals in this group. To prevent obscuring the relationship between
amplitude transfer function curves, the associated standard error bars
were not plotted. Tables 14a & 14b contains the amplitude transfer
function data with standard errors for each harmonic, broken down into
three levels of hypercarbia (normocapnia, 5%, 10%) and the three
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Figure 47 is a combined plot for this animal showing cerebrovascular
pressure transmission (amplitude transfer function and fundamental phase
shift), cerebrovascular resistance and craniospinal compliance at
normocapnia and with 5% and 10% inspired C02. With 5% C02,
cerebrovascular resistance decreased significantly (P < 0.05) and was
associated with a large increase in both low and high frequency (first and
fourth harmonic) components of the amplitude transfer function (P < 0.01,
P < 0.001). There were no significant changes in craniospinal compliance
or the fundamental phase shift with 5% C02. With 10% C02 there was no
significant change in cerebrovascular resistance from the 5% level, nor
was there a change in low frequency pressure transmission. However,
high frequency pressure transmission decreased significantly (P < 0.001)
with 10% C02 which was also associated with a significant increase in
craniospinal compliance (P < 0.001).
Abdominal compression (Figure 48) caused a small increase in low
frequency pressure transmission (P < 0.01) and was associated with the
fundamental phase shift becoming less negative (P < 0.01).
b. Animal P015
This animal (Figure 49) showed similar responses with C02 and
abdominal compression to the previous animal P014 (Figure 48). With 5%
C02 there was a large increase in low frequency pressure transmission (P
< 0.001) but with no major change in either compliance or phase. The
principal change occurred when 10% C02 caused reduced high frequency
pressure transmission (P < 0.001) associated with increased compliance (P
< 0.001). Similar to the previous animal, there was no change in the low
frequency pressure transmission with 10% C02 despite a marked reduction
in CVR (P < 0.01) consistent with vasodilation.
Like the previous animal, abdominal compression (Figure 50) caused
a small increase (P < 0.05) in the low frequency pressure transmission,

















































































































































































































































































































































Figure 50: Cerebrovascular Resistance, Pressure Transmission and
Craniospinal Compliance vs Abdominal Compression, Animal P015.
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c. Animal P016
With 5% C02, this animal (Figure 51) similar to the previous two
animals, showed a significant decrease in cerebrovascular resistance
(P < 0.01) which was associated with an increase in low frequency
pressure transmission (P < 0.001). The high frequency pressure
transmission showed no significant change. Compliance showed only a
small decrease (P < 0.05), and the fundamental phase shift became more
negative (P < 0.001) with 5% C02. However, with 10% C02 there was no
significant change in cerebrovascular resistance, although the increase
in IS flow from 52 to 58 ml/lOOg/min despite very little change in CPP
would suggest that some vasodilation may have been occurring.
Consistent with vasodilation there was a further increase in low frequency
pressure transmission above that of the 5% level (P < 0.001). Also with
10% C02, there was now a large increase (P < 0.01) in the high frequency
pressure transmission, associated this time with a large decrease (P <
0.001) in compliance.
Abdominal compression (Figure 52) showed significant increases in both
low and high frequency pressure transmission (P < 0.01), which was
associated with the fundamental phase shift becoming less negative.
d. Animal P017
The final animal in this group showed responses with C02 and
abdominal compression similar to those of the previous animal P016. With
5% C02 (Figure 53) there was a significant decrease in cerebrovascular
resistance (P < 0.05) which was associated with a large increase in low
frequency pressure transmission (P < 0.001). Like the previous animal,
the high frequency pressure transmission also showed a large increase (P
< 0.001). Following this increase in the high frequency pressure
transmission there was a large decrease in compliance (P < 0.001), with
the fundamental phase shift becoming more negative (P < 0.001) with 5%
C02. However, with 10% C02 there was no significant change in
cerebrovascular resistance, although similar to the previous animal the
maintenance of flow from 44 to 42 ml/lOOg/min despite a falling CPP would
suggest that some vasodilation was occurring. This is consistent with the
further increase in low frequency pressure transmission above that of the
5% level (P < 0.001). Also with 10% C02, however, there was no significant
change in the high frequency pressure transmission from that of the 5%
132
level which was mirrored by very little change in compliance with 10%
C02.
Abdominal compression (Figure 54) showed a significant increase in
only the low frequency pressure transmission (P < 0.05), which was
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Figure 54: Cerebrovascular Resistance, Pressure Transmission and
Craniospinal Compliance vs Abdominal Compression, Animal P017.
137
3. Commentary
All animals showed a decrease in cerebrovascular resistance with 5%
C02, and an associated increase in low frequency pressure transmission.
However, the animals can be divided into two groups depending on their
response to 10% C02. Both animals (Figures 47,49) that failed to show a
further increase in low frequency pressure transmission with 10% C02,
despite an indication of a reduction in cerebrovascular resistance
consistent with vasodilation, were also the only two animals that
demonstrated a marked increase in compliance with 10% C02. In the
other two animals (Figures 51,53) 10% C02 induced further decrease in
cerebrovascular resistance with an increase in low frequency pressure
transmission but also were associated with either no significant change or
a decrease in compliance.
The other consistent waveform change in this group of animals was
with the relationship between compliance and high frequency pressure
transmission. With one exception, every significant change in compliance
was followed by an inverse change in the high frequency pressure
transmission, as measured by the amplitude of the fourth harmonic in the
amplitude transfer function. Figure 55 is a plot of the percentage change
in amplitude of the fourth amplitude transfer function harmonic versus
the associated change in compliance. As can be seen from this plot, a
decrease in compliance (negative change) is associated with an increase
(positive change) in the fourth harmonic amplitude and vice-versa.
The changes in the fundamental phase shift can also be divided into
two groups. With 5% C02, the two animals (Figures 51,53) that showed a
consistent decrease in compliance with C02, both showed the fundamental
phase shift become more negative (P < 0.001). The phase of the other two
animals (Figures 47,49), that both showed large increases in compliance
especially with 10% C02, showed either no change or become less negative.
There were no consistent significant changes in the fundamental phase
shift with 10% C02.
Finally, with abdominal compression, because the perturbation to the
craniospinal system with this method was small there were no significant
changes in compliance. However, in three of the four animals (Figures
48,52,54), abdominal compression increased predominantly low frequency
pressure transmission with an associated fundamental phase shift
becoming less negative.
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Figure 55: Plot of the Percentage Change of the Amplitude Transfer
Function Fourth Harmonic vs Percentage Change in Compliance. Also
shown is the linear equation of best fit (least squares method) to the data
with the correlation coefficient (r) and the probability level (P) that the
relationship is not statistically different from a linear relationship.
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D. Induced Arterial Hypertension
This arm of the study was designed to examine the relationship
between cerebrovascular pressure transmission, craniospinal compliance
and cerebrovascular resistance both within and beyond the normal
autoregulatory range of CBF to arterial BP.
1. Protocol
The BP of four animals was raised in stages. BP was raised with
intravenous infusion (6 - 40 ml/hour) of Angiotensin II (100 ug/ml) and
supplemented as required with adrenalin (0.2 mg/ml at 10 - 40 ml/hour).
ICP was raised, by slow intraventricular infusion (3 ml/hour) of saline or
Hartman's solution, to a baseline level of between 10 and 15 mm Hg. At
each level of BP, four sequential 30 second samples of ICP and BP
waveform data were stored to FM magnetic tape for subsequent offline
calculation of cerebrovascular pressure transmission, which was
immediately followed by four sequential measurements of craniospinal
compliance using the SPR method. As previously, compliance for a given
stage of the protocol was the average of the four sequential
measurements, where each measurement was the signal average of 50
stimulus presentations. Five minutes after the final compliance
measurement had been obtained, CBF was determined using the hydrogen
clearance technique, with 10 minutes of hydrogen saturation. Just prior
to desaturation, arterial blood gas samples were taken. During the initial
slope phase of desaturation, BP and ICP were recorded for calculation of
the CPP.
2. Results
Cerebrovascular pressure transmission and CBF changes with altered
BP were sufficiently different between animals to cause grouped analysis
to obscure the relationship between the two variables. As a result, the
relationship between cerebrovascular pressure transmission, craniospinal
compliance and cerebrovascular resistance will be reported individually
for the four animals.
BP was increased from a mean control level of 137 +- 7 mm Hg to 202
+- 3.7 mm Hg (P < 0.01). In all animals, a further set of measurements was
obtained at an average BP level of 118 +- 16 mm Hg during a second
experimental run post arterial hypertension. Table 15 contains the
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physiological data (ICP, BP, CPP, Tc, PaC02, Pa02, pH, pupil size) recorded
at each stage in the protocol averaged across all animals in this group.
To prevent obscuring the relationship between amplitude transfer
function curves, the associated standard error bars were not plotted.
Table 16 contains the amplitude transfer function data with standard
errors for each harmonic, broken down by BP level,
a. Animal P027
Figure 56 is a combined plot for this animal showing cerebrovascular
pressure transmission (amplitude transfer function and fundamental phase
shift), cerebrovascular resistance and craniospinal compliance at control
BP, raised BP, and again at a control BP level post arterial hypertension
during a second experimental run. When BP increased from 133 to 206 mm
Hg, cerebrovascular resistance decreased significantly (P < 0.01),
consistent with pressure passive vasodilation, which was followed by a
small but significant increase (P < 0.01) in low frequency pressure
transmission. Also associated with arterial hypertension, there was a
small but significant decrease in compliance (P < 0.01), but there was no
significant change in the fundamental phase shift.
During the second experimental run (BP 170 mm Hg), cerebrovascular
resistance increased again and was not significantly different from the
pre-hypertensive controls. However, there was a large increase in the
low frequency pressure transmission (P < 0.01) above that of the
hypertensive state, and the amplitude transfer function demonstrated
large fluctuations in the amplitude of the high frequency harmonics.
Associated with this inappropriate increase in low frequency pressure
transmission, there was a marked increase in compliance (P < 0.001) and
the fundamental phase shift showing a large positive phase (P < 0.001).
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In this animal (Figure 57), when BP was increased from 150 to 210 mm
Hg there was a large increase in both low (P < 0.001) and high (P < 0.05)
frequency pressure transmissions. However, there was no significant
change in cerebrovascular resistance. The ISI flows were already
elevated in this animal at 191 ml/lOOg/min which increased further in a
pressure passive manner to 226 ml/lOOg/min with arterial hypertension.
This indicates that at control BP levels, this animal may be above the
upper level of autoregulation, or may be demonstrating the onset of loss
of autoregulation. Also associated with arterial hypertension, there was
a significant decrease in compliance (P < 0.01), and the fundamental phase
shift became more negative (P < 0.001).
During the second experimental run (BP 110 mm Hg), cerebrovascular
resistance increased significantly (P < 0.05) from the pre-hypertensive
controls. However, the amplitude transfer function took on a flatter
course than before with a significant decrease (P < 0.001) in both low and
high frequency pressure transmission. As with the previous animal, there
was a marked increase in compliance (P < 0.001) and the fundamental
phase shift showed a large positive phase (P < 0.001).
c. Animal P029
When BP was increased from 150 mm Hg to 190 mm Hg in this animal
(Figure 58), there was no significant change in cerebrovascular
resistance, but there was a significant decrease in both low (P < 0.05) and
high (P < 0.01) frequency pressure transmissions. As with all previous
animals, compliance decreased (P < 0.01) with arterial hypertension.
During the second experimental run (BP 100 mm Hg), cerebrovascular
resistance increased significantly (P < 0.05) from the pre-hypertensive
controls. There was a large increase in the low frequency pressure
transmission (P < 0.01) above that of the hypertensive state, and this
inappropriate increase in low frequency pressure transmission was again
associated with a marked increase in compliance (P < 0.01) and a large


























































































































































































































With this final animal (Figure 59), when BP was increased from 115 to
200 mm Hg, cerebrovascular resistance decreased significantly (P < 0.01),
consistent with pressure passive vasodilation, which was followed by large
increases in both the low and high frequency pressure transmission (P
< 0.01). There was no significant change in compliance or the fundamental
phase shift with arterial hypertension.
During the second experimental run (90 mm Hg), cerebrovascular
resistance increased again (P < 0.01) and was not significantly different
from the pre-hypertensive controls. There was a small but significant
decrease in low frequency pressure transmission at this stage (P < 0.01),
although there was a large significant increase in the high frequency
pressure transmission (P < 0.001) above that of the hypertensive state.
Similar to all previous animals, there was also a marked increase in
compliance (P < 0.001) and an increase (P < 0.05) in a positive direction
of the fundamental phase shift.
3. Arterial Hypertension and Brain Damage
In one animal (P030), to assess blood brain barrier function, 8 ml of a
2% Evans Blue Dye was given intravenously forty minutes before the end
of the protocol (144). The brain was removed and examined for evidence
of extravasation of Evans Blue Dye.
a. Results
Figure 60 is a photograph of coronal slices taken from the brain of the
animal injected with Evans Blue Dye. Four slices are shown extending
from the forebrain to the cerebellum. All brain slices show marked
extravasation of Evans Blue Dye, both superficially and extending into the
full thickness of the cerebral and cerebellar cortex and occasionally
spreading to subcortical white matter.
In addition to blood-brain barrier breakdown, one animal had blood
stained CSF and another had an intraparenchymal haemorrhage located
just inferior to the ventricular needle catheter. As seen from Table 15,
all animals demonstrated a significant increase (P < 0.05) in pupil diameter
from a mean diameter at control BP of 6 +- 1 mm becoming fully dilated at
12 mm with arterial hypertension. The pupils remained fully dilated
















































































































Figure 60: Photograph of Coronal Slices taken from the Brain of an Animal
Injected with Evans Blue Dye after Prolonged Arterial Hypertension.
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4. Commentary
The normal upper limit of autoregulation in the cat, under alpha-
chloralose anaesthesia and using the H2 clearance technique for
measurement of CBF, has been shown to be approximately 160 mm Hg (144).
Three of the four animals in this group (Figures 56,57,59) showed large
increases in both low and high frequency pressure transmission with
arterial hypertension well above the upper limit of autoregulation. All of
these animals showed either no change or marked decreases in
cerebrovascular resistance which is consistent with a pressure passive
non-autoregulatory increase in CBF. The one animal that did not
demonstrate increased pressure transmission with arterial hypertension
also showed no change in cerebrovascular resistance. This animal had
unusually high ISI control flows (139 ml/lOOg/min) which increased
passively with arterial hypertension. It is possible that this animal has
already lost or has impaired autoregulation with resistance vessels fully
open and unable to dilate further or to increase pressure transmission.
The most consistent and striking changes in this group of animals
occurred during the second experimental run when BP was once again at
or near control levels. All animals showed a marked increase in a positive
direction of the fundamental phase shift and a marked increase in
craniospinal compliance. Also occurring at the post arterial hypertension
stage was a significant decrease in ICP in all animals from 20 mm Hg +- 3
during arterial hypertension to 5 mm Hg +- 3 post arterial hypertension
(P < 0.01).
There were less consistent changes in high frequency pressure
transmission. Three of the four animals (Figures 56,57,59) showed an
elevation in high frequency pressure transmission during arterial
hypertension although in one animal (Figure 56) the elevation was not
statistically different. Associated with the elevated high frequency
pressure transmission, compliance showed either no change (Figure 59) or
significantly decreased (Figures 56,57) with arterial hypertension. The
remaining animal (Figure 58) showed a significant decrease in high
frequency pressure transmission (P < 0.01) with arterial hypertension,
despite a significant decrease in compliance. This animal was the same
animal with abnormally elevated ISI flows and which failed to show an
increased low frequency pressure transmission with arterial hypertension.
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E. Discussion of Results
1. Intracranial Hypertension
The intracranial hypertension group of animals demonstrated both
increased low and high frequency pressure transmission which increased
in a stepwise fashion with raised ICP and was associated with decreased
craniospinal compliance. It is well documented that raised ICP decreases
compliance (41,42,49,56). More recently the relationship between raised
ICP and cerebrovascular pressure transmission has been studied
(78,81,85), but this study is the first to investigate the relationship
between cerebrovascular pressure transmission, craniospinal compliance
and cerebrovascular resistance.
Autoregulation of CBF to reduced CPP is known to exist for a CPP as
low as 50 mm Hg (160,163). The animals in this group did not demonstrate
autoregulation to a CPP range from 139 to 88 mm Hg. However, the mean
BP in this group was 149 +- 14 mm Hg bringing the preparation close to
the upper limit of CBF to raised BP of 160 mm Hg (144). It is conceivable
that the starting point for reduction of CPP in this group was already
above the upper limit of autoregulation for these animals. Alternatively,
loss of autoregulation may have been the result of H2 electrode placement,
which can occasionally cause sufficient cortical damage to impair
autoregulation (144). This is usually associated with slow monoexponential
clearances, whereas the majority of H2 electrodes placed in this study
demonstrated bicompartmental ISI flows over a range of CBF values from
30 to 130 ml/lOOg/min. Whatever the cause, the measurements obtained
indicate a pressure passive decrease in CBF as ICP increased, which may
have been as a result of compression of the large cerebral veins and
sinuses (164,165,166), where the major site of compression is believed to
have been located at the intradural portion of the venous drainage system
adjacent to the major dural sinuses (lateral lacunae) (167,168). This
compression will have increased venous impedance and hence upstream
venous pressure, which explains the increased pressure transmission from
BP to ICP'l The major source of cerebrovascular resistance (> 65%) at
71If the cerebrovascular bed is modelled as the series combination of two
resistances R1 and R2, where R1 is the arteriolar segment and R2 is the venous
segment, and if R1 remains unchanged and R2 increases, then for a given input
pressure (P) an increased pressure will now be dropped across R2. P2 = P *
(R2/R1+R2). This results in an increased pressure transmission into the CSF
space.
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normocapnia has been shown to be predominantly the small calibre
arteries and arterioles (169). Pial arteries have also been shown to dilate
in cats with an intraventricular infusion model of raised ICP (170), but
this vasodilation appears not to be occurring in this non-autoregulating
group of animals. As a consequence the increased cerebrovascular
pressure transmission observed with this group of animals appears to be
solely as a result of the increased venous impedance brought on by
vascular compression.
2. Arterial Hypercarbia
In both this group of animals and the arterial hypertension group, it
was necessary to present results according to individual animals. Studies
of pressure transmission across the cerebrovascular bed have a large
inherent variability because the impedance of vascular beds are highly
dependent on the animal body size and weight (117). These studies had
a large variation (2.0 - 5.5 Kg) in animal body weight. Furthermore, in
the C02 group of animals, there were unique responses made by some
animals to 10% C02. Although this adds to the variability of the absolute
values for cerebrovascular pressure transmission, the relationship
between the changes in arterial PaC02 and pressure transmission,
compliance and cerebrovascular resistance remains unchanged.
All animals in this group showed a decrease in cerebrovascular
resistance with 5% C02 and an associated increase in low frequency
pressure transmission. Cerebrovascular resistance is known to decrease
with arterial hypercarbia (107) and it is most likely the small calibre
arteries and arterioles which are mainly affected (169). In this group, for
the same level of arterial hypercarbia (Table 13), increases in low
frequency pressure transmission from control levels ranged from 50% to
over 300%. All increases were associated with decreased cerebrovascular
resistance with no significant change in BP, indicating an active arteriolar
vasodilation.
A greatly increased low frequency pressure transmission was proposed
by Portnoy et al (81,82) to be an indicator for loss of autoregulatory
vasomotor tone. It is known that loss of CBF autoregulation to raised
blood pressure can often occur in conjunction with loss of C02 reactivity
(171,189) where the latter process was described by Langfitt as vasomotor
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paralysis (39). Loss of autoregulation can be induced by high levels of
arterial hypercarbia (191,192). Two animals in this study (Figures 47,50),
showed no further increase in low frequency pressure transmission with
10% C02 despite additional decreases in cerebrovascular resistance. The
apparent dissociation of cerebrovascular l-esistance and low frequency
pressure transmission found in these two animals, in conjunction with an
existing elevated low frequency pressure transmission, would support
Portnoy's theory. However, an increased low frequency pressure
transmission could be due either to loss of autoregulatory tone through
vasomotor paralysis or paradoxically to intact autoregulation compensating
for reduced CPP through active vasodilation. The large variation in both
the degree of elevation of low frequency pressure transmission and in the
CBF responsiveness to C02 found in these studies would make it difficult
to distinguish these two mechanisms.
An elevated high frequency pressure transmission without an associated
low frequency elevation, has been found clinically, as reported in this
thesis, and by other investigators both experimentally (87,88) and
clinically (83,89,90), and is believed to be due to the presence of a
resonant peak in the amplitude transfer function. However, in this C02
group of animals, the increased high frequency pressure transmission
occurred in conjunction with an elevated low frequency transmission,
often with a considerable degree of variation in the amplitude of the
higher harmonics. It is unlikely that this form of pressure transmission
is indicating a resonant rise in pressure transmission. In these studies,
the high frequency pressure transmission as measured by the amplitude
of the fourth harmonic demonstrated a consistent inverse relationship to
craniospinal compliance. However, the large variation in the amplitude of
the higher harmonics, particularly with the presence of large swings in
their amplitude, weakens the relationship between compliance and high
frequency pressure transmission, particularly if one uses only a single
harmonic amplitude as the only measure of high frequency response.
Some measure of average high frequency pressure transmission may be
required before further study of this relationship between compliance,
resonance and high frequency pressure transmission.
Abdominal compression causes increased transmission of abdominal
pressure to the lumbar CSF space and to venous channels, like the
longitudinal vertebral veins (178). Increased intracranial venous
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pressure may lead to intracranial vascular engorgement and raised ICP
(104,105). In these studies, abdominal compression failed to produce large
changes in craniospinal compliance, but despite this, in each animal, small
but significant increases in mainly low frequency pressure transmission
occurred with abdominal compression. These results contrast with pilot
clinical data reported in this thesis (page 39) where jugular compression
was found to affect predominantly the higher harmonics in the amplitude
transfer function. ICP increased considerably more (from 17 to 29 mm Hg)
(Figure 19) in the clinical study than it did in this experimental study (15
to 19 mm Hg) (Table 13), suggesting possibly that an altered high
frequency pressure transmission may result only with greater
perturbation to the craniospinal system. Jugular compression was not
attempted in this experimental study, as it was found difficult to avoid
compression of the carotid arteries in the process. This would alter the
input function to the cerebrovascular bed which would not be detected
because of the proximal location of the thoracic BP transducer.
3. Arterial Hypertension
Acutely raised arterial pressure has been previously shown, in an
experimental study in cats using identical anaesthesia to this study, to
cause loss of CBF autoregulation, damage to the blood-brain barrier and
overdistension of the cerebral resistance vessels (144). The present
study from the arterial hypertension group has shown that three of the
four animals (Figures 56,57,59) demonstrated large increases in low
frequency pressure transmission when arterial hypertension was well
above the upper limit of autoregulation. All of these animals showed
either no change or marked decreases in cerebrovascular resistance,
which indicates a pressure passive non-autoregulatory increase in CBF.
This further supports Portnoy's hypothesis that an increased low
frequency pressure transmission may be a marker for loss of
autoregulation.
The most consistent and marked changes in the arterial hypertension
group of animals occurred during the second experimental run when BP
was once again at or near control levels. All animals showed a large
increase in a positive direction of the fundamental phase shift and a
marked increase in craniospinal compliance. Similar large increases in
compliance and phase were also found in two animals (Figures 47,49) in
the C02 group during 10% C02 inhalation where both animals failed to
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show an increase in low frequency pressure transmission despite
reductions in cerebrovascular resistance. Phase changes have also been
found clinically by Anile and co-workers (179) who reported that, in
patients with normal pressure hydrocephalus that showed a favourable
outcome, all demonstrated a change in the fundamental phase shift from
a positive to a negative phase. They subsequently demonstrated (180),
experimentally in dogs, that if the craniospinal system is opened to
atmospheric pressure (increased transmural pressure) there is an
associated increase in the fundamental phase shift in a positive direction.
The marked changes in compliance and phase seen with the BP group
of animals are best understood in electronic terms, where a more negative
system phase indicates increased capacitance, and an increase in system
phase in a positive direction indicates an increased inductance. In
mechanical terms, capacitance is equivalent to compliance and inductance
7?
to inertance . During the second BP run, the increased phase shift in a
positive direction may indicate a greatly increased inertance brought on
by the distention of the blood vessels with an increased mass of blood'l
A possible sequence of events might be that the increased mass of blood,
forced in under arterial hypertension, in combination with blood vessels
exhibiting reduced tone, results in both greater inertance and decreased
compliance. The decreased compliance being the result of increased
transmural pressure with raised BP. At this time, the decreased
compliance is the dominant factor determining the system phase. When BP
is then reduced, the transmural pressure decreases and hence the
72
Inertance is a measure of the force required to set a mass in motion or
alter its direction once it is in motion (161).
71JThe value of system phase at any one time is dependent on the sum of
the phase shift due to inertial or inductive effects and those due to the
compliant or capacitive effects. The phase shift due to the inertial effects is
calculated from: = Tan"' (Xj/R), where Xj = 2tiF1. X]is the inductive reactance
and R is the system resistance, and F and L are the frequency and inductance
respectively. Similarly the phase shift due to the capacitive effects is calculated
from: $c = Tan"' (-Xc/R), where Xc = l/(2itFC). Xcis the capacitive reactance and
R is the system resistance, and F and C are the frequency and capacitance
respectively.
Fluid Inertance will be dependent on the mass of fluid and factors affecting
the movement (vessel diameter) of the fluid within the containing vasculature.
Vascular compliance will be dependent on the physical dimensions of the
containing vasculature and factors affecting the compressibility of the contained
fluid and containing structures, and for thick walled vessels, the pressure
across the vessel wall (transmural pressure) (162).
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compliance increases. However, after 30 minutes of severe arterial
hypertension, the inertance is now the main determinant of the system
phase, possibly as a result of the now altered visco-elastic properties of
the brain and cerebrovascular system. Some factors that may indicate
altered visco-elastic properties of the brain and cerebrovascular bed are
the disruption to the blood-brain barrier, intracerebral haemorrhage and
possibly brain-stem damage, as signified by the bilateral fully dilated
pupils. The greatly increased craniospinal compliance seen at this time
may have resulted from the increased intracranial blood volume. An
increased blood volume contained within a vasculature that has lost tone
will become more compliant, especially at low transmural pressure. As a
result, blood can be more readily displaced from the intracranial cavity.
These marked changes in compliance and phase may be interpreted as
indicators for a generalized cerebral vasodilation as a consequence of
reduced vasomotor tone. Evidence for this can be seen from Tables 14
and 15 where, during the second BP run, three out of four animals in the
BP group showed an increased low frequency pressure transmission
compared to the control run, despite there being no significant change in
CPP between the two runs. This indicates reduced arteriolar vasomotor
tone. Furthermore, the blood brain barrier disruption found in these
animals on post-mortem is further evidence for a disturbed
cerebrovascular bed. This is supported by the work of Haggendal and
Johansson (194) who have shown blood brain barrier disruption in cats
with acute aramine induced arterial hypertension. Associated with the
blood brain barrier disruption, they found that arterial hypertension
was always accompanied by cerebral venous hypertension. The increased
pressure transmission to the venous portion of the vascular bed is
presumably as a result of decreased arteriolar resistance. This is further
supported by the work of Mackenzie et al (144), who studied pial artery
dilation during angiotensin induced hypertension in cats. They found
that at pressures above 180 mm Hg there were two vascular responses.
Vessels less than 100 microns in diameter displayed a characteristic
"sausage string" morphology, that is a series of regularly spaced
vasoconstricted segments interdispersed with vasodilated segments. They
conclude that the vasoconstricted segments are the remnants of
autoregulatory constrictions. However, vessels larger than 100 microns
in diameter did not show the "sausage string" pattern but displayed
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marked vasodilation. Furthermore, the autoregulatory constrictions were
temporary and after 20 minutes of hypertension all constricted segments
gave way to a generalized marked vasodilation.
F. Discussion of Methods
All animals in this study had anaesthesia induced with ketamine
hydrochloride. Ketamine has been shown to have no significant effect on
ICP in paralysed and mechanically ventilated preparations and has a
duration of anaesthesia of less than 25 minutes (181). The main
anaesthetic used was alpha-chloralose which has been shown to provide
stable anaesthesia with no effect on vascular smooth muscle and minimal
effect on the autonomic reflexes (182).
Arterial hypertension was induced with angiotensin II which is known
to have no pharmacological action on the cerebral circulation (184,185,186).
However, tachyphylaxis to angiotensin occurred within 15 minutes, after
w^hich angiotensin was supplemented with adrenalin, which does alter
vascular smooth muscle tone. All BP and ICP waveforms were collected
prior to use of adrenalin, although the later stages of the CBF
measurements after the initial two to three minutes may have been
affected by the adrenalin administration.
H2 electrodes for measurement of CBF were positioned as described by
Mackenzie et al (144), which in the cat would record CBF in the boundary
region of the middle and anterior cerebral arteries. The electrode
positions were maintained close to the midline to reduce any effects of
lateral brain displacement on disruption of the electrode position in the
cortex. The majority of blood flow curves were found to be biexponential
(> 80%). However, unpredictably during intracranial and arterial
hypertension, some electrodes which were previously biexponential would
become monoexponential. As a result, bicompartmental analysis was not
possible. The ISI of CBF was used throughout the studies, which has




These experimental studies show that, despite inter-animal variability,
there are consistent relationships between cerebrovascular pressure
transmission, craniospinal compliance and cerebrovascular resistance.
1) Increased low frequency pressure transmission either with or without
elevated high frequency pressure transmission, can occur with raised
ICP, arterial hypercarbia or arterial hypertension.
2) This increased pressure transmission is associated with reduced
craniospinal compliance, reduced cerebrovascular resistance and a
negative fundamental phase shift. Furthermore, during intracranial
hypertension and arterial hypertension, the increased pressure
transmission is associated with impaired autoregulation.
3) Post arterial hypertension, and in two instances of severe arterial
hypercarbia, there was an abnormally high craniospinal compliance and
a positive fundamental phase shift. This combination of factors may
be characteristic of a generally vasodilated cerebrovascular bed with
normal or reduced ICP and BP.
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CHAPTER V. FINAL DISCUSSION
In the introduction, two questions were posed. The first concerned
defining the inherent variability of cerebrovascular pressure transmission
in severely head injured patients. The results of that study raised
questions which could be better answei-ed from the knowledge gained by
attempting to answer the second question. The second question
concerned the definition of the relationships between cerebrovascular
pressure transmission, craniospinal compliance and cerebrovascular
resistance under a series of normal and abnormal physiological conditions.
Prior to performing experimental studies aimed at providing an answer to
the second question, it was necessary to develop an improved method of
measuring craniospinal compliance. This was subsequently validated in
both physical and animal experiments. Having applied this improved
method of compliance measurement to three sets of experimental studies
aimed at answering the second question, it is now appropriate to discuss
whether the data obtained from those experimental studies might aid the
interpretation of the results obtained from the clinical studies of
cerebrovascular pressure transmission.
A. Relationships between Patterns of Cerebrovascular Pressure
Transmission in Head Injured Patients and Experimental Animals.
Four forms of cerebrovascular pressure transmission were observed
in head injured patients (Figure 21).
1. Curve Type 1 (Flat)
In patients, a flat amplitude transfer function was associated with ICP
below 20 mm Hg (mean ICP = 15 mm Hg) and with a negative fundamental
phase shift. The data from the intracranial hypertension group of animals
(Figure 46) demonstrate that a flat amplitude transfer function was found
under craniospinal conditions with ICP less than 15 mm Hg, and was
associated with normal craniospinal compliance and cerebrovascular
resistance. In this group of animals, under baseline physiological
conditions, there was also a negative value of the fundamental phase
shift.
In these experimental studies, due to unavoidable CSF leaks during
cannulation of the CSF space and placement of blood flow electrodes, it
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was necessary to correct for CSF loss. ICP was raised through slow
intraventricular infusion of fluid to a baseline of between 10 and 15 mm
Hg before starting the experimental protocol. As a result, these
experiments may have started with a craniospinal system that was volume
loaded. However, Marmarou (41) reported control values for ICP in cats
of 15 mm Hg, Sullivan (42) and Shapiro (187) reported baseline values of
ICP of 10 mm Hg, and Takizawa (143) found slightly lower mean ICP values
of 8 mm Hg. This data would suggest that an artificially adjusted baseline
ICP of between 10 and 15 mm Hg represents a close approximation to
normal ICP in the cat.
These experimental results would support the hypothesis that the
curve type 1 amplitude transfer function found in patients represents
normal and not, as previously discussed in chapter 2, reduced
cerebrovascular tone. A flat amplitude transfer function indicates equal
transmission of all harmonics of the arterial pressure waveform through
to the CSF space. In contrast to these results, Portnoy et al (82,106)
found an attenuated fundamental harmonic under control conditions. They
attributed this form of pressure transmission to functional autoregulatory
tone of the precapillary cerebral resistance vessels, proposing that the
conversion from an attenuated low frequency transmission to a flat
amplitude transfer function was evidence for loss of arteriolar vasomotor
tone. Portnoy et al (81,82), however, report a mean ICP level in cats of
4 to 5 mm Hg, which is significantly less than those reported by the other
investigators. This difference in ICP level may account for the attenuated
low frequency amplitude transfer function demonstrated in their data
which they describe as representing a functionally normal
cerebrovascular bed. Which in light of their ICP data, may represent the
response for a volume depleted craniospinal system. Furthermore,
cerebral blood flow was not measured, as a means of assessing
autoregulation, in any studies reported by Portnoy and co-workers.
It appears, from these data, that a curve type 1 (flat) amplitude
transfer function may indicate, for an ICP in the range of 10 - 15 mm Hg,
a functionally normal cerebrovascular bed and not, as indicated by
Portnoy, reduced arteriolar vasomotor tone.
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2. Curve Type 2 (Elevated Low Frequency)
In patients, this amplitude transfer function curve type was
characterized by an elevated low frequency pressure transmission which
was most often associated with ICP above 20 mm Hg. It was chiefly the
fundamental that was elevated. Furthermore, compared to curve type 1,
the fundamental phase shift became more negative. In the experimental
work, both the intracranial hypertension group (Figure 46) and arterial
hypercarbia group (Figure 47) demonstrated amplitude transfer functions
with configuration similar to the curve type 2 transfer function found in
patients. However, in the experimental data, the entire amplitude transfer
function increased, although the fundamental always showed much greater
increase than the higher harmonics. Despite this difference, it is likely
that these patterns represent similar forms of cerebrovascular pressure
transmission when it is considered that the curve type 2 transfer
function shows average data from all patients, whereas in the experimental
data, the curves show average data from within single animals.
In the experimental data, the curve type 2 transfer function occurred
with intracranial hypertension (> 20 mm Hg), whether ICP was increased
through intraventricular infusion or through inhalation of 5% C02.
Associated with these changes craniospinal compliance was decreased and,
in the case of the arterial hypercarbia group, cerebrovascular resistance
was usually decreased in conjunction with the fundamental phase shift
becoming more negative. This more negative phase is consistent with an
increase in vascular compliance. This is supported by the work of Ursino
(153,154) who demonstrated, in a mathematical model of the human
cerebrovascular bed, that the ICP pulse amplitude^ is dependent on the
lumped compliance of the arterial and venous segments of the vascular
bed. Ursino's model demonstrated that increased ICP pulse amplitude was
associated with increased vascular compliance.
An increased vascular compliance might result from active vasodilation
or from loss of autoregulatory vasomotor tone. Loss or impairment of
autoregulation does occur widely in head injured adults (175) and
children (176,177). The intracranial hypertension group of animals
demonstrated this form of elevated low frequency pressure transmission
^ICP pulse amplitude is chiefly dependent on the ICP waveform fundamental
harmonic component (78).
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in the absence of functional autoregulation. Although, the arterial
hypercarbia group of animals clearly demonstrated intact C02 reactivity
with 5% C02 administration. However, the relationship between CBF
responsiveness to C02 and autoregulation is unclear. Harper (189) and
Fieschi (171) have reported that loss of autoregulation is often
accompanied by loss of C02 reactivity, although Fieschi reports
paradoxical CBF responses to C02 when autoregulation was impaired.
Tuor (188) has shown in rabbits that impairment of autoregulation is
preceded by reduced CBF responsiveness to C02. In contrast to these
reports, Ekstom-Jodal (191) and Raichle (192) have shown that arterial
hypercarbia itself can impair autoregulation while CBF responsiveness to
C02 was retained. This was not reproduced by Symon (193) who
demonstrated autoregulation was retained during arterial hypercarbia.
In light of these conflicting reports, it remains uncertain whether the
increased low frequency pressure transmission observed clinically and
with the arterial hypercarbia group of animals indicates impaired
autoregulation.
It appears, from these data, that the curve type 2 (elevated low
frequency) form of cerebrovascular pressure transmission seen in
patients is indicative of raised ICP, reduced craniospinal compliance,
reduced arteriolar vasomotor tone and increased vascular compliance.
3. Curve Type 3 (Elevated High Frequency)
In patients, a high proportion of amplitude transfer functions (40%)
demonstrated elevated high frequency harmonics without an associated
increased fundamental. This was mostly associated with an ICP below 20
mm Hg. In the experimental studies, there were no groups of animals that
demonstrated exclusively an elevated high frequency response. However,
in the clinical study, a positive fundamental phase shift was unique to the
amplitude transfer function curve type 3. Experimentally, a positive
phase was exclusively associated with the post arterial hypertension stage
of the arterial hypertension group of animals where ICP had decreased to
below 10 mm Hg, and there was an associated abnormally high craniospinal
compliance. As discussed in the last chapter (page 156), this combination
of factors may indicate a generalized cerebral vasodilation as a
consequence of reduced vasomotor tone.
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Both Kasuga et al (87,88) and Bray et al (89,90) have shown that an
increase in high frequency pressure transmission may indicate the
occurrence of resonance within the craniospinal system. Bray and co¬
workers have shown that the frequency at which resonance occurs
increases with decreased craniospinal compliance as measured by the PVI.
These reports would support the hypothesis that an elevated high
frequency pressure transmission, as seen with the amplitude transfer
function curve type 3, is an indication of the start of a resonant peak in
the transfer function, and its detection is indicative of high intracranial
compliance. A state of reduced compliance, either with or without raised
ICP, will tend to increase the resonant frequency beyond that of the
frequency of the 6th harmonic and hence the level of detection by this
method.
However, a decrease in the resonant frequency does not necessarily
indicate an increased craniospinal compliance. By modelling the
craniospinal system as a second order system, containing both a lumped
compliance and lumped inertance, it can be shown that the resonant
frequency of such a system can decrease through increased compliance
n c
or through increased inertance . The positive phase shift seen with this
form of pressure transmission would indicate that a greatly increased
inertance and not compliance may be the dominant factor determining the
resonant frequency.
It appears, from these data, that the interpretation of this form of
pressure transmission has changed from that discussed in chapter 2. A
curve type 3 amplitude transfer function, despite being associated with
low ICP, may indicate high craniospinal compliance and a generalized
cerebral vasodilation.
4. Curve Type 4 (Elevated Low and High Frequency)
In patients, this group was the smallest in number and most often
associated with ICP raised above 20 mm Hg (Figure 21). Similar to the
curve type 2 transfer function, there was a more negative fundamental
rj c
A second order system will contain two reactive terms: capacitance or
compliance (C) and inductance or inertance (L). The resonant frequency (fo)
of such a system can be calculated from the formula: fo = 1/(2t:^(LC). The
resonant frequency of the system will therefore decrease if either L or C
increases (142).
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phase shift compared to curve type 1. In the experimental studies, there
were no animals that demonstrated an equivalent form of pressure
transmission. However, with the intracranial hypertension group of
animals, the fundamental often increased in combination with all higher
harmonics and was associated with raised ICP, decreased craniospinal
compliance and a negative fundamental phase shift.
It would appear, following on from the previous discussion, that the
curve type 4 amplitude transfer function may indicate decreased
cerebrovascular resistance, increased vascular compliance and decreased
craniospinal compliance.
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B. Recommendations for Future Research
1) The clinical studies described in chapter two, demonstrated clearly
definable patterns of cerebrovascular pressure transmission in head
injured patients. However, the observational design of that study with
waveform sampling only once every 30 minutes, makes it difficult to
comment on the temporal relationships between the observed amplitude
transfer function curve types and raised ICP. Certain forms of
cerebrovascular pressure transmission may be predictive of raised ICP
or of its underlying cause. To investigate this, a further clinical
study is required using on-line minute by minute analysis of
cerebrovascular pressure transmission in head injured patients. Such
a study would ideally measure, concurrently with cerebrovascular
pressure transmission, craniospinal compliance and either
cerebrovascular resistance or flow/metabolism coupling as a means of
identifying autoregulation.
2) The SPR method of measuring craniospinal compliance, was designed
for measuring compliance in the experimental studies in cats, but may,
with some modification of the technique, be applicable clinically. The
method has been shown in both physical and animal models to be less
variable than the VPR method. The automatic nature of the technique
which requires less operator intervention, may reduce the risk of
infection to the patient. Similarly, the smaller volume injection with
the SPR method, which is subsequently withdrawn, should be less
likely to precipitate a secondary rise in ICP. Further developmental
work is needed to design a unit based on a single ventricular access
device which would allow simultaneous pressure pulse application and
recording of the intracranial pressure response. Such a unit, if
feasible, should undergo further experimental validation in animals,
particularly with regard to its safety, before it is tested on patients.
3) The experimental wrork described in chapter four of this thesis
should be extended. The intracranial hypertension group of animals
failed to show functional autoregulation to reduced CPP. Furthermore,
two of the four animals in the arterial hypercarbia group produced
unique compliance responses to inhalation of 10% C02 gas. The data
from these animals turned out to be the most helpful and important
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because a study of cerebrovascular pressure transmission under
conditions of abnormal autoregulation is just as important clinically as
it would be with normal autoregulation. A further study investigating
the relationship between intracranial hypertension, cerebrovascular
pressure transmission, craniospinal compliance and cerebrovascular
resistance should be performed in a group of animals with functional
autoregulation. Additional experiments in the arterial hypercarbia
group should be performed to investigate further the unique
compliance response obtained with 10% C02 administration.
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Appendix A: Derivation of the ICP Pulse vs ICP Relationship
(Adapted from Avezaat and Van Eijndhoven, reference 70)
since VPR = dP/dV, if dV = 1 ml then VPR = dP.
if the steady state volume-pressure relationship can be described by
equation:
P = Peq e E'^e + Po 1)
where: P = ICP
Peq = equilibrium pressure
El = elastic coefficient
Ve = elastic volume (defined as addition to total craniospinal
volume)
Po = constant
when system volume increases by an amount dvb (pulsatile blood volume)
then ICP increases by a pressure increment of dP:
P + dP = Peq e E1'Ve + dvb' + Po 2)
=> P + dP = Peq e E1 Ve e E1 dvb + Po 3)
=> (P - Po) + dP = Peq e EI Ve e E1 dvb 4)
substituting (P - Po) for Peq e E' (see equation 1)
=> (P - Po) + dP = (P-Po) e E1 dvb
since (AB - A) = A(B-l)
5)
=> dP = (P-Po)(e E1 dVb- 1) 6)
equation 6 describes the relationship between the ICP pulse and the
elastic properties of the craniospinal system.
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Appendix B: Systems Analysis and the Fourier Method of Signal Analysis
(Adapted from Stremler, reference 97)
A system can be described as a group of objects or elements that are
combined in a manner intended to achieve a desired object. A signal is
an event that is capable of starting some action. In systems analysis, a
system is characterized by its response to an input signal where a signal
is a single valued function of time. The signals of interest in this study
are real valued signals, that is, signals that have energy or power (which
they must have in order to be measured at all). Although the signals of
interest are all real valued ones, they are often expressed in complex
notation as this form of representation leads to simpler analysis.
Sinusoidal signals play a major role in waveform analysis as they are
periodic signals which can be fully described by a single expression for
all values of time:
f(t) = A cos( wt + 0 ) where: f(t) = sinusoidal signal
A = Amplitude
w = 2rcf (radian frequency)
0 = phase
A more complex signal f(t) can be described approximately in vector
notation:
f(t) * S ( fn 0n ) (t)
rv»t
for n = 1 to a value N which completely describes the signal f(t) at
time (t).
where: 0n is a set of orthogonal functions (functions that act at 90
degrees to one another such as the x and y coordinate axis or sine and
cosine functions) and fn is a set of numbers describing the amplitude of
the component along a given vector axis.
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As an example, it can be shown that the two dimensional vector Aj in the
vector space of orthogonal functions 0j and 0^ can be represented as:
A1 - An 0 J + A j20 2
where: Ajj = ( A1 . 0j )/( 0j . 0 j ) or A1 . ( 0 j / K j)
Kn = ( 0n . 0B )
and Ajj = ( A1 . 0g )/( 0 2 • 0 2) or A1 . ( 0 K 2)
7fiThe principal Dirichlet condition is that a signal has finite energy over
a period tj -> t2 or, as is more often applied, has finite power ie:
!f(t)!2 dt < o (most real valued laboratory signals meet this condition)
Provided a signal represented in vector notation also meets the Dirichlet
conditions, the vector notation described above can be extended by
Parseval's theorem:
C ^\ |f(t)|2 dt = 2 ( JfDj2 ) for n = 1 to <».\ r*\
T v
This theorem demonstrates that a function f(t) can be represented by an
infinite set of mutually orthogonal functions. This is called the
generalized Fourier series representation of f(t):
OO
f(t) = a0 + 2 ( aE cos n w t + bn sin n w t )
<\* 1
for f(t) over the interval (tj -> t2)
where: a0 = 1/( 12 — tj ) \f(t) dt
)+,£
tj ) (f(tan = 2/( 12 — ) cos n w t dt
7fi
The conditions, known as the Dirichlet conditions, for the existence of the
Fourier series representation that will converge on a signal f(t) over the
interval (0,T) are:
1) f(t) has only a finite number of maxima and minima in the interval T;
2) f(t) has only a finite number of finite discontinuities in the interval T;
3) f(t) satisfies the inequality:/!-
(If(t)! dt < tc
•)o
bn = 2/( 12 — tj ) \f(t) sin n w t
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dt
where: w = 2n/( - tj ) = angular frequency and over this interval sin
and cos are orthogonal functions.
This representation can be extended from the interval tj -> tg
for all (t) provided the signal is periodic, that is f(t + T) = f(t), where T
is the period over which the signal repeats itself exactly. Under these
conditions the Fourier series can be expressed:
GO
f(t) = a0 + 2 ( afi cos n w0 t + bn sin n wQ t ) for all (t) where wfl = 2ti/T
and the coefficients are now expx^essed as:
T
a0 = 1/T \f(t) dt
/o
a^ = 2/T ^f(t) cos n wQ t dt
o
rr
bR = 2/T \f(t) sin n wfl t dt
'o
This trigonometric Fourier series can also be expressed more compactly
in polar notation:
oO
f(t) = 2 Cn cos( n w0 t + 0B )
where: Cn = ^ja^ + bn^ Cn is the magnitude of the sinusoid
and 0n = tan"' ( -bn / an ) 6n is the phase of the sinusoid
Expressed in polar notation the relationship between the trigonometric
and exponential Fourier representations can be more readily seen. From
Euler's identity:
ejwot _ cog( w0 t + 0 )
=> f(t) = 2 Fn where: e JW0': is a complex exponential function.
- oO
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The Fourier method of signal analysis lends itself to systems analysis, as
it allows the description of a complex signal as a summation of sinusoidal
components and therefore provides a means of describing a systems
response to a given input signal. Mathematically, a system is a "rule"
used for assigning a function g(t) (the output) to a function f(t) (the
input):
g(t) = H{ f(t) } where H{) is the "rule".
A system is "linear" if the superposition theorem applies:
if gj (t) = H{ fj (t) } and g2 (t) = H{ f2 (t) }
then aj Gj (t) + a2 G2 (t) = H{ aj f j (t) + a 2 f 2(t) )
where aj and a2 are constants.
A system is "time invariant" if a time shift in the input signal results in
the same time shift in the output:
g( t - t0 ) = H{ f( t - t0 ) } for any tQ = time shift.
A fundamental property of a linear time invariant system is that the input
signal f(t) and output signal g(t) are related by linear differential
equations with constant coefficients:
a0 g(t) + aj dg/dt + ... = bQ f(t) + b j df/dt + ...
where a's and b's are constants.
There are advantages to using the complex exponential function e^0*' as
the input signal ( f(t) ) for solving for such a differential equation,
because the complex exponential function repeats itself under the
operation of differentiation. Such a function at the input will yield the
same function at the output multiplied by an algebraic expression in terms
of the differential equation and the input function. Under these
conditions, when the output response is divided by the input signal, the
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original input function cancels and what results is an algebraic equation
which describes the system characteristics. This result is termed the
frequency transfer function H(w):
g(t) = H(w) eJwot
As an example of this, the differential equation for the simple RC circuit
shown above can be solved through summing the currents.
f(t)/R - g(t)/R = ic(t)
=> 1/R( f(t) - g(t) ) = ic(t)
since ic = C (dg/dt)
=> 1/R( f(t) - g(t) ) = C (dg/dt)
=> f(t) - g(t) = RC (dg/dt)
=> f(t) = RC (dg/dt) + g(t)
let f(t) = eJ1<0^
and since for a linear time invariant system:
g(t) = H(w)e,'wo^
=> jwRC H(w)eJwoW Hwe
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=> ejxot _ H(w)e ^^(jwRC + 1)
dividing output by input function e^0*'
=> 1 = ( H(w)e^W0\jwRC + 1) ) / e
solving for H(w)
=> H(w) = 1 / (jwRC + 1)
The frequency transfer function H(w) is therefore independent of the
If an analytical expression for a complex signal is not known, the
frequency transfer function H(w) can be determined through measurement
of the Fourier transform of the input and output signals. Where the
Fourier transform is expressed in complex exponential form:
This permits the input and output signals to be expressed as a series of
complex exponential functions which, because of the nature of complex
exponentials as previously described, alkrws one to relate the input and
output functions of the system by a simple linear relation:
Y(w) = H(w) x X(w)
where X(w) and Y(w) are the Fourier transforms of the input and output
signals respectively. The frequency transfer function H(w) is calculated
simply as:
complex exponential input function eJW0':
(input signal)
(output signal)
H(w) = Y(w) / X(w)
The frequency transfer function H(w) is a complex valued function of
frequency and is usually expressed in polar notation:
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H(w) = !H(w)! eJ0'*' = !Y(w)| / |X(w)| e i 1 6* M " 8x (*• J
where: |X(w)J refers to the modulus or amplitude of the signal
and 0(w) is the phase of the signal
The Fast Fourier Transform algorithm used in this analysis yields the
result in rectilinear notation where each signal is expressed in terms of
real (r) and imaginary (x) terms:
r + jx
The conversion to polar notation is:
The frequency transfer function is then calculated in polar notation where
the amplitude component or amplitude transfer function is:
6(w) = tan"1 ( -X(w) / r („))
i'Y(w)! / !X(w)
and the phase component or phase transfer function is:
ey(w) " 6 x(«)
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Appendix C; Transient Response Analysis of Catheter-Transducer Systems
A catheter-transducer system can be described as a second order
mechanical system and, if underdamped, will oscillate at its own natural
frequency producing significant pressure waveform amplitude and phase
distortion. The degree of distortion will depend on the damping factor
(13) of the system. The figures below show the effect of different amounts
of damping on the relative amplitude and absolute phase of a sine wave
pressure signal as the frequency of the signal approaches the resonant
frequency of the catheter-transducer system. For most purposes it can
be seen that a damping factor of 0.64 (optimal damping) is desirable, as
the amplitude error will be less than 2% for up to two-thirds of the
natural frequency of the system and the phase lag will be approximately
linear over this range. A linear system phase shift will not distort a
waveform but will only cause an overall time delay to the pressure
77
signal".
^Higher frequencies are phase shifted over more of their period than lower
frequencies. Higher frequencies, however, have smaller periods than lower
frequencies, so if the degree of phase shift with frequency is linear, all
frequencies are phase shifted by the same amount in terms of time, which on
summation will cause no waveform distortion but only a time delay.
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The natural frequency and damping properties of a system can be
tested by applying a step or transient pressure to the input of the
system and recording the output pressure response. This transient
response or "pop" test technique will cause the catheter-transducer
system to oscillate at its natural resonant frequency. The resonant
frequency (fo) and damping ((3) can then be calculated, as shown below,
by the method of Hanson (95) through measurement of the pop-test output













Ja 2 . 27T + A
2"7Ttd
As shown overleaf, transient response analysis of the fluid-filled
catheter-transducer system used in these studies has shown that it is
underdamped (B = 0.310 +- 0.021) with a resonant frequency (fo) of 21 Hz.
Two and a half turns of an Acudynamic adjustable damping unit placed
in series with the catheter-transducer system tubing, provided optimal
damping (B = 0.622 +- 0.04). The flat frequency response up to 14 Hz,
with optimal damping, was confirmed through a test of the system
frequency response with a sine-wave pressure generator over a





































































































Appendix D: Flow Chart of the Data Collection Program
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Appendix E: Schematic Diagram of the Waveform Conditioning Amplifier
All operational amplifiers used in this design are BIFET low noise
amplifiers except the for LTC 1062^ low pass filter chip which is a silicon
gate CMOS device. All power is a regulated +- 8 volts DC and decoupled
with 0.01 pF capacitors. The schematic diagram shown below is for a
single channel conditioning amplifier.
UK. This device is a 5th order all pole maximally flat lowpass filter with no DC
error.
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Appendix F: Frequency Analysis of the Waveform Recording System
8 n












Appendix H: Sample Normal Probability and Box and Whisker Plots
In a normal probability plot each observed value is paired with the
expected value from a normal distribution, where the expected value is
calculated from the normal distribution equation based on the number of
samples in the population and the rank order of the value from the
population. If the distribution is normal then the points will fall
approximately onto a straight line. The figure shown below is a
probability plot of the natural log transformation of the fundamental of
the curve type 4 amplitude transfer function group. The points fall on








-3.6 -2.4 -1.2 0
Normal Plot
The Lillifors modification of the Kolmogorov-Smirnov (K-S) test was
calculated as a measure of the goodness of fit of the data to a normal
distribution. The K-S statistic for the data plotted above is 0.1342 with
201 degrees of freedom. This value of the statistic rejects the null
hypothesis that the data is not significantly different from a normal
population. However, with large data sets, it is virtually impossible to
find data that is exactly normal and any goodness of fit test will reject
the null hypothesis. In such instances it is sufficient that the data is
approximately normally distributed (190). Lower values of the K-S
statistic indicate the data is a better fit to the normal distribution. As
can be seen from Table 3, with very few exceptions, the K-S statistic
values fall below 0.1342 indicating that the natural log transformation of






























A simple means of summarizing the distribution of the data is the box
and whisker plot, shown below for the same data as the normal probability
plot. The upper and lower box boundaries represent the 25th and 75th
percentiles, with the median value represented by an asterisk. The
"whiskers" plot the largest and smallest observed values that are not
outliers, where an outlying value is one that is more than 1.5 box-lengths






Box and Whisker Plot
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Appendix I: Derivation of Improved Compliance Method Equation
R Vc
»_AAA /W\AA
T = 1 RC Time Constant
Capacitor charge equation:
Vc = Vp (1 - e _ti/RC) 1)
=> Vc = Vp - Vp e "ti/RC 2)
=> VP ~ vc = VP e "U/RC 3>
=> Ln( Vp - Vc ) = Ln( Vpe ) 4)
=> -Ln( Vp - Vc ) = Ln( Vpe ) 5)
=> -Ln( Vp - Vc ) - LnVp = Ln e ti/RC 6)
=> Ln[ Vp / ( Vp - V£) ] = ti/RC 7)
=> RC = ti / Ln[ Vp / ( Vp - Vc) ] 8)
=> C = { ti / Ln[ Vp / ( Vp - Vc) ] } / R 9)
equation 9) is the improved compliance method equation
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Appendix J: Schematic Diagram of the Pressure Signal and Timing
Conditioning Unit
All power is a regulated +- 5 volts DC and decoupled with 0.01 pF
capacitors. Potentiometer "PI" provides a variable input pulse trigger
amplitude from zero to 2.0 Volts (producing 0 to 200 mm Hg pressure).
Potentiometer "P2" provides a variable input pulse trigger duration from
20 to 1000 msec.
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Appendix K; The Effect of the Pressure Generator Compliance on SPR
Compliance
The speaker diaphragm compliance is in series with the system
compliance and can be described by the following equivalent circuit:
With reference to the above diagram:
let E = pressure generator input pressure
R = injection tubing resistance
T = pressure generator input pressure pulse period
C2 = lumped craniospinal compliance
G1 = pressure generator diaphragm compliance
Vcl = pressure across CI
Vc2 = pressure across C2
Vc(t) = pressure across total compliance at time (t)
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Now Vc2 = Vc(t) (CI) 1)
(C1+C2)
and Vc(t) = E(1 - e "t/R(Cl.C2/C1 + C2) j 2)
For T « R (C1.C2) 3)
(C1+C2)
then Vc(t) » E . t 4)
R (C1.C2)
(C1+C2)
and when t = T, then Vc(T) = E . T 5)
R (C1.C2)
(C1+C2)
=> Vc(T) = ET(C1+C2) 6)
R.C1.C2
=> Vc2(T) = CI . Vc(T) 7)
C1+C2
substituting equation 6) for Vc(T)
=> Vc2(T) = CI ET(C1+C2) 8)
• ~~ ———— —
C1+C2 R.C1.C2
=> Vc2(T) = ET 9)
R.C2
So equation 9 shows that under the condition that:
T « R (C1.C2)
(C1+C2)
then Vc2 (and hence the compliance C2) at time (T) is independent of
the pressure generator diaphragm compliance CI.
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Appendix L: Flow Chart of the Infusion Method Data Collection Program
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dV = CSF Volume Increment
C1 = Lumped Craniospinal Compliance
R2 = Lumped CSF Outflow Resistance
T = Time Required for Pressure Response
to CSF Volume Increment
Method 1
The diagram shown above is a first approximation model of the
craniospinal system consisting of a lumped craniospinal compliance (CI)
and a CSF outflow resistance (R2). It can be seen that the pressure
response to a volume injection (dV) takes time (T) to recover. The time
to recover (T) is approximately equal to five time constants (t), where the
time constant (r) is calculated as the product of CI and R2^.
As shown overleaf, the time to recover (T) after an intraventricular
volume injection of 0.15 ml in a cat with low ICP (8 mm Hg) was 5 minutes
or 300 seconds. This value (T) of 300 seconds represents 5 time constants
(r) which equals 5 x (R2C1). One time constant (r) is therefore one-fifth
of this value or 60 seconds. By substituting the measured value of
craniospinal compliance (CI) into the equality: R2C1 = 60 seconds, the CSF
outflow resistance (R2) can be calculated. The compliance values as
measured by both SPR and VPR methods with low ICP are 0.010 and 0.021
ml/mm Hg respectively. The average compliance value from both methods
gives CI = 0.016 ml/mm Hg and substituting this value into the above
equation yields a CSF outflow resistance (R2) with low ICP of
795In electrical terms, a capacitor (C) in series with a resistance (R) will


























65 mm Hg/ml/min80. This value of R2 is 18 times greater than the SPR
















































































80One R2C1 time constant of 60 seconds with a CI compliance of
0.016 ml/mm Hg gives an outflow resistance R2 of 60/0.016 = 3871 mm Hg/ml/sec.




As shown below, the time to recover (T) after an intraventricular
volume injection of 0.15 ml in a cat with elevated ICP (90 mm Hg) was 3
minutes or 180 seconds. This value (T) of 180 seconds represents 5 time
constants (x) which equals 5 x (R2C1). One time constant (x) is therefore
one-fifth of this value or 36 seconds. By substituting the measured value
of craniospinal compliance (CI) into the equality: R2C1 = 36 seconds, the
CSF outflow resistance (R2) can be calculated. The compliance values as
measured by both SPR and VPR methods with elevated ICP are 0.0020 and
0.0035 ml/mm Hg respectively. The average compliance value from both
methods gives CI = 0.0028 ml/mm Hg and substituting this value into the
above equation yields a CSF outflow resistance (R2) with high ICP of 214
mm Hg/ml/min. This value of R2 is 61 times greater than the SPR method
injection tubing resistance of 3.5 mm Hg/ml/min.
P2 Ppn ^ K Po = 90 mmHg
\[> Pp = 133 mmHg







C = dV/dP =>
0.15 mls/43 mmHg — 0.0035 mls/mmHg
SPR Method Output Function
31.3 mmHg Pressure Response
C = 0.0020 mls/mmHg
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Method 2
Marmarou (41) derived an equation for calculation of the CSF outflow















Ro = CSF Outflow Resistance
PVI = Pressire Volume Index
t2 = time point on decay portion of response
Po = Initial ICP
Pp = Peak ICP
P2 = ICP at time t2 (usually 1 minute)
The table below substitutes the measured values of t2, Po, PVI, P2 and
Pp from the volume-pressure responses at both low and elevated ICP in
Marmarou's equation for calculation of CSF outflow resistance R2. This
method yields outflow resistance values at low and elevated ICP of 79 and
104 mm Hg/ml/min respectively. These values are 22 and 30 times greater
in value than the SPR method injection tubing resistance of
3.5 mm Hg/ml/min.
Parameter Value
ICP = 8 ICP = 9 0
t2 (min) 1 1
Po (mmHg) 8 89
PVI (mis) 0.549 0.844
P2 (mmHg) 1 1.5 92
Pp (mmHg) 15 134
Ro (mmHg/ml/min) 78.5 104.1
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Appendix N: Hydrogen Clearance Cerebral Blood Flow Method
Hydrogen gas meets most of the criteria for an ideal blood flow tracer:
a) metabolically inert;
b) not normally present in body tissues;
c) dissolves readily in lipids and diffuses rapidly in tissue (penetrates
nervous tissue well);
d) low water:gas partition coefficient (0.018) (rapidly removed from
arterial blood in pulmonary circulation).
Hydrogen can be readily measured through placement of platinum
electrodes in brain tissue where the current produced by a platinum
electrode when accepting the electrons generated by oxidation of
hydrogen gas correlates to local tissue H2 gas concentration:
H2 -> 2H* + 2e" I = nFD ( C )
L
where:
I = current density per unit area per unit time
n = number of electrons transferred by each molecule
of hydrogen gas
F = Faraday's number (6.02 x 10^)
D = diffusion coefficient for hydrogen in the
tissue
L = distance between bulk hydrogen concentration and
platinum electrode tip
C = the hydrogen concentration in the bulk tissue
Polarizing the hydrogen electrode positive relative to a silver-silver
chloride reference electrode makes the electrode more selective for
hydrogen gas.
The Hydrogen Clearance technique, like other clearance techniques, is
based on the principle of conservation of mass. As shown overleaf, if a
tracer is injected into tissue then the tracer entering must either be





Fi —» Cu —>
\1/ \l/
Tracer Taken Up dQ-j/dt
Tracer In Tracer Out
Fick was the first to use this principle to measure cardiac output





F^ = tissue flow
Cy = Concentration of tracer
leaving tissue
C& = Concentration of tracer
entering tissue
dQ^/dt = Quantity of tracer
removed by tissue
per unit time (t)
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The Hydrogen Clearance blood flow clearance equation can be derived
directly from Fick's equation.
first define:
a) Concentration = Quantity/Volume C = Q/V (grams/ml)
b) Flow = Volume/Time F = V/T (ml/min)
c) Quantity/Time = Flow times Concentration since
V Q Q
TV T
d) let quantity per unit time = dQ/dt
e) define tissue volume (V^) to include the vascular
space and assume the tracer achieves instantaneous
equilibrium between the vascular volume and tissue
volume with a partition coefficient of y^ between
blood and brain tissue
f) define:
F^ = tissue flow
Fa = arterial inflow to tissue
Fy = venous outflow from tissue
Cy = Concentration of tracer leaving tissue
Ca = Concentration of tracer entering tissue
dQ^/dt = Quantity of tracer removed by tissue
per unit time (t)
dQ£/dt = Quantity of tracer present in the
tissue arterial blood supply per
unit time (t)
dQy/dt = Quantity of tracer present in the
tissue venous blood supply per unit
time (t)
y^ = Partition coefficient of tracer
between blood and brain
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dQj/dt = Fj(Ca-C^ Starting with Fick's eqtn. 1)
divide equation 1) throughout by the tissue volume taking
into account the partition coefficient of the tracer
ie. Ci = y^Ca - y^Cv
(dQi/Vi)/dt= Fi (C4-C^ 2)
yjVi
since concentration = quantity/volume
equation 2) becomes:
dq/dt = Fi (ca - Cy) 3)
yivi
assume that, when the tissue is fully saturated with the
tracer and has had time to equilibrate between the vascular
and tissue compartments:
Ci = yi * Cy (Zuntz assumption) 4)
Zuntz assumption is that venous blood from a tissue is in
equilibrium with the tissue itself with respect to inert gas
hence eqtn. 4) can be rearranged:
Cv = Ci/yi 5)
substituting eqtn. 5) for Cv in eqtn. 3):
dC/dt = Fj (C4- Cj) 6)
yivi yi
this can be rearranged to give:
dc/dt = Fi (yjCa- C j) 7)
yiVi
and further rearranged to give:
dC/dt = -Fi (Ci - y p ^ 8)
7ivi
further take the case where the tissue compartment
is fully saturated with tracer and the arterial
concentration of the tracer has fallen to zero
eqtn. 8) becomes:




eqtn. 9) can be rearranged to:
dq/dt = -k(Ci)
eqtn. 10) can be integrated into:
eqtn. 11) is the hydrogen clearance eqtn:
where: qmis the concentration of tracer in tissue
at time (t)
C1Q is the initial concentration of tracer
at time t = 0
k k = Fj
yiVi
where:
F^ = flow through tissue of tracer
y^ = partition coefficient of tracer
between blood and brain tissue
q = tissue volume which includes
vascular volume
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since y; for hydrogen gas is thought to be approximately
1.0 for brain tissue then k approximates tissue blood flow
expressed as ml/100 grams/min, volume is expressed as grams
on the assumption that the density of brain tissue is
approximately 1.0
Ci(t) ~ C io e ^ 11)
Taking the natural logarithm of both sides of eqtn. 11)
yields:
In = In C|0~ kt 12)
=> Y = b + mX
eqtn. 12) is a linear eqtn. of form y = b + mx
By plotting the natural logarithm of the tissue hydrogen concentration
against time, the slope of the line (k) is equal to the tissue blood flow.
To calculate the blood flow it is necessary only to measure the tissue












Most experimental hydrogen clearance curves are biexponential rather
than monoexponential which indicates that two tissue compartments with
different flow rates are present (assumed to be grey and white matter
flow). The flow and the relative weight of both compartments can be
calculated as shown below.
- C(t) = Wg Cg (t) + ww cw (t)
where:
C(t) = total concentration of hydrogen in tissue at time (t)
Cg and Cw = grey and white matter tissue hydrogen concentration
at time (t)
Wg and Ww = relative amounts of grey and white matter tissue
compartments sensed by hydrogen electrode
- w( = V <V <>»* E»
where:
Ig and Iw = initial concentrations of hydrogen in grey and white
matter tissue at onset of desaturation
R = correction factor for differences in rate of saturation of the
two compartments
R = 1 for fully saturated tissue
1 min
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Advantages of Hydrogen Clearance Method:
a) Flow can be determined in any tissue where a small platinum electrode
can be inserted.
b) Multiple flow determinations from the same tissue over long periods of
time can be obtained:
- flows every 15 minutes
- ideal for testing C02 reactivity or
autoregulation.
c) It is one of the most inexpensive blood flow techniques to maintain.
Limitations of the Hydrogen Clearance Method
a) Despite the small size of electrodes some local tissue damage and
compression may occur, and decreased flow or hyperaemia may result.
The electrolytic etching of platinum electrodes to a sharp point can
minimize the amount of tissue damage and compression.
b) Bicompartmental analysis is not without difficulties,
particularly concerning the assumptions made about the partition
coefficients from blood to grey or white matter, especially during
ischaemia. To overcome this, most investigators standardize on the
initial slope technique whereby, regardless of the presence of a second
exponential component, the slope of the initial 1-2 minutes of the
clearance curve is chosen for analysis. The initial slope index shows
a good correlation to the weighted mean flow as calculated from
bicompartmental analysis.
c) The vascular and tissue compartments are not always fully saturated
with the tracer prior to clearance. Sufficient time must elapse for
tissue saturation especially at low flows.
d) The arterial concentration of hydrogen does not fall immediately to
zero during the first pass through the lungs. To overcome this, most
investigators ignore the first 20 - 30 seconds of hydrogen clearance
on the grounds that it is contaminated by arterial recirculation of H2.
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e) The animals must be anaesthetised during measurement of blood flow
because of the invasive nature of this technique, so compounding
effects of the anaesthetic agents on the blood flow physiology must
be considered.
f) Controversy still exists concerning the size of the tissue volume being
sampled during hydrogen clearance; conservative estimates put the
sample volume at 1.5 mm.
g) The sample volume will be dependent on the electrode dimensions,
which vary from laboratory to laboratory, making the comparison of
flow values difficult.
Electrode Etching Technique (Adapted from Farrar (157))
As shown overleaf, one inch length segments of 200 micron platinum
wire are cut and held at an angle of 15 degrees to the vertical by small
clips attached to a circular copper disc. The disc is rotated using a DC
motor at a constant rate of 1 revolution per 5 seconds in a solution of 15%
NaCN and 15% NaOH. The platinum wires are positioned in the clips so
that each wire penetrates the etching solution by an equal amount
(approximately 2 mm). The wires are rotated in the solution for 5 to 6
minutes while a 25 volt AC current is applied (peak current 1 Amp)
between the platinum wire and a carbon rod reference electrode^' placed
in the etching solution. This process produces platinum wire tip
diameters of between 10 and 20 microns tapering back over 1.5 mm to a
base diameter of 100 microns.
The day before an experiment, electrodes are washed (15 minutes) in
a solution containing 10% nitric acid and 30% hydrochloric acid which
increases the active sites on the platinum surface, and then washed in
distilled water. Insulation to the bared tip (1.5 mm) is provided by a set
of telescoping polyethylene tubes. To provide electrical contact with the
01
Taken from a battery.
^Portex Ltd., Hythe, UK. Polyethylene tubing nos: 800/100/240/100,
800/100/160/100, 800/100/100/100.
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platinum, a 5 cm tinned copper wire"'® is pushed between the etched
platinum wire and the PE tubing. The insulating tubing is attached using
fast drying epoxy under a dissecting microscope. This also allows
measurement of the length of the tip exposed for cortical penetration.
DC SERVO MOTOR SYSTEM
81 24 SWG tinned copper wire. Stock no. 355-085, RS-Components Ltd., Corby,
UK.
Appendix O: Flow Chart of H2 Clearance CBF Program
